The following are a collection of articles citing our products. Ansh Labs does not claim or endorse any clinical applications that may be stated or implied in the articles. These articles are provided to show that our products are well validated and trusted by the scientific community. We only support the Intended Use that is included in each product’s IFU.

 

Last Updated: Oct 17, 2024

 

ANTIBODIES*****

 

Activin and Inhibin Antibodies

Brûlé E, Wang Y, Li Y, Lin YF, Zhou X, Ongaro L, Alonso CAI, Buddle ERS, Schneyer AL, Byeon CH, Hinck CS, Mendelev N, Russell JP, Cowan M, Boehm U, Ruf-Zamojski F, Zamojski M, Andoniadou CL, Sealfon SC, Harrison CA, Walton KL, Hinck AP, Bernard DJ. TGFBR3L is an inhibin B co-receptor that regulates female fertility. Sci Adv. 2021 Dec 17;7(51):eabl4391. doi: 10.1126/sciadv.abl4391. Epub 2021 Dec 15. PMID: 34910520; PMCID: PMC8673766.

All Products Cited: Inhibin and Activin Antibodies

 

Conover CA, Bale LK, Frye RL, Schaff HV. Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes. Physiol Rep. 2019;7(4):e14006. doi:10.14814/phy2.14006

All Products Cited: Inhibin and Activin Antibodies

 

Jana A, Krett NL, Guzman G, Khalid A, Ozden O, Staudacher JJ, et al. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017;8(23):37377-37393. doi:10.18632/oncotarget.17178.

All Products Cited: Inhibin and Activin Antibodies

 

Jana A, Das A, Krett NL, Guzman G, Thomas A, Mancinelli G, Bauer J, Ushio-Fukai M, Fukai T, Jung B. . Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer. PLoS One. 2020 Jan 21;15(1):e0227916. doi: 10.1371/journal.pone.0227916

All Products Cited: Inhibin and Activin Antibodies

 

Lambert-Messerlian G, Steinhoff M, Kumar A, Eklund EE, Moore R. Comparison of Inhibin Alpha Subunit and Antimüllerian Hormone Immunoreactivity in Granulosa Cell and Mucinous Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):71-77.

All Products Cited: Inhibin and Activin Antibodies; AMH antibodies; Inhibin (Total) ELISA AL-134; AMH ELISA AL-105

 

Lilja-Maula L, Syrja P, Laurila HP, Sutinen E, Palviainen M, Ritvos O, Koli K, Rajamaki MM, Myllarniemi M., Koli K, Rajamaki MM, Myllarniemi M. Upregulation of Alveolar Levels of Activin B, but not Activin A, in Lungs of West Highland White Terriers with Idiopathic Pulmonary Fibrosis and Diffuse Alveolar Damage. J. Comp. Path. 2015, Vol. 152, 192e200

All Products Cited: Inhibin and Activin Antibodies

 

Mancinelli G, Torres C, Krett N, Bauer J, Castellanos K, McKinney R, Dawson D, Guzman G, Hwang R, Grimaldo S, Grippo P, Jung B. . Role of stromal activin A in human pancreatic cancer and metastasis in mice. Sci Rep . 2021 Apr 12;11(1):7986. doi: 10.1038/s41598-021-87213-y

All Products Cited: Inhibin and Activin Antibodies

 

Myllarniemi M et.al. Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models. BMC Pulm Med. 2014 Nov 1;14:170. PMID 25361680

All Products Cited: Inhibin and Activin Antibodies

 

Staudacher JJ, Arnold A, Kühl AA, Pötzsch M, Daum S, Winterfeld M, Berg E, Hummel M, Rau B, Stein U, Treese C. Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas. BMC Cancer. 2022;22(953):1-10. doi:10.1186/s12885-022-10016-5.

All Products Cited: Inhibin and Activin Antibodies

 

Tamminen JA et.al. Overexpression of activin-A and -B in malignant mesothelioma – attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Exp Cell Res. 2015 Mar 1;332(1):102-15 PMID 25557874

All Products Cited: Inhibin and Activin Antibodies

 

Thomas AL, Castellanos K, Mancinelli G, Xia Y, Bauer J, Yazici C, Fantuzzi G, Hwang RF, Krett NL, Papachristou GI, Whitcomb DC, Jung B. Activin A Modulat+-es Inflammation in Acute Pancreatitis and Strongly Predicts Severe Disease Independent of Body Mass Index. Clin Transl Gastroenterol . 2020 May;11(5):e00152. doi: 10.14309/ctg.0000000000000152

All Products Cited: Inhibin and Activin Antibodies

 

Wang Y, Hamang M, Culver A, Jiang H, Yanum J, Garcia V, Lee J, White E, Kusumanchi P, Chalasani N, Liangpunsakul S, Yaden BC, Dai G. Activin B promotes the initiation and progression of liver fibrosis. Hepatol Commun. 2022 Oct;6(10):2812-2826. doi: 10.1002/hep4.2037. Epub 2022 Jul 22. PMID: 35866567; PMCID: PMC9512478.

All Products Cited: Activin B ELISA AL-150; Inhibin and Activin Antibodies

 

Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, et al. Non-canonical Activin A signaling stimulates context-dependent and cellular-specific outcomes in CRC to promote tumor cell migration and immune tolerance. Cancers (Basel). 2023;15(3003):1-19. doi:10.3390/cancers15113003.

All Products Cited: Inhibin and Activin Antibodies

 

Wiley MB, Bauer J, Alvarez V, Mehrotra K, Cheng W, Kolics Z, Giarrizzo M, Ingle K, Bialkowska AB, Jung B. Activin A signaling stimulates neutrophil activation and macrophage migration in pancreatitis. Sci Rep. 2024;14(9382):1-12. doi:10.1038/s41598-024-60065-y.

All Products Cited: Inhibin and Activin Antibodies

 

AMH Antibodies

Bøtkjær JA, Jeppesen JV, Wissing ML, Kløverpris S, Oxvig C, Mason JI, Borgbo T, Andersen CY. Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels. Fertil Steril. 2015 Nov;104(5):1294-301.e1. doi: 10.1016/j.fertnstert.2015.07.1152. Epub 2015 Aug 18. PMID: 26297643.

All Products Cited: PAPP-A (pico) ELISA AL-101; AMH Antibodies

 

Chen C, Alfego D, Chun KY. SUN-446 – Analysis of Over 2.2 Million Anti-Mullerian Hormone Patient Results Across Lifespan From Birth to Over 80 Years Using a Lab Developed Chemiluminescent Immunoassay. Poster Session presented at the Annual Endocrine Society Meeting; 2024; June 1-4; Boston, MA

All Products Cited: AMH Antibodies

 

Heather J. Goux, Binh V. Vu, Katherine Wasden, Kannan Alpadi, Ajay Kumar, Bhanu Kalra, Gopal Savjani, Kristen Brosamer, Katerina Kourentzi, Richard C. Willson. Development of a quantitative fluorescence lateral flow immunoassay (LFIA) prototype for point-of-need detection of anti-Müllerian hormone. Practical Laboratory Medicine, Volume 35, 2023, https://doi.org/10.1016/j.plabm.2023.e00314.

All Products Cited: AMH Antibodies

 

Lambert-Messerlian G, Steinhoff M, Kumar A, Eklund EE, Moore R. Comparison of Inhibin Alpha Subunit and Antimüllerian Hormone Immunoreactivity in Granulosa Cell and Mucinous Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):71-77.

All Products Cited: Inhibin and Activin Antibodies; AMH antibodies; Inhibin (Total) ELISA AL-134; AMH ELISA AL-105

 

Li Y, Li X, Yang X, Cai S, Lu G, Lin G, Humaidan P, Gong F. Cumulative live birth rates in low prognosis patients according to the POSEIDON criteria: an analysis of 26,697 cycles of in vitro fertilization/intracytoplasmic sperm injection. Front Endocrinol (Lausanne). 2019;10:642. doi:10.3389/fendo.2019.00642.

All Products Cited: AMH Antibodies

 

Mamsen LS, Bøtkjær JA, Kristensen SG, Pors SE, Jeppesen JV, Kumar A, Kalra B, Ernst E, Andersen CY. High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles. Front Endocrinol (Lausanne). 2021 Mar 2;12:617523. doi: 10.3389/fendo.2021.617523. PMID: 33737910; PMCID: PMC7961079

All Products Cited: AMH Antibodies; AMH ELISA AL-105

 

Mamsen LS, Kelsey TW, Ernst E, Macklon KT, Lund AM, Andersen CY. Cryopreservation of ovarian tissue may be considered in young girls with galactosemia. J Assist Reprod Genet. 2018 May 26.

All Products Cited: AMH Antibodies; GDF-9 Antibodies; BMP-15 Antibodies

 

Mamsen LS, Petersen TS, Jeppesen JV, Mollgard K, Grondahl ML, Larsen A, Ernst E, Oxvig C, Kumar A, Kalra B, Andersen CY. Proteolytic processing of anti-Mullerian hormone differs between human fetal testes and adult ovaries. Molecular Human Reproduction, 2015 21 (7): 571-582. Epub ahead of print, April 18, 2015

All Products Cited: AMH Antibodies

 

BMP-15 Antibodies
Cadenas J, Pors SE, Kumar A, Kalra B, Kristensen SG, Andersen CY, Mamsen LS. Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. Reprod Biol Endocrinol. 2022;20(126):1-10. doi:10.1186/s12958-022-01000-6(917).

All Products Cited: GDF-9 antibodies AB-325-x; BMP-15 antibodies AB-324-x; GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181

 

Mamsen LS, Kelsey TW, Ernst E, Macklon KT, Lund AM, Andersen CY. Cryopreservation of ovarian tissue may be considered in young girls with galactosemia. J Assist Reprod Genet. 2018 May 26.

All Products Cited: AMH Antibodies; GDF-9 Antibodies; BMP-15 Antibodies

 

Mamsen LS, Kristensen SG, Pors SE, Bøtkjær JA, Ernst E, Macklon KT, Gook D, Kumar A, Kalra B, Andersen CY. Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved. Front Endocrinol (Lausanne). 2021 Jan 15;11:593718. doi: 10.3389/fendo.2020.593718. PMID: 33519708; PMCID: PMC7844814

All Products Cited: GDF-9 Antibodies; BMP-15 Antibodies

 

Follistatin Antibodies

Myllarniemi M et.al. Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models. BMC Pulm Med. 2014 Nov 1;14:170. PMID 25361680

All Products Cited: Follistatin Antibodies AB-305-AI063; AB-306-AI0005; AB-307-AF002

 

Tamminen JA et.al. Overexpression of activin-A and -B in malignant mesothelioma – attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Exp Cell Res. 2015 Mar 1;332(1):102-15 PMID 25557874

All Products Cited: AB-305-AI063; AB-306-AI0005; AB-307-AF002; AB-307-AF006

 

Tamminen JA et.al. Overexpression of activin-A and -B in malignant mesothelioma – attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Exp Cell Res. 2015 Mar 1;332(1):102-15 PMID 25557874

All Products Cited: AB-305-AI063; AB-306-AI0005; AB-307-AF002; AB-307-AF006

 

Wang X, Fischer G, Hyvonen M. Structure and activation of pro-activin A. Nature Communications, 7, 12052 (2016)

All Products Cited: Follistatin mAB AB-307-AF002

 

GDF-15 Antibodies

Fejzo M, Rocha N, Cimino I, Lockhart SM, Petry CJ, Kay RG, Burling K, Barker P, George AL, Yasara N, Premawardhena A, Gong S, Cook E, Rimmington D, Rainbow K, Withers DJ, Cortessis V, Mullin PM, MacGibbon KW, Jin E, Kam A, Campbell A, Polasek O, Tzoneva G, Gribble FM, Yeo GSH, Lam BYH, Saudek V, Hughes IA, Ong KK, Perry JRB, Sutton Cole A, Baumgarten M, Welsh P, Sattar N, Smith GCS, Charnock-Jones DS, Coll AP, Meek CL, Mettananda S, Hayward C, Mancuso N, O’Rahilly S. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06921-9. Epub ahead of print. PMID: 38092039.

All Products Cited: GDF-15 Antibodies; GDF-15 (H-Specific) ELISA AL-1018

 

Cadenas J, Pors SE, Kumar A, Kalra B, Kristensen SG, Andersen CY, Mamsen LS. Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. Reprod Biol Endocrinol. 2022;20(126):1-10. doi:10.1186/s12958-022-01000-6(917).

All Products Cited: GDF-9 antibodies AB-325-x; BMP-15 antibodies AB-324-x; GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181

 

GDF-9 Antibodies

Mamsen LS, Kelsey TW, Ernst E, Macklon KT, Lund AM, Andersen CY. Cryopreservation of ovarian tissue may be considered in young girls with galactosemia. J Assist Reprod Genet. 2018 May 26.

All Products Cited: AMH Antibodies; GDF-9 Antibodies; BMP-15 Antibodies

 

Mamsen LS, Kristensen SG, Pors SE, Bøtkjær JA, Ernst E, Macklon KT, Gook D, Kumar A, Kalra B, Andersen CY. Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved. Front Endocrinol (Lausanne). 2021 Jan 15;11:593718. doi: 10.3389/fendo.2020.593718. PMID: 33519708; PMCID: PMC7844814

All Products Cited: GDF-9 Antibodies; BMP-15 Antibodies

 

Moghassemi S, Dadashzadeh A, Camboni A, Feron O, Azevedo RB, Amorim CA. Ex vivo purging of cancer cells from ovarian tissue using photodynamic therapy: a novel strategy to restore fertility in leukemia patients. Hum Reprod Open. 2023;2023(2). doi:10.1093/hropen/hoad005.

All Products Cited: GDF-9 Antibodies AB-325-AG012

 

IGFBP-2 Antibodies
Bieghs L, Brohus M, Kristensen IB, Abildgaard N, Bøgsted M, Johnsen HE, et al. Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients. PLoS ONE 11(4): e0154256. 2016 April 25

All Products Cited: IGFBP-2 Antibodies

 

Tang Z, Gillatt D, Rowe E, Koupparis A, Holly JMP, Perks CM. IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells. Oncotarget. 2019 Dec 17;10(66):7043-7057. doi: 10.18632/oncotarget.27355. PMID: 31903164; PMCID: PMC6925026.

All Products Cited: IGFBP-2 Antibodies

 

Oxyntomodulin Antibodies

Fothergill LJ, Ringuet MT, Sioras E, Hunne B, Fazio Coles TE, Martins PR, Furness JB. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat. Cell Tissue Res. 2019 Feb;375(2):359-369.

All Products Cited: Oxyntomodulin ELISA AL-139; Oxyntomodulin antibody AB-323-AO010

 

PAPP-A Antibodies

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; Rat / Mouse IGF-I ELISA AL-137; PAPP-A Neutralizing Antibodies

 

Heitzeneder S, Sotillo E, Shern JF, Sindiri S, Xu P, Jones R, Pollak M, Noer PR, Lorette J, Fazli L, Alag A, Meltzer P, Lau C, Conover CA, Oxvig C, Sorensen PH, Maris JM, Khan J, Mackall CL. Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion. J Natl Cancer Inst. 2019 Sep 1;111(9):970-982. doi: 10.1093/jnci/djy209. PMID: 30698726; PMCID: PMC6748813

All Products Cited: PAPP-A Neutralizing Antibodies

 

Kashyap S, Hein KZ, Chini CC, Lika J, Warner GM, Bale LK, Torres VE, Harris PC, Oxvig C, Conover CA, Chini EN. Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. JCI Insight. 2020 Feb 27;5(4):e135700. doi: 10.1172/jci.insight.135700. PMID: 31990681; PMCID: PMC7101148.

All Products Cited: PAPP-A Neutralizing Antibodies; PAPP-A (pico) ELISA AL-101

 

Torres D, Hou X, Bale L, Heinzen EP, Maurer MJ, Zanfagnin V, Oberg AL, Conover C, Weroha SJ. . Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A. PLoS One. 2019 Nov 21;14(11):e0224564. doi: 10.1371/journal.pone.0224564

All Products Cited: PAPP-A Neutralizing Antibodies; PAPP-A (pico) ELISA AL-101

 

Antigens

Activin A Antigens
Bakrania BA, Palei AC, Bhattarai U, Chen Y, Granger JP, Shahul S. Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction. Cells. 2022 Feb 21;11(4):742. doi: 10.3390/cells11040742. PMID: 35203391; PMCID: PMC8870359.

All Products Cited: Activin A ELISA AL-110; Activin A Antigens

 

AMH Antigens

Themmen APN, Kalra B, Visser JA, Kumar A, Savjani G, Gier J, Jaques S. The use of anti-Müllerian hormone as diagnostic for gonadectomy status in dogs. Theriogenology 86 (2016) 1467–1474.

All Products Cited: AMH (Canine/Feline) ELISA AL-116; AMH Antigen AG-303-BA047

 

IMMUNOASSAYS***

 

Activin A
Activin A ELISA AL-110
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Bakrania BA, Palei AC, Bhattarai U, Chen Y, Granger JP, Shahul S. Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction. Cells. 2022 Feb 21;11(4):742. doi: 10.3390/cells11040742. PMID: 35203391; PMCID: PMC8870359.

All Products Cited: Activin A ELISA AL-110; Activin A Antigens

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Ciampa E, Li Y, Dillon S, Lecarpentier E, Sorabella L, Libermann TA, Karumanchi SA, Hess PE. Cerebrospinal Fluid Protein Changes in Preeclampsia. Hypertension. 2018 Jul;72(1):219-226. doi: 10.1161/HYPERTENSIONAHA.118.11153. Epub 2018 May 29. PMID: 29844151.

All Products Cited: Activin A ELISA AL-110

 

deMartelly VA, Dreixler J, Tung A, Mueller A, Heimberger S, Fazal AA, Naseem H, Lang R, Kruse E, Yamat M, Granger JP, Bakrania BA, Rodriguez-Kovacs J, Rana S, Shahul S. Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia. J Am Heart Assoc. 2021 Feb;10(5):e018526. doi: 10.1161/JAHA.120.018526

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A. Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kim SY, Ebbert K, Cordeiro MH, Romero MM, Whelan KA, Suarez AA, Woodruff TK, Kurita T. Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors. Cancer Res. 2016 Jul 1;76(13):3851-61

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Luan Y, Zhang Y, Yu SY, You M, Xu PC, Chung S, Kurita T, Zhu J, Kim SY. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study. J Cachexia Sarcopenia Muscle. 2022;13(1289–1301). doi:10.1002/jcsm.12864.

All Products Cited: Activin A ELISA AL-110

 

Metallinou D, Karampas G, Lazarou E, Iacovidou N, Pervanidou P, Lykeridou K, Mastorakos G, Rizos D. Serum Activin A as Brain Injury Biomarker in the First Three Days of Life. A Prospective Case—Control Longitudinal Study in Human Premature Neonates. Brain Sci. 2021, 11, 1243. https://doi.org/10.3390/brainsci11091243

All Products Cited: Activin A ELISA AL-110

 

Naseem H, Dreixler J, Mueller A, Tung A, Dhir R, Chibber R, Fazal A, Granger JP, Bakrania BA, deMartelly V, Rana S, Shahul S. Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 Jun 16;9(12):e015997. doi: 10.1161/JAHA.119.015997. Epub 2020 Jun 4. PMID: 32495688; PMCID: PMC7429043.

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117, Follistatin-Like 3 ELISA AL-152

 

Paajanen J, Ilonen I, Lauri H, Järvinen T, Sutinen E, Ollila H, Rouvinen E, Lemström K, Räsänen J, Ritvos O, Koli K, Myllärniemi M. Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30287-6. doi: 10.1016/j.cllc.2019.10.013. [Epub ahead of print]

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Palin NK, Savikko J, Pasternack A, Rintala JM, Kalra B, Mistry S, Kumar A, Roth MP, Helin H, Ritvos O. Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study. Transpl Int. 2017 Jan;30(1):96-107. doi: 10.1111/tri.12876. Epub 2016 Nov 23. PMID: 27732750.

All Products Cited: Activin B (Mouse) ELISA AL-156; Activin A ELISA AL-110

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Short-term treatment with high dose liraglutide improves lipid and lipoprotein profle and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-…. Peradze et al. Cardiovasc Diabetol (2019) 18:141 https://doi.org/10.1186/s12933-019-0945-7

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Activin B ELISA AL-150; Follistatin ELISA AL-117;
Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Chen J, Ghaly W, Vamvini MT, Mantzoros CS. Effects of oral and intravenous lipid administration on hormones affecting energy balance. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Oxyntomodulin ELISA AL-139

 

Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, Ghaly W, Mantzoros CS. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3890-3899.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-like 3 ELISA AL-152

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function. Metabolism. 2018 May 9. pii: S0026-0495(18)30120-3.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Mantzoros CS. Leptin-dependent and leptin-independent pathways linking energy sufficiency with reproduction. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Roh JD, Castro C, Yu A, Rana S, Shahul S, Gray KJ, Honigberg MC, Ricke-Hoch M, Iwamoto Y, Yeri A, Kitchen R, Guerra JB, Hobson R, Chaudhari V, Chang B, Sarma A, Lerchenmüller C, Al Sayed ZR, Diaz Verdugo C, Xia P, Skarbianskis N, Zeisel A, Bauersachs J, Kirkland JL, Karumanchi SA, Gorcsan J 3rd, Sugahara M, Damp J, Hanley-Yanez K, Ellinor PT, Arany Z, McNamara DM; IPAC Investigators; Hilfiker-Kleiner D, Rosenzweig A. Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human. Sci Transl Med. 2024 Apr 17;16(743):eadi0077. doi: 10.1126/scitranslmed.adi0077. Epub 2024 Apr 17. PMID: 38630848; PMCID: PMC11331492.

All Products Cited: Activin A ELISA AL-110; Follistatin Like-3 ELISA AL-152

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Shahul S, Ramadan H, Nizamuddin J, Mueller A, Patel V, Dreixler J, Tung A, Lang RM, Weinert L, Nasim R, Chinthala S, Rana S. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 Jul;72(1):188-193. doi: 10.1161/HYPERTENSIONAHA.118.10888. Epub 2018 May 29. PMID: 29844146.

All Products Cited: Activin A ELISA AL-110

 

Skory R, Xu Y, Shea L, Woodruff T. Engineering the ovarian cycle using in vitro follicle culture. Human Reproduction 2015 Mar 16 Epub ahead of print.

All Products Cited: Activin A ELISA AL-110

 

Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, Gavriil A, Tsigalou C, Tziolos NR, Sertaridou E, Kalra B, Kumar A, Rafailidis P, Pasternack A, Boumpas DT, Germanidis G, Ritvos O, Metallidis S, Skendros P, Sideras P. The Activin/Follistatin-axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality. J Infect Dis. 2021 Feb 24:jiab108. doi: 10.1093/infdis/jiab108. Epub ahead of print. PMID: 33625513; PMCID: PMC7928794

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) AL-122

 

Xu PC, You M, Yu SY, Luan Y, Eldani M, Caffrey TC, Grandgenett PM, O’Connell KA, Shukla SK, Kattamuri C, Hollingsworth MA, Singh PK, Thompson TB, Chung S, Kim SY. Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022;12(1659):1-13. doi:10.1038/s41598-022-05660-7.

All Products Cited: Activin A ELISA AL-110

 

Yu SY, Luan Y, Tang S, Abazarikia A, Dong R, Caffrey TC, Hollingsworth MA, Oupicky D, Kim SY. Uncovering tumor-promoting roles of Activin A in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2023;10(2207010):1-13. doi:10.1002/advs.202207010.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123

 

Activin AB
Activin AB ELISA AL-153
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A . Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Short-term treatment with high dose liraglutide improves lipid and lipoprotein profle and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-…. Peradze et al. Cardiovasc Diabetol (2019) 18:141 https://doi.org/10.1186/s12933-019-0945-7

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Activin B ELISA AL-150; Follistatin ELISA AL-117;
Follistatin-Like 3 ELISA AL-152

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Activin B
Activin B (Mouse) ELISA AL-156
Palin NK, Savikko J, Pasternack A, Rintala JM, Kalra B, Mistry S, Kumar A, Roth MP, Helin H, Ritvos O. Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study. Transpl Int. 2017 Jan;30(1):96-107. doi: 10.1111/tri.12876. Epub 2016 Nov 23. PMID: 27732750.

All Products Cited: Activin B (Mouse) ELISA AL-156; Activin A ELISA AL-110

 

Rodriguez KF, Brown PR, Amato CM, Nicol B, Liu CF, Xu X, Yao HH. Somatic cell fate maintenance in mouse fetal testes via autocrine/paracrine action of AMH and activin B. Nat Commun. 2022;13(4130):1-12. doi:10.1038/s41467-022-31486-y.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113; Activin B (Mouse) ELISA AL-156

 

Activin B
Activin B ELISA AL-150
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. Circulation. 2023 Jun 13;147(24):1809-1822. doi:10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. PMID: 37096577.

All Products Cited: Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin (Total) ELISA AL-134

 

Houston BJ, O’Connor AE, Wang D, Goodchild G, Merriner DJ, Luan H, Conrad DF, Nagirnaja L, Aston KI, Kliesch S, Wyrwoll MJ, Friedrich C, Tüttelmann F, Harrison C, O’Bryan MK, Walton K. Human INHBB Gene Variant (c.1079T>C:p.Met360Thr) Alters Testis Germ Cell Content, but Does Not Impact Fertility in Mice. Endocrinology. 2022 Mar 1;163(3):bqab269. doi: 10.1210/endocr/bqab269. PMID: 35022746.

All Products Cited: Activin B ELISA AL-150

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A . Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117

 

Paajanen J, Ilonen I, Lauri H, Järvinen T, Sutinen E, Ollila H, Rouvinen E, Lemström K, Räsänen J, Ritvos O, Koli K, Myllärniemi M. Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30287-6. doi: 10.1016/j.cllc.2019.10.013. [Epub ahead of print]

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Short-term treatment with high dose liraglutide improves lipid and lipoprotein profle and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-…. Peradze et al. Cardiovasc Diabetol (2019) 18:141 https://doi.org/10.1186/s12933-019-0945-7

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Activin B ELISA AL-150; Follistatin ELISA AL-117;
Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Chen J, Ghaly W, Vamvini MT, Mantzoros CS. Effects of oral and intravenous lipid administration on hormones affecting energy balance. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Oxyntomodulin ELISA AL-139

 

Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, Ghaly W, Mantzoros CS. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3890-3899.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-like 3 ELISA AL-152

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function. Metabolism. 2018 May 9. pii: S0026-0495(18)30120-3.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Mantzoros CS. Leptin-dependent and leptin-independent pathways linking energy sufficiency with reproduction. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Richani D, Constance K, Lien S, Agapiou D, Stocker WA, Hedger MP, Ledger WL, Thompson JG, Robertson DM, Mottershead DG, Walton KL, Harrison CA, Gilchrist RB. Cumulin and FSH Cooperate to Regulate Inhibin B and Activin B Production by Human Granulosa-Lutein Cells In Vitro. Endocrinology. 2019 Apr 1;160(4):853-862.

All Products Cited: Activin B ELISA AL-150

 

Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, Gavriil A, Tsigalou C, Tziolos NR, Sertaridou E, Kalra B, Kumar A, Rafailidis P, Pasternack A, Boumpas DT, Germanidis G, Ritvos O, Metallidis S, Skendros P, Sideras P. The Activin/Follistatin-axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality. J Infect Dis. 2021 Feb 24:jiab108. doi: 10.1093/infdis/jiab108. Epub ahead of print. PMID: 33625513; PMCID: PMC7928794

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) AL-122

 

Wang Y, Hamang M, Culver A, Jiang H, Yanum J, Garcia V, Lee J, White E, Kusumanchi P, Chalasani N, Liangpunsakul S, Yaden BC, Dai G. Activin B promotes the initiation and progression of liver fibrosis. Hepatol Commun. 2022 Oct;6(10):2812-2826. doi: 10.1002/hep4.2037.

All Products Cited: Activin B ELISA AL-150; Activin B Antibodies

 

AMH
AMH (Bovine) CLIA AL-214
Gobikrushanth M, Dutra PA, Bruinje TC, Colazo MG, Butler ST, Ambrose DJ. Repeatability of antral follicle counts and anti-Müllerian hormone and their associations determined at an unknown stage of follicular growth and an expected day of follicular wave emergence in dairy cows. Theriogenology. 2017 Apr 1;92:90-94. Epub 2017 Jan 11.

All Products Cited: AMH (Bovine) CLIA AL-214

 

Gobikrushanth M, Dutra PA, Felton CA, Ruiz-Sanchez A, Bruinje TC, Colazo MG, Butler ST, Ambrose DJ. The association between Anti-Mullerian Hormone concentrations, antral follicle count and fertility measures in dairy cows. Presented at ADSA-ASAS-CSAS-WSASAS Joint Annual Meeting July 19-23, Salt Lake City, UT

All Products Cited: AMH (Bovine) CLIA AL-214

 

Gobikrushanth M, Dutra PA, Felton CA, Ruiz-Sanchez A, Bruinje TC, Colazo MG, Butler ST, Ambrose DJ. The repeatability of antral follicle count and anti-Müllerian hormone concentration at two different postpartum stages in dairy cattle. Presented at ADSA-ASAS-CSAS-WSASAS Joint Annual Meeting July 19-23, Salt Lake City, UT

All Products Cited: AMH (Bovine) CLIA AL-214

 

Ribeiro ES, Bisinotto RS, Lima FS, Greco LF, Morrison A, Kumar A, Thatcher WW, Santos JE. Plasma anti-Müllerian hormone in adult dairy cows and associations with fertility. Journal of Dairy Science. 2014 Nov; 97(11):6888-900.

All Products Cited: AMH (Bovine) CLIA AL-214

 

Ribeiro ES, Cerri R, Bisinotto R, Lima F, Greco L, Morrison A, Kumar A, Thatcher W, Santos J. Associations Between Plasma Anti-Müllerian Hormone and Fertility Responses of Seasonally Calving Grazing Dairy Cows. Poster session presented at American Dairy Science Association; 2012; July 15-19; Phoenix, AZ.

All Products Cited: AMH (Bovine) CLIA AL-214

 

Ribeiro ES, Greco LF, Bisinotto RS, Lima FS, Thatcher WW, Santos JE. Biology of Preimplantation Conceptus at the Onset of Elongation in Dairy Cows. Biol Reprod. 2016 Apr;94(4):97. doi: 10.1095/biolreprod.115.134908. Epub 2016 Mar 2. PMID: 26935601.

All Products Cited: AMH (Bovine) CLIA AL-214

 

Xu J, Xu F, Lawson MS, Tkachenko OY, Ting AY, Kahl CA, Park BS, Stouffer RR, Bishop CV. Anti-Müllerian hormone is a survival factor and promotes the growth of rhesus macaque preantral follicles during matrix-free culture. Biol Reprod. 2017 Dec 27.

All Products Cited: AMH (Bovine) CLIA AL-214

 

AMH (Bovine) ELISA AL-114
Akbarinejad V, Gharagozlou F, Vojgani M. Temporal effect of maternal heat stress during gestation on the fertility and anti-Müllerian hormone concentration of offspring in bovine. Theriogenology. 2017 Sep 1;99:69-78.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Alward KJ, Graves WM, Palomares RA, Ely LO, Bohlen JF. Characterizing Anti-Müllerian Hormone (AMH) concentration and change over time in Holstein dairy cattle. Theriogenology. 2021 Jul 1;168:83-89. doi: 10.1016/j.theriogenology.2021.03.007. Epub 2021 Mar 16. PMID: 33872933.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Baldrighi JM, Sá Filho MF, Batista EO, Lopes RN, Visintin JA, Baruselli PS, Assumpção ME. Anti-Mullerian hormone concentration and antral ovarian follicle population in Murrah heifers compared to Holstein and Gyr kept under the same management. Reproduction in Domestic Animals. 2014 Dec; 49(6):1015-20.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Baruselli PS, Batista EOS, Vieira LM, Souza Ah. Relationship between follicle population, AMH concentration and fertility in cattle. Anim Reprod. 2015 Sep. 12 (3): 487-497

All Products Cited: AMH (Bovine) ELISA AL-114

 

Batista E, Macedo G, Sala R, Filho M, Lopez R, Ortolan M, Valle T, Renno F, Jesus E, Baroselli E. Plasma Antimullerian Hormone as a Predictor of Ovarian Antral Follicular Population in Bos indicus (Nelore) and Bos taurus (Holstein) Heifers. 4/1/2014, Reproduction in Domestic Animals 49(3), DOI:10.1111/rda.12304

All Products Cited: AMH (Bovine) ELISA AL-114

 

Batistia E, Guerreiro BM, Freitas BG, Silva JCB, Vieira LM, Ferreira RM, Rezende RG, Basso AC, Lopes, R, Renno FP, Souza AH, Baruselli PS. Plasma anti-Mullerian hormone as predictive endocrine marker to select Bos taurus (Holstein) and Bos indicus (Nelore) calves for in vitro embryo production. Domestic Animal Endocrinology, 2015 Aug 54: 1-9 epub ahead of print.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Batistia E, Macedo G, Sala R, Ortolan M, Sa Filho M, Del Valle T, Jesus E, Lopes R, Renno F, Baruselli P. Plasma Anti-mullerian Hormone as a Predictor of Ovarian Antral Follicular Population in Bos indicus (Nelore) and Bos Taurus (Holstein) Heifers. Reproduction in Domestic Animals. 2014 Jun; 49(3):448-452.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Berdugo J, Tarazona-Moraels A, Echeverry-Zuluaga J, Cordona Maya W, Lopez-Herrera A, Crudeli G, Konrad J, Espasandin G. Antimullerian hormone levels in different bovine species and the relationship with in vitro embryo production. Poster Presentation at the International Embryo Transfer Society, Jan 16-19, 2020, New York, New York.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Bo G, Anduaga I, Bernal B, Moreira G, Cedeno A, Barajas J, Pelizzari M, Andrada S, Tribulo A. Serum AMH concentrations and in vitro embryo production in beef cattle. Poster presented at 42nd International Embryo Transfer Society Annual Meeting; 2016 Jan; Louisville, Kentucky

All Products Cited: AMH (Bovine) ELISA AL-114

 

Cardoso CJT, Oliveira Junior JS, Kischel H, Silva WAL, Arruda EDS, Souza-Cáceres MB, Oliveira F A M, Nogueira E, Nogueira GP, Melo-Sterza FA. Anti-Müllerian hormone (AMH) as a predictor of antral follicle population in heifers. Animal Reproduction, v. 15, p. 12-16, 2018.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Carter AS. Anti-Mullerian Hormone as a Marker of Oocyte Quantity, Developmental Potential, and Fetal Sex. [Dissertation, 2016]. Ontario (Canada): The University of Guelph.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Catussi BLC, da Silva LG, Schalch FJ Jr, Auder RMS, Morales JFG, Mingoti RD, Morgulis SCF, Baruselli PS. Prepartum and/or postpartum supplementation with monensin-molasses multinutrient blocks to optimize fertility and calf performance in primiparous beef cows. Anim Biosci. 2022;35(11):1675-1688. doi:10.5713/ab.22.0068.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Center K, Dixon D, Looney C, Rorie R. Anti-Mullerian Hormone and Follicle Counts as Predictors of Superovulatory Response and Embryo Production in Beef Cattle. Advances in Reproductive Sciences. January 2018 06(01):22-33. DOI: 10.4236/arsci.2018.61003

All Products Cited: AMH (Bovine) ELISA AL-114

 

Center K. Prediction of Superovulatory Response in Beef Cows Based on Serum Anti-Mullerian Hormone and Antral Follicle Number. [Thesis].Fayetteville (AR): University of Arkansas.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Chachere JA. Anti-Mullerian Hormone Concentrations as a Predictor of Superovulation Response and Conception Rate in Beef Females. [Thesis].College Station (TX)]: Texas A&M University.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Coen SP, Keogh K, Byrne CJ, Lonergan P, Fair S, Crowe MA, Kenny DA. . Effect of plane of nutrition during the first 12 weeks of life on growth, metabolic and reproductive hormone concentrations, and testicular relative mRNA abundance in preweaned Holstein Friesian bull calves. J Anim Sci. 2021 Aug 1;99(8):skab195. doi: 10.1093/jas/skab195

All Products Cited: AMH (Bovine) ELISA AL-114

 

Copping KJ, Ruiz-Diaz MD, Rutland CS, Mongan NP, Callaghan MJ, McMillen IC, Rodgers RJ, Perry VEA. Peri-conception and first trimester diet modifies reproductive development in bulls. Reprod Fertil Dev. 2017 Nov 16.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Dickson MJ, Piersanti RL, Ramirez-Hernandez R, de Oliveira EB, Bishop JV, Hansen TR, Ma Z, Jeong KCC, Santos JEP, Sheldon MI, Block J, Bromfield JJ. . Experimentally Induced Endometritis Impairs the Developmental Capacity of Bovine Oocytes. Biol Reprod. 2020 Oct 5;103(4):907. doi: 10.1093/biolre/ioaa129

All Products Cited: AMH (Bovine) ELISA AL-114

 

Fushimi Y, Monniaux D, Takagi M. Efficacy of a single measurement of plasma anti-Müllerian hormone concentration for ovum pick-up donor selection of Japanese Black heifers in herd breeding programs. J Reprod Dev. 2019 Aug 9;65(4):369-374. doi: 10.1262/jrd.2019-003. Epub 2019 Mar 30.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Fushimi Y, Okawa H, Monniaux D, Takagi M. Efficacy of a single blood anti-Müllerian hormone (AMH) concentration measurement for the selection of Japanese Black heifer embryo donors in herd breeding programs. J Reprod Dev. 2020 Dec 22;66(6):593-598. doi: 10.1262/jrd.2020-069. Epub 2020 Sep 17. PMID: 32938834; PMCID: PMC7768178.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Grigoletto L, Santana MHA, Bressan FF, Eler JP, Nogueira MFG, Kadarmideen HN, Baruselli PS, Ferraz JBS, Brito LF. . Genetic Parameters and Genome-Wide Association Studies for Anti-Müllerian Hormone Levels and Antral Follicle Populations Measured After Estrus Synchronization in Nellore Cattle. Animals (Basel) . 2020 Jul 13;10(7):1185. doi: 10.3390/ani10071185.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Guerreiro BM, Batista EO, Vieira LM, Sá Filho MF, Rodrigues CA, Castro Netto A, Silveira CR, Bayeux BM, Dias EA, Monteiro FM, Accorsi M, Lopes RN, Baruselli PS. Plasma anti-mullerian hormone an endocrine marker for in vitro embryo production from Bos taurus and Bos indicus donors. Domestic Animal Endocrinology. 2014 Oct; 49:96-104.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Ilha GF, Rovani MT, Gasperin BG, Ferreira R, de Macedo MP, Neto OA, Duggavathi R, Bordignon V, Gonçalves P. Regulation of Anti-Mullerian Hormone and Its Receptor Expression around Follicle Deviation in Cattle. Reprod Domest Anim. 2016 Apr;51(2):188-94. Epub 2016 Jan 27.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Iván AM, Cedeño A, Tríbulo A, Tapia C, Mata J, Mata C, Cavallero J, Bo G. HORMONA ANTIMULLERIANA (AMH) Y PRODUCIÓN INVITRO DE EMBRIONE. June 2017 Argentina [unknown where it was ultimately published].

All Products Cited: AMH (Bovine) ELISA AL-114

 

Jaques JT, Cardoso RC, Chachere J, Sinha S. Using Anti-Müllerian Hormone (AMH) as a Predictor of Ova Production for Bovine Embryo Transfer. Advances in Reproductive Sciences January 2020 08(01):36-47. DOI: 10.4236/arsci.2020.81004

All Products Cited: AMH (Bovine) ELISA AL-114

 

Kelly AK, Byrne C, McGee M, Perry GA, Crowe MA, Sauerwein H, Kenny DA. . Effect of calfhood nutrition on metabolic hormones, gonadotropins, and estradiol concentrations and on reproductive organ development in beef heifer calves. J Anim Sci. 2020 Oct 1;98(10):skaa310. doi: 10.1093/jas/skaa310

All Products Cited: AMH (Bovine) ELISA AL-114

 

Kenichiro S, Yojiro Y, Koji Y, Tomoko S, Seiji K, Masashi N,. Relationships between the antral follicle count, steroidogenesis, and secretion of follicle-stimulating hormone and anti Müllerian hormone during follicular growth in cattle. Sakaguchi et al. Reproductive Biology and Endocrinology (2019) 17:88 https://doi.org/10.1186/s12958-019-0534-3

All Products Cited: AMH (Bovine) ELISA AL-114

 

Konrad J, Berdugo Gutierrez JA, Yuponi R, Vallejos N, Cardona-Maya W, Clerico G, Crudell G, Sansinena M. Superstimulation effect on in vitro embryo production and relationship with anti-mullerian hormone in buffaloes (Bubalus bubalis) aspirated 7 or 14 days after follicular ablation. Poster Presentation at the International Embryo Transfer Society, Jan 16-19, 2020, New York, New York.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Kumar A, Kalra B, Patel A, Shah S. New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105; AMH (Bovine) ELISA AL-114; AMH (Canine/Feline) ELISA AL-116; AMH (Equine) ELISA AL-115; AMH (Rat/Mouse) ELISA AL-113

 

Lopes Dias Queiroz V. Anti-Mullerian Serum Hormone as a Predictor of Puberty in Young Nelore Bulls. [Dissertation, 2014]. Mato Grosso (Brazil)]: Universidade Federal De Mato Grosso Do Sul.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Machado AF, Guimarães SEF, Netto DLS, Guimarães JD, Torres CAA, Sanglard LP, Gomez-Leon VE. Phenotypic and genetic relationships among anogenital distance, anti-Müllerian hormone, and in vitro embryo production in Gyr dairy cattle. J Dairy Sci. 2024;107(4):2512-2523. doi:10.3168/jds.2023-23497.

All Products Cited: AMH (pico) ELISA AL-124

 

Maculan R, Pinto TLC, Moreira GM, Vasconcelos GL, Sanches JA, Rosa RG, Bonfim RR, Gonçalves TM, Souza JC. Anti-Müllerian Hormone (AMH), antral follicle count (AFC), external morphometrics and fertility in Tabapuã cows. Anim Reprod Sci. 2018 Feb;189:84-92.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Mohamed A. Abedal-Majed, Shelby A. Springman, Courtney M. Sutton, Alexandria P. Snider, Brooke E. Bell, Mariah Hart, Scott G. Kurz, Jeff Bergman, Adam F. Summers, Renee M. McFee, John S. Davis, Jennifer R. Wood, and Andrea S. Cupp “Vascular Endothelial Growth Factor A 165 rescues steroids, inflammation and follicle arrest in High Androstenedione cows,” Biology of Reproduction 106(1), 118-131, (2 November 2021). https://doi.org/10.1093/biolre/ioab201

All Products Cited: AMH (Bovine) ELISA AL-114

 

Rorie RW, Newberry HR, Lester TD, Acharya M, Hansen CR. Anti-Müllerian Hormone at Weaning and Breeding as a Predictor of Beef Heifer Fertility. Reprod Fertil Dev. 2016 Jan;29(1):111-112.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Sakaguchi K, Yanagawa Y, Yoshioka K, Suda T, Kawano K, Katagiri S, Nagano M. Effects of antral follicle count in ovaries on follicular development and endocrine dynamics of follicle stimulating hormone and steroid hormones in cattle. Reproduction, Fertility and Development 31(1) 185-186, 2018.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Santa Cruz R, Cushman RA, Viñoles C. Antral follicular count is a tool that may allow the selection of more precocious Bradford heifers at weaning. Theriogenology. 2018 Oct 1;119:35-42. doi: 10.1016/j.theriogenology.2018.06.010. Epub 2018 Jun 19. PMID: 29982134.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Sasazaki N, Toda K, Hasunuma H, Matsumoto M, Shinya U, Yamato O, et al. Effects of dietary feed supplementation with heat-treated Lactobacillus sakei HS-1 on the health status, blood parameters, and fecal microbes of Japanese Black calves before weaning. Vet World. 2023;16(11):2293-2302. doi:10.14202/vetworld.2023.2293-2302.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Sequeira M, Guillen S, Meikle A, Viñoles C. Relación entre la máxima cuenta folicular, las concentraciones de hormona antimüleriana y la concepción en vaquillonas Hereford. Poster session presented at Proceedings del 2do Congreso de la Sociedad Argentina de Tecnologías Embrionari a Arbitrado; 2014; May26-27; Buenos Aires, Argentina.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Stojsin A, Sovernigo T, Filho M, Gillis D, Adona P, Miranda M, Ohashi O, Neal M, Madan P, King A. Plasma anti-müllerian hormone predicts bovine ovary size, number of antral follicles, and overall animal fertility in three breeds of cattle. Poster session presented at Ovarian Club III; 2013 Nov; Paris France.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Vales C, Recavarren M, Ranochia R, Bianchi C, De La Mata A, De La Mata J, Alberio RH. Determinación de la hormona antimulleriana (AMH) en plasma de vacas superovuladas como predictora de la respuesta. Poster session presented at 2° Congreso de Sociedad Argentina de Tecnologías Embrionarias; 2014; May 28-31; Buenos Aires, AR.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Widodo OS, Nishihara S, Pambudi D, Kusakabe KT, Taura Y, Nishi Y, Yamato O, Taniguchi M, Takagi M. Relationship between ovary size and Anti-Müllerian hormone levels in Holstein–Friesian cows. Front Vet Sci. 2022;9:828123. doi:10.3389/fvets.2022.828123.

All Products Cited: AMH (Bovine) ELISA AL-114

 

Widodo OS, Pambudi D, Etoh M, Kokushi E, Uno S, Yamato O, Taniguchi M, Lamid M, Takagi M. Practical application of a urinary zearalenone monitoring system for feed hygiene management of a Japanese Black cattle breeding herd—Relevance to Anti-Müllerian Hormone and Serum Amyloid A clarified from a two-year survey. Toxins (Basel). 2023;15(317):1-10. doi:10.3390/toxins15050317.

All Products Cited: AMH (Bovine) ELISA AL-114

 

AMH (Canine/Feline) ELISA AL-116
Ackermann C, Kozlowski C, Callahan M, Bauman K, Clawitter H, Asa C, Lopes M. Anti- Müllerian hormone concentration in female gray wolf (Canis lupus) – preliminary results. Reproduction In Domestic Animals. Hoboken: Wiley, v. 54, p. 52-53, 2019.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

Bovell R, Comizzoli P, Place NJ. (P-016) Pre-Stimulation Level of Serum Anti-Müllerian Hormone is Associated with Subsequent Quality of Ovarian Response to eCG/pLH in the Domestic Cat (Felis catus). Poster Session presented at the Society Study of Reproduction; 2024; July 15-19; Dublin, Ireland

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Chotimanukul S, Goericke-Pesch S, Suwimonteerabutr J, Singlor J, Sangkrachang E, Tummaruk P, Ponglowhapan S. Serum Anti-Müllerian Hormone Levels and Estrous Monitoring of GnRH Agonist Deslorelin-Induced Estrus in Bitches: A Pilot Study. Animals (Basel). 2023 Jan 12;13(2):258. doi: 10.3390/ani13020258. PMID: 36670799; PMCID: PMC9855037.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Constantin T, Micsa C, Posastiuc F, Sprintu I, Andrei C, Iordache F, Bilteanu L, Zelli R, Serban A. Can anti-Müllerian hormone levels be relevant for semen evaluation and chillability in dog? Poster Session at the 1st European Symposium on Animal Reproduction, 21st – 23rd September 2023, Nantes, France

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Cusatti AC, Somoza R, Marchetti IA. Antimullerian Hormone (AMH) as biomarker of Granulosa Cell Tumor (GCT), case report. Abstract presented at the 20th European Veterinary Society for Small Animal Reproduction Congress, 29th June – 1st Jul 2017 Vienna Austria

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Ganz S, Wehrend A. Uptake of exogenous estrogen as a differential diagnosis of ovarian-remnant-syndrome in a bitch: a case report. BMC Vet Res. 2021 Jun 25;17(1):225. doi: 10.1186/s12917-021-02923-9. PMID: 34172052; PMCID: PMC8235845.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Gültiken N, Yarim M, Aslan S, Gürler H, Yarim GF, Tuncay M, İṅal S, Schäfer-Somi S. Expression of Anti-Müllerian Hormone and its type 2 receptor in the ovary of pregnant and cyclic domestic cats. Animals (Basel). 2022;12(877):1-15. doi:10.3390/ani12070877.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Hollinshead FK, Walker C, Hanlon DW. Determination of the normal reference interval for anti-Müllerian hormone (AMH) in bitches and use of AMH as a potential predictor of litter size. Reprod Domest Anim. 2017 Apr;52 Suppl 2:35-40.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Holst BS. Diagnostic possibilities from a serum sample—Clinical value of new methods within small animal reproduction, with focus on anti-Müllerian hormone. Reprod Domest Anim. 2017 Apr;52 Suppl 2:303-309. doi: 10.1111/rda.12856. Epub 2016 Oct 18. PMID: 27758004.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Johnson AK, Hollinshead FK, Berger T, Cotterman RF, Caruso CJ, Conley AJ. Anti-Müllerian hormone and inhibin-B concentrations vary cyclically in nonovulating queens within reference ranges established for determining gonadal status in cats. J Am Vet Med Assoc. 2023 Aug 22;261(12):1796-1803. doi: 10.2460/javma.23.06.0320. PMID: 37607677.

All Products Cited: AMH (Canine/Feline) ELISA AL-116; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Kumar A, Kalra B, Patel A, Shah S. New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105; AMH (Bovine) ELISA AL-114; AMH (Canine/Feline) ELISA AL-116; AMH (Equine) ELISA AL-115; AMH (Rat/Mouse) ELISA AL-113

 

Micsa C, Posastiuc F, Constantin T, Nicolae G, Sprintu I, Andrei C, Stanca L, Iordache F, Serban A. Comparative analysis between AMH levels and histomorphometry in cryptorchid, intact and sterilized tomcats. Poster Session at the 1st European Symposium on Animal Reproduction, 21st – 23rd September 2023, Nantes, France

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Posastiuc F, Constantin T, Micsa C, Andrei C, Sprintu I, Petcu M, Diaconescu A, Codreanu M, Iordache F, Nicolae G, Serban A. Is serum anti-Mullerian hormone a useful biomarker for testicular atrophy in dogs? Poster Session at the 1st European Symposium on Animal Reproduction, 21st – 23rd September 2023, Nantes, France

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Themmen APN, Kalra B, Visser JA, Kumar A, Savjani G, Gier J, Jaques S. The use of anti-Müllerian hormone as diagnostic for gonadectomy status in dogs. Theriogenology 86 (2016) 1467–1474.

All Products Cited: AMH (Canine/Feline) ELISA AL-116; AMH Antigen AG-303-BA047

 

Walter B. Anti-Müllerian hormone in dogs and cats reproduction. Reprod Domest Anim. 2020 Jul;55 Suppl 2:26-31. doi: 10.1111/rda.13603. Epub 2020 Feb 7. PMID: 32031297.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

Yilmaz O, Toydemir T, Kirsan I, Ucmak Z, Karacam E. Anti-Mullerian hormone as a diagnostic tool for ovarian remnant syndrome in bitches. Vet Res Commun. First published online June 24, 2015.

All Products Cited: AMH (Canine/Feline) ELISA AL-116

 

AMH (Dried Blood Spot) ELISA AL-129
Davidson S, Jahnke S, Jung AM, Burgess JL, Jacobs ET, Billheimer D, Farland LV. Anti-Müllerian Hormone Levels among Female Firefighters. Int J Environ Res Public Health. 2022 May 14;19(10):5981. doi: 10.3390/ijerph19105981. PMID: 35627519; PMCID: PMC9141260.

All Products Cited: AMH (DBS) ELISA AL-129

 

Din HN, Singh-Carlson S, Corliss HL, Hartman SJ, Strong D, Madanat H, Su HI. Perceived and Objective Fertility Risk Among Female Survivors of Adolescent and Young Adult Cancer. JAMA Netw Open. 2023 Oct 2;6(10):e2337245. doi: 10.1001/jamanetworkopen.2023.37245. PMID: 37819662; PMCID: PMC10568355.

All Products Cited: AMH (DBS) ELISA AL-129; LH (DBS) ELISA AL-187

 

Hall KS, Rentmeester ST, Zhao Y, Hankus AN, Pei Y, Riley HE, McCloud C, Pearce BD. . A pilot study for exploring blood spot anti-mullerian hormone for population-based adolescent reproductive health research. Front Womens Health. 2020;5(1):10.15761/fwh.1000177. doi: 10.15761/fwh.1000177

All Products Cited: AMH (DBS) ELISA AL-129

 

Kumar A, Kalra B, Oxvig C. Development of a sensitive Dried Blood Spot Anti-Müllerian Hormone (AMH) ELISA. Poster session presented at American Association for Clinical Chemistry; 2014 Jul 27-31; Chicago, IL.

All Products Cited: AMH (DBS) ELISA AL-129

 

Kumar A, Kalra B, Patel AS, Kumar T, Savjani G. Validation of Dried Blood Spot AMH ELISA: A Convenient Alternative to Venipuncture. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: AMH (DBS) ELISA AL-129

 

Kumar A, Kalra B, Schanne A, Lechtenberg L, Gracia C. Bloodspot AMH may be used to assess the impact of cancer therapies on ovarian reserve. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH (DBS) ELISA AL-129

 

Kumar T, Chauhan R, Kalra B, Patel AS, Chauhan S, Kumar A. Novel comparative analysis of dried blood spot and serum ELISAs for AMH, FSH, and LH in patients seeking IVF treatment. J Endocr Soc. 2019;3(Supplement_1)

All Products Cited: AMH (pico) ELISA AL-124; AMH (DBS) ELISA AL-129; LH (DBS) ELISA AL-190; FSH (DBS) ELISA AL-187

 

Medica ACO, Whitcomb BW, Shliakhsitsava K, Dietz AC, Pinson K, Lam C, Romero SAD, Sluss P, Sammel MD, Su HI. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors. J Clin Endocrinol Metab. 2021 Feb; 106(2): e1002–e1013.
Published online 2020 Nov 3. doi: 10.1210/clinem/dgaa797

All Products Cited: FSH (DBS) ELISA AL-187; AMH (DBS) ELISA AL-129

 

Roberts SC, Seav SM, McDade TW, Dominick SA, Gorman JR, Whitcomb BW, Su HI. Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors. Human Reproduction, Vol.31, No.7 pp. 1570–1578, 2016

All Products Cited: AMH (DBS) ELISA AL-129

 

Su HI, Kwan B, Whitcomb BW, Shliakhsitsava K, Dietz AC, Stark SS, Martinez E, Sluss PM, Sammel MD, Natarajan L. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH. J Clin Endocrinol Metab. 2020 Aug 1;105(8):2740–51. doi: 10.1210/clinem/dgaa172. PMID: 32270202; PMCID: PMC7329316.

All Products Cited: AMH (DBS) ELISA AL-129

 

AMH (Equine) ELISA AL-115
Acharya M, Burke JM, Anshworth AJ, Rorie R. Relationship of Anti-Mullerian Hormone to Reproductive Traits in Katahdin Ewes Bred in Late Spring or Fall. Advances in Reproductive Sciences January 2020 08(01):48-56. DOI: 10.4236/arsci.2020.81005

All Products Cited: AMH (Equine) ELISA AL-115

 

Hanlon D, Hllinshead F, Evans M. Anti-Mullerian Hormone (AMH) as a potential predective marker of fertility in mares. unpublished

All Products Cited: AMH (Equine) ELISA AL-115

 

Kaps M, Okada CTC, Gautier CM, Aurich J, Aurich C. . Deslorelin Slow-Release Implants Delay Ovulation and Increase Plasma AMH Concentration and Small Antral Follicles in Haflinger Mares. Animals (Basel). 2021 May 28;11(6):1600.

All Products Cited: AMH (Equine) ELISA AL-115

 

Kumar A, Kalra B, Patel A, Shah S. New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105; AMH (Bovine) ELISA AL-114; AMH (Canine) ELISA AL-116; AMH (Equine) ELISA AL-115; AMH (Rat/Mouse) ELISA AL-113

 

Renata Cristina Uliani. Disseration: Efeito da Ovariectomia e Idade Sobre as Concentrações Séricas de Hormônio Anti-Mülleriano em Éguas. [Dissertation, 2016]. Universidade Estadual Paulista “Júlio de Mesquita Filho” (Brazil), Faculdade de Medicina Veterinária e Zootecnia”.

All Products Cited: AMH (Equine) ELISA AL-115

 

Scarlet D, Kuhl J, Wulf M, Ille N, Aurich C. Antral Follicle Count of 2-Year-Old Mares is Highly Correlated with Anti-Müllerian Hormone Concentrations at 24 to 28 Weeks of Age. Reprod Fertil Dev. 2016 Jan;29(1):168-169.

All Products Cited: AMH (Equine) ELISA AL-115

 

Scarlet D, Wulf M, Kuhl J, Köhne M, Ille N, Conley AJ, Aurich C. Anti-Müllerian hormone profiling in prepubertal horses and its relationship with gonadal function. Theriogenology. 2018 Sep 1;117:72-77.

All Products Cited: AMH (Equine) ELISA AL-115

 

Uliani RC, Conley AJ, Corbin CJ, Friso AM, Maciel LFS, Alvarenga MA. . Anti-Müllerian hormone and ovarian aging in mares. J Endocrinol . 2019 Feb 1;240(2):147-156. doi: 10.1530/JOE-18-0391.

All Products Cited: AMH (Equine) ELISA AL-115

 

Uliani RC, Conley AJ, Corbin CJ, Friso AM, Maciel LFS, Alvarenga MA. . Experimental validation of anti-Mullerian hormonae as a quantitative marker of ovarian follicular reserve using unilateral ovariectomy in mares. Clinical Theriogenology 2017 Vol.9 No.3 pp.462

All Products Cited: AMH (Equine) ELISA AL-115

 

AMH (MenoCheck) (pico) ELISA AL-124
Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM, Burnett-Bowie SA, Darakananda K, Donahoe PK, Harlow SD, Prizand SH, Joffe H, Kumar A, Martin DE, McConnell D, Merrilat S, Morrison A, Pastore LM, Randolph JF, Greendale GA, Santoro N. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women’s Health Across the Nation. The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 4, April 2020, Pages e1862–e1871, https://doi.org/10.1210/clinem/dgz283

All Products Cited: AMH (MenoCheck) (pico) ELISA AL-124; Inhibin B ELISA AL-107

 

Sluss PM, Palomaki G, Kumar A, Morrison A, Kalra B, Alpadi K. Analytical Performance and Clinical Value of AMH Testing. J Endocr Soc. 2020 May 8; 4(Suppl 1): SAT-016.Published online 2020 May 8. doi: 10.1210/jendso/bvaa046.1970

All Products Cited: AMH (MenoCheck) (pico) ELISA AL-124

 

AMH (Ovine) ELISA AL-119
Lahoz B, Alabart JL, Cocero MJ, Monniaux D, Fabre S, Folch J. The use of plasma anti-müllerian hormone in sheep as an endocrine marker of the ovarian response to follicle-stimulating hormone in multiple-ovulation embryo transfer programs. Reproduction, Fertility and Development. 2014 Dec; 27(1):264.

All Products Cited: AMH (Ovine) ELISA AL-155

 

Lahoz B, Alabart JL, Sanchez P, Echegoyen E, Folch, J. Elección de las Mejores Ovejas Donantes de Embriones Mediante la Determinación Plasmática de su Amh (Hormona Anti-Mülleriana). XVI Jornadas sobre Producción Animal. 2015; Vol II: 447-9.

All Products Cited: AMH (Ovine) ELISA AL-155

 

Pool K, Rickard J, Pini T, de Graaf S. Exogenous melatonin advances the ram breeding season and increases testicular function. Sci Rep . 2020 Jun 16;10(1):9711. doi: 10.1038/s41598-020-66594-6.

All Products Cited: AMH (Ovine) ELISA AL-155

 

Seccafien J, McGrice H, Kelly J, van Wettere W. The effect of oestrous synchronisation and breed on Anti-Mullerian hormone (AMH) concentrations in Merino and Suffolk ewes. Poster session presented at the Endocrine Society of Australia (ESA) and Society for Reproductive Biology (SRB) Meeting, August 19 – 22, Adelaide, South Australia.

All Products Cited: AMH (Ovine) ELISA AL-155

 

Smartt JA. Anti-Mullerian Hormone: Potential Association with Fertility in Ewes. [Thesis].San Angelo (TX)]: San Angelo University.

All Products Cited: AMH (Ovine) ELISA AL-155

 

AMH (PCOCheck) ELISA AL-196
Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Kumar A, Kalra B, Alpadi K, Green K, Wittmaack F. [Audio Presentation] PCOCheck AMH ELISA: A Clinical Case Report to Resolve Mismatched Antral Follicle Counts (AFC) to Serum AMH. Poster presented at Endo SocMeeting; 2021 (Virtual).

All Products Cited: AMH (PCOCHeck)ELISA AL-196

 

Kumar A, Kalra B, Alpadi K, Green K, Wittmaack F. PCOCheck AMH ELISA: A Clinical Case Report to Resolve Mismatched Antral Follicle Counts (AFC) to Serum AMH. Poster presented at Endo SocMeeting; 2021 (Virtual).

All Products Cited: AMH (PCOCheck) ELISA AL-196

 

L Melado Vidales, B Lawrenz, A Kumar, B Kalra, B Ata, R Patel, E Kalafat, R Loja Vitorino, I ElKhatib, H Fatemi, O-067 Does the measurement of different AMH isoforms in poor responder patients improve the prediction of ovarian response?, Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.081, https://doi.org/10.1093/humrep/dead093.081

All Products Cited: AMH (PCOCheck) ELISA AL-196; AMH (pico) ELISA AL-124; AMH ELISA AL-105; AMH (Total Mature) ELISA AL-133

 

AMH (pico) ELISA AL-124
Anderson C, Mark Park YM, Stanczyk FZ, Sandler DP, Nichols HB. Dietary factors and serum Anti-Mullerian hormone concentrations in late premenopausal women. Fertil Steril. 2018 Nov;110(6):1145-1153. doi: 10.1016/j.fertnstert.2018.06.037

All Products Cited: AMH (pico) ELISA AL-124

 

Anderson RA, Su HI. The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer. Front Endocrinol (Lausanne). 2020 Oct 7;11:574263. doi: 10.3389/fendo.2020.574263. PMID: 33117288; PMCID: PMC7577190.

All Products Cited: AMH (pico) ELISA AL-124

 

Barad D, Kushnir V, Khanna P, Gleicher N. Clinical in Vitro Fertilization (IVF) Outcomes Based on Comparative Anti-Müllerian Hormone (AMH) Testing with a Standard and New Highly Sensitive Assay. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH (pico) ELISA AL-124

 

Barbagallo F, van der Ham K, Willemsen SP, Louwers YV, Laven JS. Age-related curves of AMH using the Gen II, the picoAMH, and the Elecsys assays in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2024;00(00):1-10. doi:10.1210/clinem/dgae153.

All Products Cited: AMH (pico) ELISA AL-124

 

Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study. Hum Reprod. 2021 Dec 27;37(1):109-118. doi: 10.1093/humrep/deab232. PMID: 34741176.

All Products Cited: AMH (pico) ELISA AL-124

 

Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, Hankinson SE, Rosner BA, Whitcomb BW. A prospective study of inflammatory biomarker levels and risk of early menopause. Menopause. 2019 Jan;26(1):32-38. doi: 10.1097/GME.0000000000001162

All Products Cited: AMH (pico) ELISA AL-124

 

Bertone-Johnson ER, Manson JE, Purdue-Smithe AC, Steiner AZ, Eliassen AH, Hankinson SE, Rosner BA, Whitcomb BW. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod. 2018 Jun 1;33(6):1175-1182.

All Products Cited: AMH (pico) ELISA AL-124

 

Bertrand KA, Baer HJ, Orav EJ, Klifa C, Kumar A, Hylton NM, LeBlanc ES, Snetselaar LG, Van Horn L, Dorgan JF. Early life body fatness, serum antimüllerian hormone and breast density in young adult women. Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1151-7. doi: 10.1158/1055-9965.EPI-16-0185

All Products Cited: AMH (pico) ELISA AL-124

 

Bertrand KA, Eliassen AH, Hankinson SE, Rosner BA, Tamimi RM. Circulating Hormones and Mammographic Density in Premenopausal Women. Horm Cancer. 2018 Apr;9(2):117-127.

All Products Cited: AMH (pico) ELISA AL-124

 

Broer SL, Broekmans FJM, Laven JSE, Fauser BCJM. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum. Reprod. Update. 2014 May 12.

All Products Cited: AMH (pico) ELISA AL-124

 

Brouwer J, Dolhain RJEM, Hazes JMW, Erler NS, Visser JA, Laven JSE. . Decline of ovarian function in patients with rheumatoid arthritis: serum anti Müllerian hormone levels in a longitudinal cohort. RMD Open. 2020 Oct;6(3):e001307. doi: 10.1136/rmdopen-2020-001307

All Products Cited: AMH (pico) ELISA AL-124

 

Brouwer J, Dolhain RJEM, Hazes JMW, Visser JA, Laven JSE. Reduced Ovarian Function in Female Rheumatoid Arthritis Patients Trying to Conceive. ACR Open Rheumatol 2019 Jul 4;1(5):327-335. doi: 10.1002/acr2.11043. eCollection 2019 Jul.

All Products Cited: AMH (pico) ELISA AL-124

 

Buckbinder J, Mucowski S, Burks H, Stanczyk F, Hodis H, Mack W, Bendikson K, Shoupe D. The Detection and Clinical Utilization of Anti-Mullerian Hormone (AMH) in Postmenopausal Women Using the New Highly Sensitive ELISA. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH (pico) ELISA AL-124

 

Bungum L, Tagevi J, Jokubkiene L, Bungum M, Giwercman A, Macklon N, Andersen CY, Klausen TW, Torring N, Kumar A, Skouby SO. The Impact of the Biological Variability or Assay Performance on AMH Measurements: A Prospective Cohort Study With AMH Tested on Three Analytical Assay-Platforms. Front. Endocrinol., 16 October 2018.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA-124

 

Burks H, Ross L, Opper N, Stancyzk F. Can Ultrasensitive Anti-Mullerian Hormone Testing Predict Failed Response to Ovarian Stimulation? . PCRS Abstracts Vol. 101, No. 2, Supplement, February 2014

All Products Cited: AMH (pico) ELISA AL-124

 

Burks HR, Ross L, Opper N, Paulson E, Stanczyk F, Chung K. Can highly sensitive antimullerian hormone testing predict failed response to ovarian stimulation? . Fertility and Sterility. 2015 Sep; 104(3):643-648.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Caanen MR, Peters HE, van de Ven PM, Jüttner AMFM, Laven JSE, van Hooff MHA, Lambalk CB. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1084-e1095. doi: 10.1210/clinem/dgaa949. PMID: 33351079; PMCID: PMC7947839

All Products Cited: AMH (pico) ELISA AL-124

 

Cameron K, Sammel MD, Prewitt M, Gracia C. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan. J Clin Endocrinol Metab. 2019 May 1;104(5):1813-1822. doi: 10.1210/jc.2018-02257. PMID: 30566616; PMCID: PMC6456010.

All Products Cited: AMH (pico) ELISA AL-124

 

Chai J, Cameron D, Howie F, Anderson A. A Highly-Sensitive AMH Assay Improves Analysis of Ovarian Function Following Chemotherapy for Early Breast Cancer. European Journal of Cancer 2014 Sep; 50(14):2367-74.

All Products Cited: AMH (pico) ELISA AL-124

 

Chai J, Howie F, Cameron DA, Anderson, RA. Analysis of ovarian function following chemotherapy for early breast cancer using an ultra-sensitive assay. Poster session presented at: European Society for Human Reproduction and Embryology; 2014, Jun 29 – July 2 Munich, Germany.

All Products Cited: AMH (pico) ELISA AL-124

 

Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Bertone-Johnson E, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women. The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 11, November 2021, Pages e4542–e4553

All Products Cited: AMH (pico) ELISA AL-124

 

Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Zeleniuch-Jacquotte A, Liu M. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model. Breast Cancer Res. 2019 Mar 19;21(1):42.

All Products Cited: AMH (pico) ELISA AL-124

 

Cordeiro Mitchell, C.N., McGuinness, B., Fine, E. et al. Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis. Journal of Assisted Reproduction and Genetics volume 37, pages1037–1055 (2020)

All Products Cited: AMH (pico) ELISA AL-124

 

Crawford S, Finkelstein J, Gold E, Greendale G, Harlow S, Joffe H, Kalra B, Kumar A, Martin D, Merillat S, Morrison A, Sluss P, Thurston R, Avis N. Predicting Onset of Menopausal Vasomotor Symptoms with Anti-Mullerian Hormone in the Study of Women’s Health Across the Nation (SWAN). Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: AMH (pico) ELISA AL-124

 

Cui L, Qin Y, Gao X, Lu J, Geng L, Ding L, Qu Z, Zhang X, Chen Z. Anti-Mullerian Hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Reproductive Endocrinology. 2016 Feb, 105(2):481-5.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

de Kat AC, van der Schouw YT, Eijkemans MJ, Herber-Gast GC, Visser JA, Verschuren WM, Broekmans FJ. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Med. 2016 Oct 3;14(1):151.

All Products Cited: AMH (pico) ELISA AL-124

 

de Kat AC, van der Schouw YT, Eijkemans MJC, Broer SL, Verschuren WMM, Broekmans FJM. Can menopause prediction be improved with multiple AMH measurements? Results from the prospective Doetinchem Cohort Study. J Clin Endocrinol Metab. 2019 Apr 22. pii: jc.2018-02607.

All Products Cited: AMH (pico) ELISA AL-124

 

De Kat AC, van der Schouw YT, Eijkemans MJC, Herber-Gast GC, Visser JA, Verschuren WMM, Broekmans FJM. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Medicine. 2016;14:151.

All Products Cited: AMH (pico) ELISA AL-124

 

Dean A, van den Driesche S, Wang Y, McKinnell C, Macpherson S, Eddie S, Kinnell H, Hurtado-Gonzalez P, Chambers T, Stevenson K, Wolfinger E, Hrabalkova L, Calarrao A, Bayne R, Hagen C, Mitchell R, Anderson R, Sharpe R. Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences. Sci. Rep. 6, 19789, 2016 Jan 27

All Products Cited: AMH (pico) ELISA AL-124

 

Decanter C, Cloquet M, Dassonneville A, D’Orazio E, Mailliez A, Pigny P. Different patterns of ovarian recovery after cancer treatment suggest various individual ovarian susceptibilities to chemotherapy. Reprod Biomed Online. 2018 Jun;36(6):711-718.

All Products Cited: AMH (pico) ELISA AL-124

 

Decanter C, Peigne M, Mailliez A, Morschhauser F, Dassonneville A, Dewailly D, Pigny P. Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay. Fertility and Sterility. 2014 Aug; 102(2):483-7.

All Products Cited: AMH (pico) ELISA AL-124

 

Ding N, Zheutlin E, Harlow SD, Randolph JF Jr, Mukherjee B, Park SK. Associations between repeated measures of urinary phthalate metabolites with hormones and timing of natural menopause. J Endocr Soc. 2023;7(4):1-11. doi:10.1210/jendso/bvad024.

All Products Cited: AMH (pico) ELISA AL-124

 

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros CS. Glycosylated Fibronectin and Inhibin are Lower and Anti-Müllerian Hormone is Higher in Umbilical Cord Blood when Mothers have Preeclampsia. Endocr Pract. 2020 Mar;26(3):318-327. doi: 10.4158/EP-2019-0448. Epub 2019 Dec 20. PMID: 31859547.

All Products Cited: AMH (pico) ELISA AL-124

 

Drechsel KCE, Broer SL, Stoutjesdijk FS, Twisk JWR, van den Berg MH, Lambalk CB, et al. Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma. J Cancer Res Clin Oncol. 2023;149(13677–13695). doi:10.1007/s00432-023-05035-z.

All Products Cited: AMH (pico) ELISA AL-124

 

Dykgraaf RHM, Schalekamp-Timmermans S, Adank MC, van den Berg SAA, van de Lang-Born BMN, Korevaar TI, Kumar A, Kalra B, Savjani GV, Steegers EAP, Louwers YV, Laven JSE. Reference ranges of AMH and interaction with placental biomarkers in early pregnancy: the Generation R Study, a population-based prospective cohort study. Endocr Connect. 2022 Dec 1:EC-22-0320. doi: 10.1530/EC-22-0320. Epub ahead of print. PMID: 36524811.

All Products Cited: AMH (pico) ELISA AL-124

 

El Khoudary SR, Wang L, Brooks MM, Matthews KA, Thurston RC, Crawford S, Derby C, Jackson EA, Lee JS, Un-Yong Chae C, McConnell DS, Finkelstein J. Associations of Anti-Mullerian Hormone Premenopausal Levels and Their Changes over the Menopausal Transition with Lipids: The Study of Women′s Health Across the Nation (SWAN). Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: AMH (pico) ELISA AL-124

 

Ferguson J, Hockley J, Rigsby P, Burns C. Establishment of a WHO Reference Reagent for anti-Mullerian hormone. Ferguson et al. Reproductive Biology and Endocrinology (2020) 18:86 https://doi.org/10.1186/s12958-020-00641-9

All Products Cited: AMH (pico) ELISA AL-124

 

Finkelstein JS, Lee H, Burnett-Bowie SAM, Santoro N, Yu EW, Joffe H, Morrison A, Kumar A, Greendale GA, Gold E, Harlow S, Lasley BL, Derby C, Randolph JF, Matthews KA, Kravitz HM, McConnell DS, Brooks MM, Martin D, Darakananda K, Hirsch SC, Sluss PM. Utility of Anti-Mullerian Hormone (AMH) for Predicting the Time to the Final Menstrual Period: The Study of Women’s Health Across the Nation (SWAN). Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: AMH (pico) ELISA AL-124

 

Freeman JR, Whitcomb BW, Roy A, Bertone-Johnson ER, Reich NG, Healy AJ. A pilot longitudinal study of anti-Müllerian hormone levels throughout gestation in low risk pregnancy. Health Sci Rep. 2018 Jun 19;1(8):e53.

All Products Cited: AMH (pico) ELISA AL-124

 

Garnett ER, Jariwala P, Rector K, Gibbons WE, Zarutskie PW, Devaraj S. Validation of the picoAMH assay on the Dynex DS2 platform. Pract Lab Med. 2019;17. doi:10.1016/j.plabm.2019.e00140.

All Products Cited: AMH (pico) ELISA AL-124

 

Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ,, Visvanathan K,, Liu M,, Zeleniuch-Jacquotte A. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer. 2018 Jun 1;142(11):2215-2226.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Giuliani E, Waldo A, Bernardi L, Carnethon M, Neff L, Marsh E. Gravidity, Parity, Breastfeeding, and AMH: Findings from the Ovarian Aging and Reserve Study (SOAR). Fertility and Sterility Abstract, Volume 114, Issue 3, Supplement E88, September 01, 2020

All Products Cited: AMH (pico) ELISA AL-124

 

Golenbock SW, Wise LA, Lambert-Messerlian GM, Eklund EE, Harlow BL. Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles. Womens Midlife Health. 2020 Sep 1;6:9. doi: 10.1186/s40695-020-00056-x. PMID: 32884826; PMCID: PMC7461252.

All Products Cited: AMH (pico) ELISA AL-124

 

Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018 Jan 16;90(3):e254-e260. doi: 10.1212/WNL.0000000000004843

All Products Cited: AMH (pico) ELISA AL-124

 

Grynnerup G, Løssl K, Pilsgaard F, Lunding S, Storgaard M, Bogstad J, Prætorius L, Zedeler A , Bungum L , Nyboe A, Pinborg A. Prediction of the lower serum anti Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys AMH assay: a prospective observational study. Grynnerup et al. Reproductive Biology and Endocrinology (2019) 17:11 https://doi.org/10.1186/s12958-019-0452-4

All Products Cited: AMH (pico) ELISA AL-124

 

Hawkins Bressler L, Bernardi LA, De Chavez PJ, Baird DD, Carnethon MR, Marsh EE. Alcohol, cigarette smoking, and ovarian reserve in reproductive age African-American women. Am J Obstet Gynecol. 2016 Dec;215(6):758.e1-758.e9. doi: 10.1016/j.ajog.2016.07.012

All Products Cited: AMH (pico) ELISA AL-124

 

Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA. Loss of Antimullerian hormone immunoreactivity due to a homozygous AMH gene mutation Rs10417628 in a woman with classical polycystic ovary syndrome. J Endocr Soc. 2020;4(Supplement_1). doi:10.1210/jendso/bvaa046.

All Products Cited: AMH (pico) ELISA AL-124

 

Huddleston H, Santoro N, Eisenberg E, Haisenleder DJ, Diamond MP, Cedars M. Can We Expect to Improve Age at Menopause Predictions with Repeated AMH Measurements. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH (pico) ELISA AL-124

 

Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015 Nov-Dec;21(6):698-710.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Mullerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment, a Systematic Narrative Review. Reproductive Sciences. 2015 May, 22(5):519-26.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F. Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?. Reprod Med Biol (2016) 15:127–136

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Iwase A, Osuka S, Nakamura T, Kato N, Takikawa S, Goto M, Kikkawa. Usefulness of the Ultrasensitive Anti-Mullerian Hormone Assay for Predicting True Ovarian Reserve. Reproductive Sciences, 2015, 1-5.

All Products Cited: AMH (pico) ELISA AL-124

 

Joffe H, Crawford S, Bromberger JT, Kalra B, Kumar A, Morrison A, Finkelstein J, Kravitz JM. Vasomotor Symptoms Mediate the Association Between Anti-Mullerian Hormone Levels and New-Onset Sleep Disturbance in Women during the Menopause Transition: Study of Women’s Health Across the Nation (SWAN). Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: AMH (pico) ELISA AL-124

 

Johnson L, Sammel MD, Domchek S, Schanne A, Prewitt M, Gracia C. Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Fertil Steril. 2017 May;107(5):1256-1265.e6.

All Products Cited: AMH (pico) ELISA AL-124

 

Jones BY, Bell HV, et al. Impact of a hypocaloric dietary intervention on antral follicle dynamics in eumenorrheic women with obesity. Hum Reprod. 2024 Feb 9;deae017. doi: 10.1093/humrep/deae017.

All Products Cited: AMH (pico) ELISA AL-124

 

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF. Anti-Müllerian Hormone and risk of ovarian cancer in nine cohorts. Int J Cancer. 2017 Sep 18.

All Products Cited: AMH (pico) ELISA AL-124

 

Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sánchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjønneland A, Trichopoulou A, Tworoger S, Visvanathan K, Krogh V, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertil Steril. 2017 Apr;107(4):1012-1022.e2.

All Products Cited: AMH (pico) ELISA AL-124

 

Karlamangla AS, Shieh A, Burnett-Bowie SA, Yu EW, Greendale GA, Sluss PM, Martin D, Finkelstein JS. Anti-Mullerian Hormone and Prediction of Trans-Menopausal Bone Loss. Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: AMH (pico) ELISA AL-124

 

Karlamangla AS, Shieh A, Greendale GA, Yu EW, Burnett-Bowie SM, Sluss PM, Martin D, Morrison A, Finkelstein JS. Anti-Mullerian Hormone as Predictor of Future and Ongoing Bone Loss During the Menopause Transition. J Bone Miner Res. 2022 Jul;37(7):1224-1232. doi: 10.1002/jbmr.4525.

All Products Cited: AMH (pico) ELISA AL-124

 

Karlamangla AS. Anti-Mullerian hormone may estimate magnitude of menopausal bone loss. 2016 April 1. Retrieved from http://www.healio.com/endocrinology/bone-mineral-metabolism/news/online/%7B4f8e49d7-e1e8-4567-bdca-dd7d018f7fea%7D/anti-mullerian-hormone-may-estimate-magnitude-of-menopausal-bone-loss .

All Products Cited: AMH (pico) ELISA AL-124

 

Kohn SA, Fought AJ, Kuhn K, Slogett KJ, Bradford AP, Santoro N, Schauer I. Heparin effects on serum gonadotropins. J Endocr Soc. 2022;6(1):1-7. doi:10.1210/jendso/bvab178.

All Products Cited: AMH (pico) ELISA AL-124

 

Kopp DM, Wilkinson J, Bengtson A, Chipungu E, Pope RJ, Moyo M, Tang JH. Fertility outcomes following obstetric fistula repair: a prospective cohort study. Kopp et al. Reproductive Health (2017) 14:159 DOI 10.1186/s12978-017-0415-1

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kumar A, Kalra B, Patel A, Shah S, Savjani G, Themmen A, Visser J, Pruysers, Robertson D. Development of Stable picoAnti-Müllerian Hormone ELISA: Sensitive, Reliable and Reproducible Results. Poster session presented at the 96th Annual Endocrine Society Meeting; 2014 Jun 21-24; Chicago, IL.

All Products Cited: AMH (pico) ELISA AL-124

 

Kumar T, Chauhan R, Kalra B, Patel AS, Chauhan S, Kumar A. Novel comparative analysis of dried blood spot and serum ELISAs for AMH, FSH, and LH in patients seeking IVF treatment. J Endocr Soc. 2019;3(Supplement_1)

All Products Cited: AMH (pico) ELISA AL-124; DBS AMH ELISA AL-129; DBS LH ELISA AL-190; DBS FSH ELISA AL-187

 

L Melado Vidales, B Lawrenz, A Kumar, B Kalra, B Ata, R Patel, E Kalafat, R Loja Vitorino, I ElKhatib, H Fatemi, O-067 Does the measurement of different AMH isoforms in poor responder patients improve the prediction of ovarian response?, Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.081, https://doi.org/10.1093/humrep/dead093.081

All Products Cited: AMH (PCOCheck) ELISA AL-196; AMH (pico) ELISA AL-124; AMH ELISA AL-105; AMH (Total Mature) ELISA AL-133

 

Lambert­Messerlian G. The New Egg Timer – Anti­Mullerian Hormone Levels for Assessing Ovarian Reserve. Clinical Laboratory News. Jan 2015:14-18.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Lu J, Holt C, Choi M, Kalp K, Straseski J. Quantitation of Anti-Müllerian Hormone by the AnshLabs picoAMH ELISA Assay. Poster session presented at American Association for Clinical Chemistry; 2014 Jul 27-31; Chicago, IL.

All Products Cited: AMH (pico) ELISA AL-124

 

Lukaszuk K, Plociennik L, Lukaszuk A, Dialobrzeska D. The Heterogenity of Anti-Mullerian Hormone Depletion in Models Across Assays in 12917 Women. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH (pico) ELISA AL-124

 

Mamsen LS, Bøtkjær JA, Kristensen SG, Pors SE, Jeppesen JV, Kumar A, Kalra B, Ernst E, Andersen CY. O-081 High variability of molecular isoforms of AMH in follicular fluid and granulosa cells from human small antral follicles. Front Endocrinol (Lausanne). 2021 Mar 2;12:617523. doi: 10.3389/fendo.2021.617523

All Products Cited: AMH (pico) ELISA AL-124; Various AMH Isoform Assays

 

Mamsen LS, Munthe-Fog L, Petersen TS, Jeppesen JV, Møllgård K, Grøndahl ML, Larsen A, Ernst E, Oxvig C, Kumar A, Kalra B, Andersen CY. Reply: Methodological considerations in measuring different AMH splice forms using ELISA: validity of proAMH ELISA. Mol Hum Reprod. 2016 May;22(5):374-5.

All Products Cited: AMH (pico) ELISA AL-124

 

Marquez K, Hoyos LR. Serum levels of anti-Mullerian hormone (AMH): More than meets the eye. F&S Reports. 2024 Feb 19; S2666-3341(24)00039-4. doi: 10.1016/j.xfre.2024.02.010.

All Products Cited: AMH (pico) ELISA AL-124

 

Marsh EE, Bernardi LA, Steinberg ML, de Chavez PJ, Visser JA, Carnethon MR, Baird DD. Novel correlates between antimullerian hormone and menstrual cycle characteristics in African-American women (23–35 years-old). Fertil Steril. 2016 Apr 23. pii: S0015-0282(16)61100-7. Epub ahead of print.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

McLennan IS, Koishi K, Batchelor NJ, Pankhurst MW. Mice with either diminished or elevated levels of anti-Müllerian hormone have decreased litter sizes. Biol Reprod. 2018 Jan 1;98(1):54-62. doi: 10.1093/biolre/iox151. PMID: 29177503.

All Products Cited: AMH (pico) ELISA AL-124

 

Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, Jakiel G, Maciejewska-Jeske M, Lukaszuk K. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest. 2016 Nov;39(11):1259-1265.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Meng L, McLuskey A, Dunaif A, Visser JA. Functional analysis of rare anti-Müllerian hormone protein-altering variants identified in women with PCOS. Mol Hum Reprod. 2023;29(5). doi:10.1093/molehr/gaad011.

All Products Cited: AMH (pico) ELISA AL-124

 

Moolhuijsen L, Meun C, Louwers Y, Broer L, Uitterlinden A, Laven J, Visser J, MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–208, https://doi.org/10.1210/js.2019-MON-208

All Products Cited: AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Louwers YV, Laven JSE, Visser JA. Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3714-e3722. doi: 10.1210/clinem/dgac370. PMID: 35737957. PMCID: PMC9387710.

All Products Cited: AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Louwers YV, Laven JSE, Visser JA. Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome.Poster Session at the 1st European Symposium on Animal Reproduction, 21st – 23rd September 2023, Nantes, France

All Products Cited: AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Louwers YV, McLuskey A, Broer L, Uitterlinden AG, Verdiesen RMG, Sisk RK, Dunaif A, Laven JSE, Visser JA. Association between an AMH promoter polymorphism and serum AMH levels in PCOS patients. Human Reproduction, 2022, deac082, https://doi.org/10.1093/humrep/deac082

All Products Cited: AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361–73. doi: 10.1210/clinem/dgaa513. PMID: 32770239; PMCID: PMC7486884

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Visser JA. . Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361-3373. doi: 10.1210/clinem/dgaa513

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Morse H. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer. [Dissertation, 2017]. Lund (Sweden): Lund University.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Nichols H, Baird D, Stanczyk F. Anti-Müllerian Hormone Concentrations in Premenopausal Women and Breast Cancer Risk. Cancer Prevention Research. 2015 April 14 epub ahead of print.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Oktay KH, Bedoschi G, Goldfarb SB, Taylan E, Titus S, Palomaki GE, Cigler T, Robson M, Dickler MN. . Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. Fertil Steril. 2020 Jun;113(6):1251-1260.e1. doi: 10.1016/j.fertnstert.2020.01.033

All Products Cited: AMH (pico) ELISA AL-124

 

Oktay KH, Turan V, Bedoschi G, Abdo N, Bang H, Goldfarb S. A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants. Cancer Med. 2023 Sep;12(18):19225-19233. doi: 10.1002/cam4.6527. Epub 2023 Sep 12. PMID: 37698031; PMCID: PMC10557848.

All Products Cited: AMH (pico) ELISA AL-124

 

Pankhurst MW, Leathart BL, Batchelor NJ, McLennan IS. The Anti-Müllerian Hormone Precursor (proAMH) Is Not Converted to the Receptor-Competent Form (AMHN,C) in the Circulating Blood of Mice. Endocrinology. 2016 Apr;157(4):1622-9. Epub 2016 Feb 1.

All Products Cited: AMH (pico) ELISA AL-124

 

Pilsgaard F, Grynnerup AG, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling. Acta Obstet Gynecol Scand. 2018 Feb 24.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Purdue-Smithe AC, Whitcomb BW, Manson JE, Hankinson SE, Troy LM, Rosner BA, Bertone-Johnson ER. . Vitamin D Status Is Not Associated with Risk of Early Menopause. J Nutr. 2018 Sep 1;148(9):1445-1452. doi: 10.1093/jn/nxy129

All Products Cited: AMH (pico) ELISA AL-124

 

Ramezani Tehrani F, Sheidaei A, Firouzi F, Tohidi M, Azizi F, Behboudi-Gandevani S. Does the Anti-Mullerian Hormone Decline Rate Improve the Prediction of Age at Menopause?. Front Endocrinol (Lausanne). 2021 Sep 16;12:727229. doi: 10.3389/fendo.2021.727229. eCollection 2021

All Products Cited: AMH (pico) ELISA AL-124

Rivak P, Sachin B. Variation in the Measurement of Anti-Müllerian Hormone – What Are the Laboratory Issues?. Front Endocrinol (Lausanne). 2021 Sep 3;12:719029. doi: 10.3389/fendo.2021.719029

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Robertson DM, Kumar A, Kalra B, Shah S, Pruysers E, Vanden Brink H, Chizen D, Visser JA, Themmen AP, Baerwald A. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays. Menopause. 2014 Dec; 21(12):1277-86.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Robertson DM, Lee CH, Baerwald A. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age. Endocrinol Diabetes Metab. 2020 Aug 8;4(2):e00172. doi: 10.1002/edm2.172. PMID: 33855196; PMCID: PMC8029535.

All Products Cited: AMH (pico) ELISA AL-124

 

Rodriguez-Purata J, Luna M, Cervantes E, Lee J, Whitehouse M, Copperman A, Bandler B. Very Low Levels of Anti-Mullerian Hormone (AMH) in a Large Cohort of ART Patients. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH (pico) ELISA AL-124

 

Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R. Anti-Müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021;22(12507):1-12. doi:10.3390/ijms222212507.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Ruth KS, Soares ALG, Borges MC, Eliassen AH, Hankinson SE, Jones ME, Kraft P, Nichols HB, Sandler DP, Schoemaker MJ, Taylor JA, Zeleniuch-Jacquotte A, Lawlor DA, Swerdlow AJ, Murray A. Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan. Hum Mol Genet. 2019 Apr 15;28(8):1392-1401. doi: 10.1093/hmg/ddz015

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Saito A, Akira I, Tomoko N, Satoko O, Bayasula, Tomohiko M, Nao K, Chiharu I, Sachiko T, Maki G, Fumitaka K. Involvement of mesosalpinx in endometrioma is a possible risk factor for decrease of ovarian reserve after cystectomy: a retrospective cohort study. Saito et al. Reproductive Biology and Endocrinology (2016) 14:72 DOI 10.1186/s12958-016-0210-9

All Products Cited: AMH (pico) ELISA AL-124

 

Santoro N, Kuhn K, Pretzel S, et al. A high-fat eucaloric diet induces reprometabolic syndrome of obesity in normal weight women. PNAS Nexus. 2024 Dec 18; pgad440. doi: 10.1093/pnasnexus/pgad440.

All Products Cited: AMH (pico) ELISA AL-124

Schon S, Jiang C, Ferrell EL, Valbuena F, Neff L, Carnethon M, Marsh EE. Obesity and adiposity are associated with decreased Anti-Mullerian hormone (AMH) levels in a reproductive-aged Latina/LatinX population. J Endocr Soc. 2023;7(Supplement_1). doi:10.1210/jendso/bvad114.1616.

All Products Cited: AMH (pico) ELISA AL-124

 

Shamsa A, Gilchrist RB, Robertson DM, et al. Oocyte-secreted serum biomarkers GDF9 and BMP15 in women with endometriosis. Reprod Sci. 2023;30(3):1521-7. doi: 10.1007/s43032-022-01107-6.

All Products Cited: AMH (pico) ELISA AL-124

 

Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018 Mar;109(3):516-525.e1.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA-124

 

Shankara-Narayana N, Yu C, Savkovic S, Desai R, Fennell C, Turner L, Jayadev V, Conway AJ, Kockx M, Ridley L, Kritharides L, Handelsman DJ. Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgz324. doi: 10.1210/clinem/dgz324. PMID: 32030409.

All Products Cited: AMH (pico) ELISA AL-124

 

Sivanandy MS, Ha SK. The role of serum Anti-Mullerian hormone measurement in the diagnosis of polycystic ovary syndrome. Diagnostics (Basel). 2023;13(907):1-12. doi:10.3390/diagnostics13050907.

All Products Cited: AMH (pico) ELISA AL-124

 

Steiner AZ. AMH as a Predictor of the Final Menstrual Period. J Clin Endocrinol Metab. April 1;105(4):e1908–e1909. https://doi.org/10.1210/clinem/dgaa025

All Products Cited: AMH (pico) ELISA AL-124

 

Straseski J, Lu J, Holt C, Choi M, Kalp K. Analytical Evaluation of the Ansh Labs picoAMH ELISA assay for Anti-Mullerian Hormone. Poster session presented at the 96th Annual Endocrine Society Meeting; 2014 Jun 21-24; Chicago, IL.

All Products Cited: AMH (pico) ELISA AL-124

 

Su HI, Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk FZ. Comparability of antimüllerian hormone levels among commercially available immunoassays. Fertility and Sterility. 2014 Jun; 101(6):1766-72.e1.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Toribio M, Neilan TG, Awadalla M, Stone LA, Rokicki A, Rivard C, Mulligan CP, Cagliero D, Fourman LT, Stanley TL, Ho JE, Triant VA, Burdo TH, Nelson MD, Szczepaniak LS, Zanni MV. Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6090-6100. doi: 10.1210/jc.2019-01096. PMID: 31393564; PMCID: PMC6954489.

All Products Cited: AMH (pico) ELISA AL-124

 

Upson K, Chin HB, Marsh EE, Baird DD. Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women. J Womens Health (Larchmt). 2019 Dec;28(12):1711-1720. doi: 10.1089/jwh.2018.7382

All Products Cited: AMH (pico) ELISA AL-124

 

Verdiesen RM, van der Schouw YT, van Gils CH, et al. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv. 2020 Nov 3;2020.10.29.20221390. doi: 10.1101/2020.10.29.20221390

All Products Cited: AMH (pico) ELISA AL-124

 

Verdiesen RMG, Onland-Moret NC, van Gils CH, Stellato RK, Spijkerman AMW, Picavet HSJ, Broekmans FJM, Verschuren WMM, van der Schouw YT. Anti-Müllerian hormone levels and risk of type 2 diabetes in women. Diabetologia. 2021 Feb;64(2):375-384. doi: 10.1007/s00125-020-05302-5. Epub 2020 Oct 13. PMID: 33048171; PMCID: PMC7801305.

All Products Cited: AMH (pico) ELISA AL-124

 

Welsh P, Smith K, Nelson SM. A single-centre evaluation of two new Anti-Mullerian Hormone assays and comparison with the current clinical standard assay. Human Reproduction. 2014 May; 29(5):1035-41.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Whitcomb BW, Purdue-Smithe A, Hankinson SE, Manson JE, Rosner BA, Bertone-Johnson ER. Menstrual Cycle Characteristics in Adolescence and Early Adulthood Are Associated With Risk of Early Natural Menopause. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3909-3918. doi: 10.1210/jc.2018-01110. PMID: 30060103; PMCID: PMC6179161.

All Products Cited: AMH (pico) ELISA AL-124

 

White A, Sandler D, D’Aloisio A, Stanczyk F, Whitworth K, Baird D, Nichols H. Anti-Mullerian hormone (AMH) in relation to tobacco and marijuana use and sources of indoor heating/cooking. Fertility and Sterility. First published online May 27, 2016.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Wise LA, Wang TR, Mikkelsen EM, Wesselink AK, Calafat AM, Wegienka G, Geller RJ, Coleman CM, Willis MD, Marsh EE, Schildroth S, Botelho JC, Messerlian-Lambert G, Hatch EE. Per- and Polyfluoroalkyl Substances and Anti-Müllerian Hormone Concentrations in Two Preconception Cohort Studies. Environ Health Perspect. 2023 Oct;131(10):107703. doi: 10.1289/EHP12592. Epub 2023 Oct 26. PMID: 37882725; PMCID: PMC10601879.

All Products Cited: AMH (pico) ELISA AL-124; AMH ELISA AL-105

 

Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, Qiao J. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update. Innovation (Camb). 2021 Feb 9;2(1):100091. doi: 10.1016/j.xinn.2021.100091. PMID: 34557745; PMCID: PMC8454570.

All Products Cited: AMH (pico) ELISA AL-124; AMH ELISA AL-105

 

Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, Qiao J. Clinical Applications of Serum Anti-Mullerian Hormone Measurements in Both Males and Females: An Update. Innovation (N Y). 2021 Feb 9;2(1):100091. doi: 10.1016/j.xinn.2021.100091

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

AMH
AMH (Rat/Mouse) ELISA AL-113
Aiken CE, Tarry-Adkins JL, Ozanne SE. Transgenerational Developmental Programming of Ovarian Reserve. Sci Rep. 2015 Nov 3;5:16175. doi: 10.1038/srep16175

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Aiken CE, Tarry-Adkins JL, Ozanne SE. Transgenerational Developmental Programming of Ovarian Reserve. Scientific Reports, 5:16175. Published 2015 Nov 3.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Arroyo E, Patiño C, Ciccarelli M, Raudsepp T, Conley A, Tibary A. Clinical and Histological Features of Ovarian Hypoplasia/Dysgenesis in Alpacas. Front Vet Sci. 2022 Mar 25;9:837684. doi: 10.3389/fvets.2022.837684. PMID: 35400100; PMCID: PMC8990812.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Barrett, C. Effects of Photoperiod on Novelty Preference in Preadolescent Siberian Hamster (Phodopus sungorus) Pups. [Thesis, 2014]. Ithaca (NY)]: Cornell University.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGF-I (Rat/Mouse) ELISA AL-137; PAPP-A Neutralizing Antibodies

 

Bourgneuf C, Bailbé D, Lamazière A, Dupont C, Moldes M, Farabos D, et al. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun. 2021;12(1064):1-13. doi:10.1038/s41467-021-21308-y.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Carolino ROG, Barros PT, Kalil B, Anselmo-Franci J. . Endocrine profile of the VCD-induced perimenopausal model rat. PLoS One. 2019 Dec 30;14(12):e0226874. doi: 10.1371/journal.pone.0226874

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Devillers MM, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol. 2019 Feb 1;240(2):215-228. doi: 10.1530/JOE-18-0313. PMID: 30403655.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Dopavogui L, Cadoret F, Loison G, El Fouikar S, Frenois FX, Giton F, et al. Pre- and postnatal dietary exposure to a pesticide cocktail disrupts ovarian functions in 8-week-old female mice. Int J Mol Sci. 2022;23(7525):1-17. doi:10.3390/ijms23147525.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Habara O, Logan CY, Kanai-Azuma M, Nusse R, Takase HM. WNT signaling in pre-granulosa cells is required for ovarian folliculogenesis and female fertility. Development. 2021 May 1;148(9):dev198846. doi: 10.1242/dev.198846

All Products Cited: AMH (Rat/Mouse) ELISA AL-113; Inhibin A (Equine / Canine / Rodent) ELISA AL-161

 

Hoek J, van Houten E, Kramer P, McLuskey A, Karels B, Themmen A, Visser A. Analysis of the Metabolic Phenotype of Female Mice Lacking Anti-Mullerian Hormone Signaling. Poster session presented at the 96th Annual Endocrine Society Meeting; 2014 Jun 21-24; Chicago, IL.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Hohos NM, Elliott EM, Cho KJ, Lin IS, Rudolph MC, Skaznik-Wikiel ME. . High-Fat Diet-Induced Dysregulation of Ovarian Gene Expression is Restored with Chronic Omega-3 Fatty Acid Supplementation. Mol Cell Endocrinol. 2020 Jan 1;499:110615. doi: 10.1016/j.mce.2019.110615

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Holland S, Prescott M, Pankhurst M, Campbell RE. The infuence of maternal androgen excess on the male reproductive axis. Sci Rep . 2019 Dec 11;9(1):18908. doi: 10.1038/s41598-019-55436-9.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Kalem MN, Anadol E, Kalem Z, et al. A rat study on the PTEN expression in ovarian tissue in PCOS and folliculogenesis. Sci Rep. 2023 Dec;13:20774. doi: 10.1038/s41598-023-47809-y.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Kumar A, Kalra B, Patel A, Shah S. New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105; AMH (Bovine) ELISA AL-114; AMH (Canine/Feline) ELISA AL-116; AMH (Equine) ELISA AL-115; AMH (Rat/Mouse) ELISA AL-113

 

Luba Sominsky, Simin Younesi, Simone N De Luca, Sophie M Loone, Kylie M Quinn, Sarah J Spencer, Ovarian follicles are resistant to monocyte perturbations—implications for ovarian health with immune disruption, Biology of Reproduction, Volume 105, Issue 1, July 2021, Pages 100–112, https://doi.org/10.1093/biolre/ioab049

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Mohamed SA, Shalaby SM, Abdelaziz M, Brakta S, Hill WD, Ismail N, Al-Hendy A. Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure. Reprod Sci. 2017 Jan 1:1933719117699705.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Montano GA, Robeck TR, Steinman KJ, O’Brien JK. Circulating anti-Müllerian hormone concentrations in relation to age and season in male and female beluga (Delphinapterus leucas). Reprod Fertil Dev.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Razawy W, Alves CH, Koedam M, Asmawidjaja PS, Mus AMC, Oukka M, Leenen PJM, Visser JA, van der Eerden BCJ, Lubberts E. IL‑23 receptor defciency results in lower bone mass via indirect regulation of bone formation. Sci Rep. 2021 May 13;11(1):10244. doi: 10.1038/s41598-021-89625-2. PMID: 33986359; PMCID: PMC8119722.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Robert T Rydze, Bethany K Patton, Shawn M Briley, Hannia Salazar Torralba, Gregory Gipson, Rebecca James, Aleksandar Rajkovic, Thomas Thompson, Stephanie A Pangas, Deletion of Gremlin-2 alters estrous cyclicity and disrupts female fertility in mice, Biology of Reproduction, Volume 105, Issue 5, November 2021, Pages 1205–1220, https://doi.org/10.1093/biolre/ioab148

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Rodriguez A, Briley SM, Patton BK, Tripurani SK, Rajapakshe K, Coarfa C, Rajkovic A, Andrieux A, Dejean A, Pangas SA. . Loss of the E2 SUMO-conjugating enzyme Ube2i in oocytes during ovarian folliculogenesis causes infertility in mice
. Development. 2019 Dec 2;146(23):dev176701. doi: 10.1242/dev.176701

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Rodriguez KF, Brown PR, Amato CM, Nicol B, Liu CF, Xu X, Yao HH. Somatic cell fate maintenance in mouse fetal testes via autocrine/paracrine action of AMH and activin B. Nat Commun. 2022;13(4130):1-12. doi:10.1038/s41467-022-31486-y.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113; Activin B (Mouse) ELISA AL-156

 

Roy S, Gandra D, Seger C, Biswas A, Kushnir VA, Gleicher N, Kumar TR, Sen A. Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells. Endocrinology. 2018 Sep 1;159(9):3433-3445.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Ruohonen ST, Gaytan F, Usseglio Gaudi A, Velasco I, Kukoricza K, Perdices-Lopez C, Franssen D, Guler I, Mehmood A, Elo LL, Ohlsson C, Poutanen M, Tena-Sempere M. Selective loss of kisspeptin signaling in oocytes causes progressive premature ovulatory failure. Hum Reprod. 2022 Apr 1;37(4):806-821. doi: 10.1093/humrep/deab287. PMID: 35037941; PMCID: PMC8971646.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Ruth KS, Day FR, Hussain J, et al. Genetic insights into biological mechanisms governing human ovarian ageing. Nature. 2021 Aug;596(7872):393-397. doi: 10.1038/s41586-021-03779-7. Epub 2021 Aug 4

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Sara M, Shahinaz S, Soumia B, Lelyand E, Amro E, Ayman A. Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency. Biomedicines. 2019 Jan 18;7(1):7. doi: 10.3390/biomedicines7010007

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Silva MSB, Decoster L, Delpouve G, Lhomme T, Ternier G, Prevot V, Giacobini P. Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice. eBioMedicine. 2023;97:104850. doi:10.1016/j.ebiom.2023.104850.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Wang Z, Shen M, Xue P, DiVall SA, Segars J, Wu S. Female Offspring From Chronic Hyperandrogenemic Dams Exhibit
Delayed Puberty and Impaired Ovarian Reserve. Endocrinology. 2018 Feb 1;159(2):1242-1252. doi: 10.1210/en.2017-03078

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Winship AL, Griffiths M, Lliberos Requesens C, Sarma U, Phillips KA, Hutt KJ. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation. Hum Reprod. 2020 Aug 1;35(8):1864-1874. doi: 10.1093/humrep/deaa128. PMID: 32604417.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Ygnacio RHC. Determinación de la Reserva Ovárica en Alpacas Mediante la Concentración de la Hormona Anti-Mülleriana (AMH) en el Plasma Sanguíneo. [Thesis, 2017]. Lima (Peru)]: Universidad Nacional Agraria la Molina Escuela de Posgrado Maestría en Producción Animal.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Zheng M, Cadenas J, Pors SE, Esa T, Kristensen SG, Mamsen LS, Adrados CS, Andersen CY. Reducing 3D hydrogel stiffness, addition of oestradiol in a physiological concentration, and increasing FSH concentration improve in vitro growth of murine preantral follicles. Int J Mol Sci. 2023;24(12499):1-13. doi:10.3390/ijms241512499.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

Zhou Y, Scott KL, Quin E, Pankhurst MW. Serum Anti-Müllerian Hormone Is an Effective Indicator of Antral Follicle Counts but Not Primordial Follicle Counts. Endocrinology. 2023 Jun 26;164(8):bqad098. doi: 10.1210/endocr/bqad098. PMID: 37337678; PMCID: PMC10318615.

All Products Cited: AMH (Rat/Mouse) ELISA AL-113

 

AMH
AMH (Total Mature) ELISA AL-133
L Melado Vidales, B Lawrenz, A Kumar, B Kalra, B Ata, R Patel, E Kalafat, R Loja Vitorino, I ElKhatib, H Fatemi, O-067 Does the measurement of different AMH isoforms in poor responder patients improve the prediction of ovarian response?, Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.081, https://doi.org/10.1093/humrep/dead093.081

All Products Cited: AMH (PCOCheck) ELISA AL-196; AMH (pico) ELISA AL-124; AMH ELISA AL-105; AMH (Total Mature) ELISA AL-133

 

 

AMH
AMH CLIA AL-205
Attaelmannan M, Pandian R, Sadri M, Thomassian K, Khachatryan S, Kumar A. Development of a Broad-range, Sensitive, and Specific Immunoassay for Anti-Müllerian Hormone (AMH) with No Dilution Issues. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH CLIA AL-205

 

de Kat AC, van der Schouw YT, Eijkemans R, Verschuren M, Broekmans FJ. Insulin-Like Growth Factor-2 (IGF2) Production and Regulation in Macaque Preantral Follicles During 3-Dimensional Culture. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH CLIA AL-205

 

Visser J, Laven J, McLuskey A, Louwers Y, van Dorp W, Themmen A, Kalra B, Patel A, Kumar A. Development of a Well Characterized Ultra-Sensitive Human Anti-Mullerian Hormone Chemiluminescence Assay: Evaluation of Potential Clinical Applications. Poster session presented at 95th Annual Endocrine Society Meeting; 2013; Jun 15-18; San Diego, CA.

All Products Cited: AMH CLIA AL-205

 

AMH
AMH ELISA AL-105
Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod. 2017 Apr 1;32(4):923-936. doi: 10.1093/humrep/dex036. PMID: 28333238; PMCID: PMC6251677.

All Products Cited: AMH ELISA AL-105

 

Agabain E, Mohamed H, Elsheikh AE, Hamdan HZ, Adam I. Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia. BMC Res Notes. 2017 Jun 24;10(1):217

All Products Cited: AMH ELISA AL-105

 

Ahmed N, Batarfi AA, Bajouh OS, Bakhashab S. Serum Anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms. Diagnostics (Basel). 2019;9(4):136. doi:10.3390/diagnostics9040136.

All Products Cited: AMH ELISA AL-105

 

Alexis L Oldfield, Heidi Vanden Brink, Faith E Carter, Brittany Y Jarrett, Marla E Lujan. Obesity is associated with alterations in antral follicle dynamics in eumenorrheic women, Human Reproduction, Volume 38, Issue 3, March 2023, Pages 459–470, https://doi.org/10.1093/humrep/dead007

All Products Cited: AMH ELISA AL-105

 

Al-Hakeim HK, Jebur IM, Alkhafaji RS. Serum Anti-Zona Pellucida Antibodies Level is Correlated with Estradiol Level in Women with In Vitro Fertilization Failure. Int J Pharm Pharm Sci, Vol 8, Issue 5, 41-44.

All Products Cited: AMH ELISA AL-105

 

Anagnostou E, Mavrogianni D, Prifti I-N, Dimitroulia E, Protopapas A, Drakakis P, Loutradis D. The role of FSHR SNPs and AMH in follicular fluid and serum in ovarian response during COS: a pilot study. Int J Reprod Med. 2021;2021:8685158. doi:10.1155/2021/8685158.

All Products Cited: AMH ELISA AL-105

 

Anderson R, Fairbairn C, Lucas D, Gaudoin, Fleming R. Analysis of Two Assays for the Measurement of AMH in Women with Low Ovarian Reserve. Poster session presented at: American Society for Reproductive Medicine; 2013 Oct 12-17; Boston, MA

All Products Cited: AMH ELISA AL-105

 

Angley M, Spencer JB, Lim SS, Howards PP. Anti-Müllerian hormone in African-American women with systemic lupus erythematosus. Lupus Sci Med. 2020 Nov;7(1):e000439. doi: 10.1136/lupus-2020-000439. PMID: 33132225; PMCID: PMC7607611.

All Products Cited: AMH ELISA AL-105

 

Aramesh S, Alifarja T, Jannesar R, Ghaffari P, Vanda R, Bazarganipour F. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study. BMC Endocr Disord. 2021 Jun 21;21(1):126. doi: 10.1186/s12902-021-00786-7. PMID: 34154571; PMCID: PMC8218405.

All Products Cited: AMH ELISA AL-105

 

Araujo DB, Yamakami LYS, Aikawa NE, Bonfa E, Vianna VST, Pasoto SG, Pereira RMR, Serafin PC, Borda EF, Silva CA. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? . Scand J Rheumatol. 2014; 43:503-511

All Products Cited: AMH ELISA AL-105

 

Asada Y, Tsuiki M, Sonohara M, Fukunaga N, Hattori Y, Inoue D, Ito R, Hashiba Y. P214 – Anti-Müllerian hormone (AMH) as a predictor of oocyte yield following controlled ovarian stimulation in rhesus macaque (Macaca mulatta). Reprod Med Biol. 2019 Apr 8;18(3):273-277. doi: 10.1002/rmb2.12271. PMID: 31312106; PMCID: PMC6613014.

All Products Cited: AMH ELISA AL-105

 

Atkins HM, Willson CJ, Silverstein M, Jorgensen M, Floyd E, Kaplan JR, Appt SE. Characterization of ovarian aging and reproductive senescence in vervet monkeys (Chlorocebus aethiops sabaeus). Comparative Medicine. 2014 Feb; 64(1):55-62.

All Products Cited: AMH ELISA AL-105

 

Aydogan B, Mirkin S. The utility of measuring anti-Müllerian hormone in predicting menopause. Climacteric. 2015 Dec; 18(6):777-89.

All Products Cited: AMH ELISA AL-105

 

Baba T, Ting AY, Tkachenko O, Xu J, Stouffer RL. Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro. Hum Reprod. 2017 Dec 1;32(12):2456-2464.

All Products Cited: AMH ELISA AL-105

 

Bala J, Seth S, Dhankhar R, Ghalaut VS. Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma. J Clin Diagn Res. 2016 Feb;10(2):BC19-21.

All Products Cited: AMH ELISA AL-105

 

Bar-Sadeh, B., Amichai, O.E., Pnueli, L. et al. Epigenetic regulation of 5α reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing. BMC Biol 20, 11 (2022). https://doi.org/10.1186/s12915-021-01219-6

All Products Cited: AMH ELISA AL-105

 

Batarfi AA, Filimban N, Bajouh OS, et al. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia. BMC Med Genet. 2019;20:144. doi: 10.1186/s12881-019-0876-x.

All Products Cited: AMH ELISA AL-105

 

Bedenk J, Vrtačnik-Bokal E, Virant-Klun I. The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet . 2020 Jan;37(1):89-100. doi: 10.1007/s10815-019-01622-7. Epub 2019 Nov 21

All Products Cited: AMH ELISA AL-105

 

Bernardi L, Chavez, Baird D, Marnethon M, Marsh E. Factors associated with low Anti-Mullerian Hormone (AMH) levels in young African American women. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH ELISA AL-105

 

Bingqian Z, Yueru M, Xiao J, Chao L, Huihui Z , Linlin C, Zi-Jiang C. IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels. Zhang et al. Reproductive Biology and Endocrinology (2019) 17:58 https://doi.org/10.1186/s12958-019-0498-3

All Products Cited: AMH ELISA AL-105

 

Borgbo T, Klučková H, Macek M, Chrudimska J, Kristensen SG, Hansen LL, Anderssen CY. The Common Follicle-Stimulating Hormone Receptor (FSHR) Promoter Polymorphism FSHR −29G > A Affects Androgen Production in Normal Human Small Antral Follicles. Frontiers in Endocrinology. 2017;8:122.

All Products Cited: AMH ELISA AL-105

 

Bovell R, Comizzoli P, Place NJ. (P-016) Pre-Stimulation Level of Serum Anti-Müllerian Hormone is Associated with Subsequent Quality of Ovarian Response to eCG/pLH in the Domestic Cat (Felis catus). Poster Session presented at the Society Study of Reproduction; 2024; July 15-19; Dublin, Ireland

All Products Cited: AMH ELISA AL-105

 

Brittany Jarrett, Heidi Vanden Brink, Kathleen Hoeger, Steven Spandorfer, Roger Pierson, Donna Chizen, Marla Lujan, MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–215, https://doi.org/10.1210/js.2019-MON-215

All Products Cited: AMH ELISA AL-105

 

Brittany Jarrett, Heidi Vanden Brink, Kathleen Hoeger, Steven Spandorfer, Roger Pierson, Donna Chizen, Marla Lujan, MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–215, https://doi.org/10.1210/js.2019-MON-215

All Products Cited: AMH ELISA AL-105

 

Bungum L, Tagevi J, Jokubkiene L, Bungum M, Giwercman A, Macklon N, Andersen CY, Klausen TW, Torring N, Kumar A, Skouby SO. The Impact of the Biological Variability or Assay Performance on AMH Measurements: A Prospective Cohort Study With AMH Tested on Three Analytical Assay-Platforms. Front. Endocrinol., 16 October 2018.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA-124

 

Burks HR, Ross L, Opper N, Paulson E, Stanczyk F, Chung K. Can highly sensitive antimullerian hormone testing predict failed response to ovarian stimulation? . Fertility and Sterility. 2015 Sep; 104(3):643-648.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Bustillo M, Alford C, Collazo I, Pomeroy K. The Correlation of Anti-Mullerian Hormone Concentrations to Oocyte Maturity at Retrieval. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH ELISA AL-105

 

Butts S, Senapati S, Coutifaris C, Bartolomei M. Adipocity and Fetal Follicular Development: An association between Leptin and Cord Blood AMH. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Butts S, Senapati S, Coutifaris C, Bartolomei M. Are Markers of Ovarian Reserve Lower in Women with Unexplained Infertility Compared to Community Controls?. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Charlotte Paul. L’hormone anti-müllerienne dans le syndrome des ovaires polykystiques. Quelle valeur diagnostique ? Évaluation du dosage de l’hormone anti-müllerienne à l’aide du kit Ultra-sensitive Ansh Labs assays dans le centre d’Aide Médicale à la. Médecine humaine et pathologie. 2015.

All Products Cited: AMH ELISA AL-105

 

Chen Y, Pei H, Chang Y, Chen Y, Wang H, Xie H, Yao S. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum Anti-Mullerian Hormone: a prospective cohort study. Journal of Ovarian Research 2014 Nov; 7(1):108.

All Products Cited: AMH ELISA AL-105

 

Cheru LT, Saylor CF, Fitch KV, Looby SE, Lu M, Hoffmann U, Stanley TL, Lo J. . Low vitamin D is associated with coronary atherosclerosis in women with HIV. Antivir Ther. 2019;24(7):505-512. doi: 10.3851/IMP3336

All Products Cited: AMH ELISA AL-105

 

Cui L, Qin Y, Gao X, Lu J, Geng L, Ding L, Qu Z, Zhang X, Chen Z. Anti-Mullerian Hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause. Reproductive Endocrinology. 2016 Feb, 105(2):481-5.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Cui L, Sheng Y, Sun M, Hu J, Qin Y, Chen ZJ. Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mülerrian Hormone. PLoS One. 2016 Jun 6;11(6):e0156130.

All Products Cited: AMH ELISA AL-105

 

Davis S, Lahlou N, Bardsley M, Temple M, Kowal K, Ross J. Longitudinal Study of Boys with Klinefelter Syndrome Gives Evidence of Prepubertal Testis Defect. Abstract presented at 97th Annual Endocrine Society Meeting; 2015; Mar 5-8; San Diego, CA.

All Products Cited: AMH ELISA AL-105

 

de Michele F, Poels J, Vermeulen M, Ambroise J, Gruson D, Guiot Y, Wyns C. Haploid Germ Cells Generated in Organotypic Culture of Testicular Tissue From Prepubertal Boys. Front Physiol. 2018 Oct 9;9:1413. doi: 10.3389/fphys.2018.01413. eCollection 2018

All Products Cited: AMH ELISA AL-105

 

de Michele F, Poels J, Weerens L, Petit C, Evrard Z, Ambroise J, Gruson D, Wyns C. Preserved seminiferous tubule integrity with spermatogonial survival and induction of Sertoli and Leydig cell maturation after long-term organotypic culture of prepubertal human testicular tissue. Hum Reprod. 2017 Jan;32(1):32-45. Epub 2016 Dec 6.

All Products Cited: AMH ELISA AL-105

 

de Souza FH, da Silva CA, Yamakami LY, dos Santos Trindade Viana V, Bonfa E, Shinjo SK. Reduced ovarian reserve in patients with adult polymyositis. Clin Rheumatol. 2015 Oct;34(10):1795-9.

All Products Cited: AMH ELISA AL-105

 

Di F, Liu J, Li S, Yao G, Hong Y, Chen Z-J, Li W, Du Y. ATF4 contributes to ovulation via regulating COX2/PGE2 expression: A potential role of ATF4 in PCOS. Front Endocrinol (Lausanne). 2018;9:669. doi:10.3389/fendo.2018.00669.

All Products Cited: AMH ELISA AL-105

 

Drummer C, Münzker J, Heistermann M, Becker T, Mißbach S, Behr R. Performance of marmoset monkeys as embryo donors is reflected by different stress-related parameters. Animals (Basel). 2022;12(2414):1-19. doi:10.3390/ani12182414.

All Products Cited: AMH ELISA AL-105

 

Du YY, Guo N, Wang YX, Hua X, Deng TR, Teng XM, Yao YC, Li YF. Urinary phthalate metabolites in relation to serum anti-Müllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis. Du et al. Reproductive Health (2018) 15:33 https://doi.org/10.1186/s12978-018-0469-8

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Dumont A, Robin G, Catteau-Jonard, Dewailly D. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reproductive biology and Endocrinology. 2015 13:137.

All Products Cited: AMH ELISA AL-105

 

Eckersten D, Giwercman A, Bruun L, Christensson A. Anti-Mullerian Hormone, a sertoli cell-derived marker, is decreased in plasma of male patients in all stages of chronic kidney disease. Andrology. 2015 Nov; 3(6):1160-4.

All Products Cited: AMH ELISA AL-105

 

Eckersten D, Tsatsanis C, Giwercman A, Bruun L, Pihlsgård M, Christensson A. MicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease
. Nephron Extra 2017;7:33-4

All Products Cited: AMH ELISA AL-105

 

Findley AD, Siedhoff MT, Hobbs KA, Steege JF, Carey ET, McCall CA, Steiner AZ. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertility and Sterility. 2013 Dec; 100(6):1704-8.

All Products Cited: AMH ELISA AL-105

 

Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reproductive BioMedicine Online. 2015 epub ahead of print.

All Products Cited: AMH ELISA AL-105

 

Fuentes A, Sequeira K, Tapia-Pizarro A, Muñoz A, Salinas A, Céspedes P, Escalona J, Godoy A. Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study. Front Endocrinol (Lausanne). 2019 Jul 16;10:458. doi: 10.3389/fendo.2019.00458. eCollection 2019

All Products Cited: AMH ELISA AL-105

 

Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ,, Visvanathan K,, Liu M,, Zeleniuch-Jacquotte A. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer. 2018 Jun 1;142(11):2215-2226.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Gorsic LK, Dapas M, Legro RS, Hayes MG, Urbanek M. Functional Genetic Variation in the Anti-Mullerian Hormone Pathway in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2855-2874. doi: 10.1210/jc.2018-02178.

All Products Cited: AMH ELISA AL-105

 

Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG, Teixeira JM, Dunaif A, Urbanek M. Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2862-2872.

All Products Cited: AMH ELISA AL-105

 

Greenwood EA, Cedars MI, Santoro N, Eisenberg E, Kao CN, Haisenleder DJ, Diamond MP, Huddleston HG. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility. Fertil Steril. 2017 Dec;108(6):1070-1077.

All Products Cited: AMH ELISA AL-105

 

Gruson D, Homsak E. Measurement of Anti-Mullerian Hormone Performance of a New UltraSensitive Immunoassay. Clin Biochem 2015 Apr; 48(6):453-5.

All Products Cited: AMH ELISA AL-105

 

Gruson D. Performance of a New Ultra-Sensitive Immunoassay for the Measurement of Anti-Müllerian Hormone. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Gruson D. Performance of a New Ultra-Sensitive Immunoassay for the Measurement of Anti-Müllerian Hormone. Poster session presented at: EuroMedLab; 2015 Oct 22-24; Paris, France.

All Products Cited: AMH ELISA AL-105

 

Guedikian AA, Lee AY, Grogan TR, Abbott DH, Largaespada K, Chazenbalk GD, Dumesic DA. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome. Fertil Steril. 2018 Mar;109(3):508-515.

All Products Cited: AMH ELISA AL-105

 

Haltia UM, Hallamaa M, Tapper J, Hynninen J, Alfthan H, Kalra B, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors. Gynecol Oncol. 2017 Jan;144(1):83-89.

All Products Cited: AMH ELISA AL-105

 

Haltia UM, Hallamaa M, Tapper J, Hynninen J, Alfthan H, Kalra B, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Färkkilä. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors. Gynecol Oncol. 2017 Jan;144(1):83-89.

All Products Cited: AMH ELISA AL-105

 

Haltia UM, Hallamaa M, Tapper J, Hynninen J, AlLhan H, Ritvos O, Heikinheimo M, Unkila-Kallio L, Perheentupa A, Farkkila A. Diagnostic markers for patients with ovarian granulosa cell tumors; comparative analysis of CA125, HE4, Inhibin B, and AMH. Presented at 8th Ovarian Cancer Research; 2016 May 15-17; Niagra Falls, ON, Canada.

All Products Cited: AMH ELISA AL-105

 

Hariton E, Morris J, Kao CN, Jaswa EG, Quinn MM, Cedars MI, Huddleston HG. An AMH-Based Screening Tool is both Sensitive and Specific for Predicting a Diagnosis of PCOS by Rotterdamn Criteria. Fertilty and Sterility Abstract Only, Volume 114, Issue 3, Supplment E42, September 1, 2020.

All Products Cited: AMH ELISA AL-105

 

Harris BS, Steiner AZ, Jukic AM. Association between Ovarian Reserve and Menstrual Cycle Length. Fertility and Sterility Abstract, Volume 114, Issue 3, Supplement E88, September 01, 2020

All Products Cited: AMH ELISA AL-105

 

Harris BS, Steiner AZ, Jukic AM. Ovarian Reserve Biomarkers and Menstrual Cycle Length in a Prospective Cohort Study. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3748-e3759. doi: 10.1210/clinem/dgab204

All Products Cited: FSH ELISA AL-186; AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Homer MV, Toloubeydokhti T, Lawson MA, Garzo G, Duleba AJ, Chang RJ. Individual 17-Hydroxyprogesterone Responses to hCG Are Not Correlated With Follicle Size in Polycystic Ovary Syndrome. J Endocr Soc. 2019 Feb 7;3(4):687-698. doi: 10.1210/js.2018-00339. PMID: 30918916; PMCID: PMC6411416.

All Products Cited: AMH ELISA AL-105

 

Hong YH, Kim SJ, Kim SK, Lee SC, Jun JH, Jee BC, Kim SH. . Impact of imatinib or dasatinib coadministration on in vitro preantral follicle development and oocyte acquisition in cyclophosphamide-treated mice. Clin Exp Reprod Med. 2020 Dec;47(4):269-276. doi: 10.5653/cerm.2020.03755. Epub 2020 Nov 24

All Products Cited: AMH ELISA AL-105

 

Hosseini E, Nikmard F, Aflatoonian B, Vesali S, Alenabi T, Aflatoonian A, Mehraein F, Aflatoonian R. Controlled Ovarian Stimulation in Endometriosis Patients can be Individualized by Anti-Müllerian Hormone Levels. Acta Endocrinol (Buchar) . Apr-Jun 2017;13(2):195-202. doi: 10.4183/aeb.2017.195.

All Products Cited: AMH ELISA AL-105

 

Hou J, Cook-Andersen H, Su H, Shayya R, Maas K, Burt-Solorzano C, Kumar A, Chang RJ. 17-Hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism, 29(7), pp. 835-840.

All Products Cited: AMH ELISA AL-105

 

Hou J, Maas KH, Cook-Andersen H, Burt-Solorzano CM, Shayya R, Kumar A, Chang RJ. HCG-Stimulated 17OHP Responses and Basal Serum AMH Levels among Adolescent Women with Polycystic Ovary Syndrome. Poster session presented at: American Society for Reproductive Medicine; 2014 Oct 22; Honolulu, Hawaii.

All Products Cited: AMH ELISA AL-105

 

Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS). Hum Reprod. 2020 Oct 1;35(10):2294-2302. doi: 10.1093/humrep/deaa199. PMID: 32918081; PMCID: PMC7518710.

All Products Cited: AMH ELISA AL-105

 

Hsu JY, James KE, Bormann CL, Donahoe PK, Pépin D, Sabatini ME. Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome. Clin Endocrinol Metab. 2018 Nov 1;103(11):4187-4196.

All Products Cited: AMH ELISA AL-105

 

Hu K, Li S, Hunt S, et al. High anti-Mullerian hormone (AMH) is associated with increased risks of ectopic pregnancy in women undergoing fresh embryo transfer cycle, a cohort study. Reprod Biol Endocrinol. 2023;21:18. doi: 10.1186/s12958-022-01038-6.

All Products Cited: AMH ELISA AL-105

 

Huber HF, Considine MM, Jenkins S, Li C, Nathanielsz PW. Reproductive Cycling in Adult Baboons (Papio species) that Were Intrauterine Growth Restricted at Birth Implies Normal Fertility but Increased Psychosocial Stress. J Med Primatol. 2018 Dec;47(6):427-429. doi: 10.1111/jmp.12356

All Products Cited: AMH ELISA AL-105

 

Huber HF, Considine MM, Jenkins S, Li C, Nathanielsz PW. Reproductive cycling in adult baboons (Papio species) that were intrauterine growth restricted at birth implies normal fertility but increased psychosocial stress. J Med Primatol. 2018 Dec;47(6):427-429. doi: 10.1111/jmp.12356. Epub 2018 Jun 29. PMID: 29956833; PMCID: PMC6342511.

All Products Cited: AMH ELISA AL-105

 

Huddleston H, Diamond MP, Cedars M, Santoro N, Legro L, Haisenleder DJ. The Degree of Comparability of Two Commercially Available AMH Immunoassays Varies Across Clinical Populations in Reproductive Medicine. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Huddleston H, Santoro N, Eisenberg E, Haisenleder D, Diamond MP, Cedars M. Patients with Unexplained Infertility do not Show Evidence of Decreased Ovarian Reserve Compared to Controls. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Huiyu X, Guoshuang F, Haiyan W , Yong H, Rui Y, Ying S, Lixue C, Li S, Meng Qian Z, Rong L, Jie Q. A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study. J Assist Reprod Genet . 2020 Apr;37(4):963-972. doi: 10.1007/s10815-020-01700-1. Epub 2020 Apr 21.

All Products Cited: AMH ELISA AL-105

 

Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015 Nov-Dec;21(6):698-710.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-Mullerian Hormone and Assessment of Ovarian Reserve After Ovarian Toxic Treatment, a Systematic Narrative Review. Reproductive Sciences. 2015 May, 22(5):519-26.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F. Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?. Reprod Med Biol (2016) 15:127–136

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Jain M, Kalsi AK, Srivastava A, Gupta YK, Halder A. High Serum Estradiol and Heavy Metals Responsible for Human Spermiation Defect-A Pilot Study. J Clin Diagn Res. 2016 Dec;10(12):RC09-RC13.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Jakus AE, Laronda MM, Rashedi AS, Robinson CM, Lee C, Jordan SW, Orwig KE, Woodruff TK, Shah RN. Tissue Papers” from Organ-Specific Decellularized Extracellular Matrices. Adv Funct Mater. 2017 Sep 13;27(3):1700992. doi: 10.1002/adfm.201700992

All Products Cited: AMH ELISA AL-105

 

Jalili C, Khani Hemmatabadi F, Mansouri K, Bakhtiyari M. Effects of sodium alginate capsules as 3D scaffolds on hormones and gene expression in preantral follicles of mice compared to 2D medium: An experimental study. Int J Reprod BioMed. 2020;18(7):517-530. doi:10.18502/ijrm.v13i7.7369.

All Products Cited: AMH ELISA AL-105

 

Kastora SL, Triantafyllidou O, Kolovos G, Kastoras A, Sigalos G, Vlahos N. Combinational approach of retrospective clinical evidence and transcriptomics highlight AMH superiority to FSH, as successful ICSI outcome predictor. 2020 Jul;37(7):1623-1635. doi: 10.1007/s10815-020-01802-w. Epub 2020 May 20.

All Products Cited: AMH ELISA AL-105

 

Kataoka J, Larsson I, Lindgren E, et al. Circulating Anti-Mullerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention. Reprod Biol Endocrinol. 2022;20:153. doi: 10.1186/s12958-022-01022-0.

All Products Cited: AMH ELISA AL-105

 

Kavoussi SK, Odenwald KC, Boehnlein LM, Summers-Colquitt RB, Pool TB, Swain JE, Jones JM, Lindstrom MJ, Lebovic DI. Antimullerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels<1 ng/mL versus 1–4 ng/mL. Fertility and Sterility. 2015 Sep; 104(3):633-636.

All Products Cited: AMH ELISA AL-105

 

Kim J, You S. High housing density-induced chronic stress diminishes ovarian reserve via granulosa cell apoptosis by angiotensin II overexpression in mice. Int J Mol Sci. 2022;23(8614):1-12. doi:10.3390/ijms23158614.

All Products Cited: AMH ELISA AL-105

 

Kim JY, Tfayli H, Michaliszyn SF, Lee S, Nasr A, Arslanian S. Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome. J Adolesc Health. 2017 Mar;60(3):333-339.

All Products Cited: AMH ELISA AL-105

 

Kim SK, Jee BC, Kim SH. Effects of Supplementation of Human Endometriotic Fluids on In Vitro Mouse Preantral Follicle Culture. Reprod Sci. 2016 Nov 21.

All Products Cited: AMH ELISA AL-105

 

Kim SW, Kim YJ, Shin JH, Kim H, Ku SY, Suh CS, Kim SH, Choi YM. Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after In Vitro Fertilization and Embryo Transfer. Yonsei Med J. 2019 Mar;60(3):285-290. doi: 10.3349/ymj.2019.60.3.285

All Products Cited: AMH ELISA AL-105

 

Kollmann M, Obermayer-Pietsch B, Lerchbaum E, Lang U, Herzog SA, Trummer C, Scheuchenegger A, Ulrich D, Klaritsch P. Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome. J. Clin. Med. 2019, 8, 1817.

All Products Cited: AMH ELISA AL-105

 

Komaravalli PL, Deenadayal M, Usha Rani. VU, Gayam S, Jahan P. Anti-Müllerian hormone is a predictive biomarker for ovarian reserve in young women with ovarian failure – A preliminary study from Southern India. Helix Vol. 2: 661-667 (2015)

All Products Cited: AMH ELISA AL-105

 

Kopp DM, Wilkinson J, Bengtson A, Chipungu E, Pope RJ, Moyo M, Tang JH. Fertility outcomes following obstetric fistula repair: a prospective cohort study. Kopp et al. Reproductive Health (2017) 14:159 DOI 10.1186/s12978-017-0415-1

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Korhonen K, Unkila-Kallio L, Alfthan H, Hämäläinen E, Tiitinen A, Mikkola T, Tapanainen J, Savolainen-Peltonen H. Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women. Arch Gynecol Obstet. 2020;301:1569-1578. doi:10.1007/s00404-020-05556-9.

All Products Cited: AMH ELISA AL-105

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117

 

Kumar A, Kalra B, Patel A, Savjani G, Eklund E, Lambert-Messerlin G. Pre-analytical assessment of AMH stability in human serum using a well-characterized midpro-mature immunoassay. Poster presentation at the European Society for Human Reproduction and Embryology; 2014; Berlin, Germany.

All Products Cited: AMH ELISA AL-105

 

Kumar A, Kalra B, Patel A, Savjani G, Visser JA, Themmen AP, Torchen LC, Dunaif A. Novel Anti-Müllerian Hormone ELISAs: Help Diagnose Polycystic Ovary Syndrome. Poster session presented at: American Association for Clinical Chemistry; 2015; Jul 31-Aug 4; Philadelphia, PA.

All Products Cited: AMH ELISA AL-105

 

Kumar A, Kalra B, Patel A, Shah S. Development of a Well Characterized Ultra-Sensitive Human Anti-Müllerian Hormone (AMH) ELISA. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105

 

Kumar A, Kalra B, Patel A, Shah S. New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: AMH ELISA AL-105; AMH (Bovine) ELISA AL-114; AMH (Canine/Feline) ELISA AL-116; AMH (Equine) ELISA AL-115; AMH (Rat/Mouse) ELISA AL-113

 

Kumar A, Kalra B, Schanne A, Lechtenberg L, Gracia C. Bloodspot AMH may be used to assess the impact of cancer therapies on ovarian reserve. Poster session at American Society for Reproductive Medicine; 2015 Oct 17-21; Baltimore, Maryland

All Products Cited: AMH (DBS) ELISA AL-129

 

L Melado Vidales, B Lawrenz, A Kumar, B Kalra, B Ata, R Patel, E Kalafat, R Loja Vitorino, I ElKhatib, H Fatemi, O-067 Does the measurement of different AMH isoforms in poor responder patients improve the prediction of ovarian response?, Human Reproduction, Volume 38, Issue Supplement_1, June 2023, dead093.081, https://doi.org/10.1093/humrep/dead093.081

All Products Cited: AMH (PCOCheck) ELISA AL-196; AMH (pico) ELISA AL-124; AMH ELISA AL-105; AMH (Total Mature) ELISA AL-133

 

Lahlou N, Santullli P, Guibourdenche J, Beldjord C, Kottler, M, Chapron C, Gompel A. Unexpected Inhibin B, Insulin-like Peptide 3, and Testosterone Production by Mother Ovaries in a Pregnancy with Sustained High hCG Levels. A Clue to Hyperreactio Luteinalis?. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123

 

Lambert-Messerlian G, Plante B, Eklund E, Raker C, Moore R. Levels of antimullerian hormone in serum during the normal menstrual cycle. Fertility and Sterility. 2016 Jan, 105(1).

All Products Cited: AMH ELISA AL-105

 

Lambert-Messerlian G, Steinhoff M, Kumar A, Eklund EE, Moore R. Comparison of Inhibin Alpha Subunit and Antimüllerian Hormone Immunoreactivity in Granulosa Cell and Mucinous Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):71-77.

All Products Cited: Inhibin alpha antibodies; AMH antibodies; Inhibin (Total) ELISA AL-134; AMH ELISA AL-105

 

Lambert-Messerlian G, Straseski JA, Eklund EE, Palomaki GE, Haddow JE. Should Blood Samples Be Collected Under Fasting Conditions for Measurement Of Anti-Mullerian Hormone (AMH) Levels. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Lambert­Messerlian G. The New Egg Timer – Anti­Mullerian Hormone Levels for Assessing Ovarian Reserve. Clinical Laboratory News. Jan 2015:14-18.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Lasprilla-Tovar JD, Henao-Ochoa C, Alfaro-Velásquez JM, Campuzano-Maya G. Utilidad clínica de la medición de la hormona antimülleriana en niños. Medicina & Laboratorio Volumen 23, Numeros 7-8, 2017, 311-330.

All Products Cited: AMH ELISA AL-105

 

Lata I, Tiwari S, Gupta A, Yadav S, Yadav S. To Study the Vitamin D Levels in Infertile Females and Correlation of Vitamin D Deficiency with AMH Levels in Comparison to Fertile Females. J Hum Reprod Sci. Apr-Jun 2017;10(2):86-90. doi: 10.4103/jhrs.JHRS_105_16

All Products Cited: AMH ELISA AL-105

 

Lee MS, Lanes A, Dolinko AV, Bailin A, Ginsburg E. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone. 2020 Sep;37(9):2293-2304. doi: 10.1007/s10815-020-01865-9. Epub 2020 Jul 4.

All Products Cited: AMH ELISA AL-105

 

Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24.

All Products Cited: AMH ELISA AL-105

 

Lerchbaum E, Theiler-Schwetz V, Kollmann M, Wölfler M, Pilz S, Obermayer-Pietsch B, Trummer C. Effects of Vitamin D Supplementation on Surrogate Markers of Fertility in PCOS Women: A Randomized Controlled Trial. Nutrients. 2021 Feb 7;13(2):547. doi: 10.3390/nu13020547

All Products Cited: AMH ELISA AL-105

 

Li Y, Pan P, Yuan P, Qiu Q, Yang D. Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes. J Ovarian Res. 2016 Sep 6;9(1):54.

All Products Cited: AMH ELISA AL-105

 

Liao Z, He W, Yin Q, Ji W, Zhang L, Li Y. Anti-Mullerian Hormone Level in Healthy Adult Women Using the Ultra-Sensitive Assay. Abstract presented at 97th Annual Endocrine Society Meeting; 2015; Mar 5-8; San Diego, CA.

All Products Cited: AMH ELISA AL-105

 

Lima MLS, Romão GS, Bettiol H, Barbieri MA, Ferriani RA, Navarro PA. Association of birth weight with functional ovarian reserve during menacme estimated by serum concentration of anti-Müllerian hormone. Sci Rep . 2019 May 30;9(1):8071. doi: 10.1038/s41598-019-44016-6.

All Products Cited: AMH ELISA AL-105

 

Liss J, Kunicki M, Czyzyk A, Pastuszek E, Zabielska J, Meczekalski B, Lukaszuk K. Clinical utility of different anti-Müllerian hormone – AMH assays for the purpose of pregnancy prediction. Gynecol Endocrinol. 2017 Apr 27:1-6.

All Products Cited: AMH ELISA AL-105

 

Long H, Nie Y, Wang L, Lu Y, Wang Y, Cai Y, Liu Z, Jia M, Lyu Q, Qifeng Y, Sun Q. Serum anti-Mullerian hormone predicts ovarian response in (Macaca fascicularis) monkeys. Endocr Connect. 2018 Sep 1;7(9):983-989. doi: 10.1530/EC-18-0189

All Products Cited: AMH ELISA AL-105

 

Lukaszuk K, Kuczynski W, Kunicki M, Ludwikowaska B, Liss J, Malinowaska I, Lukasuk A, Bednarowska A, Kuczynska A, Kuc P, Pastuszek E. Comparison of the second-generation Beckman Coulter IVD and first-generation Ansh Labs ELISA assays for anti-Müllerian hormone in patients undergoing IVF treatment. Ginekol Pol. 2014 Oct;85(10):778-83.

All Products Cited: AMH ELISA AL-105

 

Lukaszuk K, Pukszta S, Ochman K, Cybulska C, Liss J, Pastuszek E, Zabielska J, Woclawek-Potocka I. Healthy Baby Born to a Robertsonian Translocation Carrier following Next-Generation Sequencing-Based Preimplantation Genetic Diagnosis: A Case Report. AJP Rep. 2015 Oct;5(2):e172-5. Epub 2015 Jul 24.

All Products Cited: AMH ELISA AL-105

 

Luna SL, Brown DI, Kohama SG, Urbanski HF. Lack of effect of short-term DHEA supplementation on the perimenopausal ovary. Biol Reprod. 2020 Dec 1;103(6):1209-1216. doi: 10.1093/biolre/ioaa160

All Products Cited: AMH ELISA AL-105

 

Mahboobifard F, Rahmati M, Tehrani FR. A single cut-off value of anti-Müllerian hormone should not be used for the diagnosis of PCOS in all reproductive-aged women. Human Reproduction, Volume 37, Issue 3, March 2022, Pages 621–622, https://doi.org/10.1093/humrep/deac012

All Products Cited: AMH ELISA AL-105

 

Mamsen LS, Bøtkjær JA, Kristensen SG, Pors SE, Jeppesen JV, Kumar A, Kalra B, Ernst E, Andersen CY. High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles. Front Endocrinol (Lausanne). 2021 Mar 2;12:617523. doi: 10.3389/fendo.2021.617523. PMID: 33737910; PMCID: PMC7961079

All Products Cited: AMH Antibodies; AMH ELISA AL-105

 

Mamsen LS, Charkiewicz K, Anderson RA, Telfer EE, McLaughlin M, Kelsey TW, Kristensen SG, Gook DA, Ernst E, Andersen CY. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019 Jun;111(6):1217-1225.e3. doi: 10.1016/j.fertnstert.2019.02.003. Epub 2019 Mar 25. PMID: 30922638.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Mamsen LS, Ernst EH, Borup R, Larsen A, Olesen RH, Ernst E, Anderson RA, Kristensen SG, Andersen CY. Temporal expression pattern of genes during the period of sex differentiation in human embryonic gonads. Scientific Reports Volume 7, Article number: 15961 (2017)

All Products Cited: AMH ELISA AL-105

 

Maredia H, Hawley N, Lambert-M, Fidow U, Reupena M, Naseri T, McGarvey S. Reproductive Health, Obesity, and Cardiometabolic Risk Factors
among Samoan Women. Am J Hum Biol. 2018 May;30(3):e23106. doi: 10.1002/ajhb.23106

All Products Cited: AMH ELISA AL-105

 

Marsh EE, Bernardi LA, Steinberg ML, de Chavez PJ, Visser JA, Carnethon MR, Baird DD. Novel correlates between antimullerian hormone and menstrual cycle characteristics in African-American women (23–35 years-old). Fertil Steril. 2016 Apr 23. pii: S0015-0282(16)61100-7. Epub ahead of print.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, Jakiel G, Maciejewska-Jeske M, Lukaszuk K. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Invest. 2016 Nov;39(11):1259-1265.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Melo P, Navarro C, Jones C, Coward K, Coleman L. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet . 2020 Apr;37(4):855-863. doi: 10.1007/s10815-020-01710-z. Epub 2020 Feb 7

All Products Cited: AMH ELISA AL-105

 

Mensah V, Alvero R, Zhang YA, Huang Y, Wang S. Low Anti-Mullerian Hormone (AMH) is a Predictor of Higher Clinical Pregnancy Probability in Younger Women Compared to Older Women. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Monastra G, Vazquez-Levin M, Bezerra Espinola MS, Bilotta G, Laganà AS, Unfer V. D-chiro-inositol, an aromatase down modulator, increases androgens and reduces estrogens in male volunteers: a pilot study. Monastra et al. Basic and Clinical Andrology (2021) 31:13 https://doi.org/10.1186/s12610-021-00131-

All Products Cited: AMH ELISA AL-105

 

Mont’Alverne AR, Yamakami LY, Gonçalves CR, Baracat EC, Bonfá E, Silva CA. Diminished ovarian reserve in Behçet’s disease patients. Clin Rheumatol. 2015 Jan;34(1):179-83.

All Products Cited: AMH ELISA AL-105

 

Mont’Alverne AR. Reduction of ovarian reserve in patients with Takayasus arteritis. [Thesis]. Sao Paulo (Brazil]: University of Sao Paulo.

All Products Cited: AMH ELISA AL-105

 

Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361–73. doi: 10.1210/clinem/dgaa513. PMID: 32770239; PMCID: PMC7486884

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Moolhuijsen LME, Visser JA. . Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020 Nov 1;105(11):3361-3373. doi: 10.1210/clinem/dgaa513

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Moreno-Asso A, Altıntaş A, McIlvenna LC, Patten RK, Botella J, McAinch AJ, et al. Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome. J Mol Endocrinol. 2021;68(1):63-76. doi:10.1530/JME-21-0212.

All Products Cited: AMH ELISA AL-105

 

Mörse H, Elfving M, Turkiewicz A, Andersen CY, Øra I. Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma. Medicine (2016) 95:33(e4512)

All Products Cited: AMH ELISA AL-105

 

Morse H, Ora I, Turkiewicz A, Andersen CY, Becker C, Isaksson A, Elfving M. Reliability of AMH in Serum after Long-term Storage at -80C and an Extended Thawing Episode. Annals of Clinical and Laboratory Research. 2016 Vol. 4 No. 1: 61.

All Products Cited: AMH ELISA AL-105

 

Morse H. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer. [Dissertation, 2017]. Lund (Sweden): Lund University.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Nair S, Slaughter JC, Terry JG, Appiah D, Ebong I, Wang E, Siscovick DS, Sternfeld B, Schreiner PF, Lewis CE, Kabagambe EK, Wellons MF. Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women’s Study. Mauritas. 2015 epub ahead of print.

All Products Cited: AMH ELISA AL-105

 

Nelson SM, Pastuszek E, Kloss G, Malinowska I, Liss J, Lukaszuk A, Plociennik L, Lukaszuk. Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays. Reproductive Endocrinology. 2015 Oct 104 (4): 1016-1021

All Products Cited: AMH ELISA AL-105

 

Nichols H, Baird D, Stanczyk F. Anti-Müllerian Hormone Concentrations in Premenopausal Women and Breast Cancer Risk. Cancer Prevention Research. 2015 April 14 epub ahead of print.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Nylander M, Frøssing S, Clausen HV, Kistorp C, Faber J, Skouby SO. Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod Biomed Online. 2017 Jul;35(1):121-127.

All Products Cited: AMH ELISA AL-105

 

Oldfield AL, Kazemi M, Lujan ME. Impact of obesity on Anti-Müllerian hormone (AMH) levels in women of reproductive age. J Clin Med. 2021;10(3192):1-13. doi:10.3390/jcm10143192.

All Products Cited: AMH ELISA AL-105

 

Ortega MT, Carlson L, McGrath JA, Kangarloo T, Adams JM, Sluss PM, Lambert-Messerlian G, Shaw ND. AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women. J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1762–71. doi: 10.1210/clinem/dgaa059. PMID: 32016427; PMCID: PMC7082083.

All Products Cited: AMH ELISA AL-105

 

Palomaki GE, Kalra B, Kumar T, Patel AS, Savjani G, Torchen LC, Dunaif A, Morrison A, Lambert-Messerlian GM, Kumar A. Adjusting antimüllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome (PCOS). Fertil Steril. 2020 Apr;113(4):876-884.e2. doi: 10.1016/j.fertnstert.2019.12.012. Epub 2020 Mar 5. PMID: 32147175.

All Products Cited: AMH ELISA AL-105

 

Patten RK, McIlvenna LC, Levinger I, Garnham AP, Shorakae S, Parker AG, McAinch AJ, Rodgers RJ, Hiam D, Moreno-Asso A, Stepto NK. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Hum Reprod. 2022 May 3;37(5):1018-1029. doi: 10.1093/humrep/deac047. PMID: 35325125.

All Products Cited: AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function. Metabolism. 2018 May 9. pii: S0026-0495(18)30120-3.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Mantzoros CS. Leptin-dependent and leptin-independent pathways linking energy sufficiency with reproduction. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Pigny P, Gorisse E, Ghulam A, Robin G, Catteau-Jonard S, Duhamel A, Dewailly D. Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome. Fertility and Sterility. 2016 epub ahead of print

All Products Cited: AMH ELISA AL-105

 

Pigny P. Interets du dosage de l’AMH (Hormone Anti-Müllerienne)? . 2014 October 17. Downloaded from http://biologiepathologie.chru-lille.fr/Flash_infos/flash_info_AMH.pdf

All Products Cited: AMH ELISA AL-105

 

Pilsgaard F, Grynnerup AG, Løssl K, Bungum L, Pinborg A. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and counseling. Acta Obstet Gynecol Scand. 2018 Feb 24.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Qiaofei H, Liming H, Mingyue N, Qin W, Ying F, Yinmei D, Yanhong Z, Shuyu W, Chenghong Y, Xiaokui Y. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. Hu et al. Journal of Ovarian Research (2017) 10:32 DOI 10.1186/s13048-017-0326-3

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Qiu W, Luo K, Lu Y, Zhao J, Wang Y, Yang H, Sun Y, Zhang J; Shanghai Birth Cohort. Anti-Müllerian hormone has limited ability to predict fecundability in Chinese women: a preconception cohort study. Reprod Biomed Online. 2022 Jun;44(6):1055-1063. doi: 10.1016/j.rbmo.2022.02.014.

All Products Cited: AMH ELISA AL-105

 

Quinn M, Kao C, Ahmad AK, Cedars M, Santoro N, Eisenberg E, Haisenleder DJ, Legro RS, Huddleston H. Anti-Mullerian Hormone (AMH) as a Predictor of Polycystic Ovary Syndrome (PCOS): Age and Body Mass Index (BMI)-Stratified Thresholds for Distinguishing PCOS from Controls Using an Identical Assay. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Quinn MM, Kao CN, Ahmad AK, Haisenleder DJ, Santoro N, Eisenberg E, Legro RS, Cedars MI, Huddleston HG. Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold. Clin Endocrinol (Oxf). 2017 Jul 6.

All Products Cited: AMH ELISA AL-105

 

Rekola M, Korhonen K, Unkila-Kallio L, et al. Serum erythropoietin level is increased during stimulation for IVF but not in OHSS. Reprod Biol Endocrinol. 2024;22:14. doi: 10.1186/s12958-023-01178-3.

All Products Cited: AMH ELISA AL-105

 

Rios JS, Greenwood EA, Pavone MEG, Cedars MI, Legro RS, Diamond MP, Santoro N, Sun F, Robinson RD, Christman G, Zhang H, Huddleston HG. Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index. J Clin Endocrinol Metab. 2020 Jan 1;105(1):e555–63. doi: 10.1210/clinem/dgz012. PMID: 31586179; PMCID: PMC7024739.

All Products Cited: AMH ELISA AL-105

 

Rivak P, Sachin B. Variation in the Measurement of Anti-Müllerian Hormone – What Are the Laboratory Issues?. Front Endocrinol (Lausanne). 2021 Sep 3;12:719029. doi: 10.3389/fendo.2021.719029

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Robertson DM, Kumar A, Kalra B, Shah S, Pruysers E, Vanden Brink H, Chizen D, Visser JA, Themmen AP, Baerwald A. Detection of serum antimüllerian hormone in women approaching menopause using sensitive antimüllerian hormone enzyme-linked immunosorbent assays. Menopause. 2014 Dec; 21(12):1277-86.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Robertson DM, Lee CH, Baerwald A. Interrelationships among reproductive hormones and antral follicle count in human menstrual cycles. Endocrine Connections. 2016;5(6):98-107

All Products Cited: AMH ELISA AL-105

 

Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R. Anti-Müllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021;22(12507):1-12. doi:10.3390/ijms222212507.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Ruth KS, Soares ALG, Borges MC, Eliassen AH, Hankinson SE, Jones ME, Kraft P, Nichols HB, Sandler DP, Schoemaker MJ, Taylor JA, Zeleniuch-Jacquotte A, Lawlor DA, Swerdlow AJ, Murray A. Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan. Hum Mol Genet. 2019 Apr 15;28(8):1392-1401. doi: 10.1093/hmg/ddz015

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Seidler EA, Rhee JS, Eklund E, Lambert-Messerlian G, Cooper AR. Like mother, like daughter? A comparison of anti-mullerian hormone levels in sample pairs of maternal serum and female neonatal cord blood. Fertility and Sterility. 2014; 102(3):e35- e36.

All Products Cited: AMH ELISA AL-105

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome. Fertil Steril. 2018 Mar;109(3):516-525.e1.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA-124

 

Sharma SK, Jain S, Bahl P, Potturi P, Rathi M, Naidu S, Sachdeva N, Dhir V, Jain S. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study. Sharma et al. Arthritis Research & Therapy (2020) 22:189 https://doi.org/10.1186/s13075-020-02292-y

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Silva C, Ribeiro Rama AC, Reis Soares S, Moura-Ramos M, Almeida-Santos T. Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments. Silva et al. Journal of Ovarian Research (2019) 12:102 https://doi.org/10.1186/s13048-019-0581-6

All Products Cited: AMH ELISA AL-105

 

Smith MB, Ho J, Ma L, Lee M, Czerwinski SA, Glenn TL, Cool DR, Gagneux P, Stanczyk FZ, McGinnis LK, Lindheim SR. . Longitudinal antim€ullerian hormone and its correlation with pubertal milestones. F S Rep. 2021 Feb 8;2(2):238-244. doi: 10.1016/j.xfre.2021.02.001. eCollection 2021 Jun

All Products Cited: AMH ELISA AL-105

 

Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association Between Biomarkers of Ovarian Reserve and Infertility Among OlderWomen of Reproductive Age. JAMA. 2017 Oct 10;318(14):1367-1376. doi: 10.1001/jama.2017.14588.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Steiner AZ, Stanczyk FZ, Kesner JS, Meadows JQ, Baird D. Biomarkers of Ovarian Reserve as Predictors of Infertility. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Su HI, Sammel MD, Homer MV, Bui K, Haunschild C, Stanczyk FZ. Comparability of antimüllerian hormone levels among commercially available immunoassays. Fertility and Sterility. 2014 Jun; 101(6):1766-72.e1.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Sydsjo G, Tornblom P, Gaddlin P-O, et al. Women born with very low birth weight have similar menstrual cycle pattern, pregnancy rates and hormone profiles compared with women born at term. BMC Womens Health. 2019;19:192. doi: 10.1186/s12905-019-0878-0.

All Products Cited: AMH ELISA AL-105

 

Tabibnejad N, Soleimani M, Aflatoonian A. Serum Anti-Mullerian hormone and embryo morphokinetics detected by time-lapse imaging: A comparison between polycystic ovarian syndrome and tubal factor infertility. Int J Reprod BioMed. 2018;16(8):483-490.

All Products Cited: AMH ELISA AL-105

 

Tahajjodi SS, Farashahi Yazd E, Agha-Rahimi A, et al. Biological and physiological characteristics of human cumulus cells in adherent culture condition. Int J Reprod Biomed. 2020;18(1):1-10. doi: 10.18502/ijrm.v18i1.6189.

All Products Cited: AMH ELISA AL-105

 

Tkachenko O, Ting AY, Xu J, Stouffer RL. Antimullerian Hormone in Prepubescent and Adolescent Girls. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Torchen L, Kumar A, Kalra B, Savjani G, Sisk R, Legro R, Dunaif A. Brothers and Fathers of Women with PCOS Have Altered Testicular Function. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Torchen LC, Kumar A, Kalra B, Savjani G, Sisk R, Legro RS, Dunaif A. Increased antim€ullerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):50-55.

All Products Cited: Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Van Helden J, Weiskirchen R. Performance of the two new fully automated anti-Mullerian hormone immunoassays compared with the clinical standard assay. Human Reproduction. 2015, 30(8) 1918-1926

All Products Cited: AMH ELISA AL-105

 

Van Houten E, Kevenaar M, Louwers Y, van Dorp W, Themmen A, Laven J, Visser, J. Serum Anti-Müllerian Hormone Levels Are Negatively Associated with Risk Factors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105

 

Verdiesen RM, van der Schouw YT, van Gils CH, Verschuren WM, Broekmans FJ, Borges MC, Soares AL, Lawlor DA, Eliassen AH, Kraft P, Sandler DP, Harlow SD, Smith JA, Santoro N, Schoemaker MJ, Swerdlow AJ, Murray A, Ruth KS, Onland-Moret NC. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women. medRxiv [Preprint]. 2020 Nov 3:2020.10.29.20221390. doi: 10.1101/2020.10.29.20221390. PMID: 33173903; PMCID: PMC7654897.

All Products Cited: AMH ELISA AL-105

 

Welsh P, Smith K, Nelson SM. A single-centre evaluation of two new Anti-Mullerian Hormone assays and comparison with the current clinical standard assay. Human Reproduction. 2014 May; 29(5):1035-41.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

White A, Sandler D, D’Aloisio A, Stanczyk F, Whitworth K, Baird D, Nichols H. Anti-Mullerian hormone (AMH) in relation to tobacco and marijuana use and sources of indoor heating/cooking. Fertility and Sterility. First published online May 27, 2016.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Wise LA, Wang TR, Mikkelsen EM, Wesselink AK, Calafat AM, Wegienka G, Geller RJ, Coleman CM, Willis MD, Marsh EE, Schildroth S, Botelho JC, Messerlian-Lambert G, Hatch EE. Per- and Polyfluoroalkyl Substances and Anti-Müllerian Hormone Concentrations in Two Preconception Cohort Studies. Environ Health Perspect. 2023 Oct;131(10):107703. doi: 10.1289/EHP12592. Epub 2023 Oct 26. PMID: 37882725; PMCID: PMC10601879.

All Products Cited: AMH (pico) ELISA AL-124; AMH ELISA AL-105

 

Woo I, Christenson LK, Gunewardena S, Ingles SA, Thomas S, Ahmady A, Chung K, Bendikson K, Paulson R, McGinnis LK. . Micro-RNAs involved in cellular proliferation have altered expression profiles in granulosa of young women with diminished ovarian reserve. J Assist Reprod Genet . 2018 Oct;35(10):1777-1786.doi: 10.1007/s10815-018-1239-9. Epub 2018 Jul 9.

All Products Cited: AMH ELISA AL-105

 

Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat Commun. 2017;8(14584):1-14. doi:10.1038/ncomms14584(904).

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Xiao S, Zhang J, Romero M, Smith K, Shea L, Woodruff T. In vitro follicle growth supports human oocyte meiotic maturation. Scientific Reports 5, Article number: 17323. Published online: 2015 November 27.

All Products Cited: AMH ELISA AL-105

 

Xingming Z, Qian Y. Relationship between inhibin B and different clinical phenotypes of polycystic ovary syndrome. Chinese Journal of Practical Gynecology and Obstetrics. 2017 eleven pages 1183-1188.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Xu H, Shi L, Feng G, Xiao Z, Chen L, Li R, Qiao J. An Ovarian Reserve Assessment Model Based on Anti-Müllerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study. J Med Internet Res. 2020 Sep 21;22(9):e19096. doi: 10.2196/19096. PMID: 32667898; PMCID: PMC7546624.

All Products Cited: AMH ELISA AL-105

 

Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, Qiao J. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update. Innovation (Camb). 2021 Feb 9;2(1):100091. doi: 10.1016/j.xinn.2021.100091. PMID: 34557745; PMCID: PMC8454570.

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, Qiao J. Clinical Applications of Serum Anti-Mullerian Hormone Measurements in Both Males and Females: An Update. Innovation (N Y). 2021 Feb 9;2(1):100091. doi: 10.1016/j.xinn.2021.100091

All Products Cited: AMH ELISA AL-105; AMH (pico) ELISA AL-124

 

Xu J, Lawson MS, Xu F, Du Y, Tkachenko OY, Bishop CV, Pejovic-Nezhat L, Seifer DB, Hennebold JD. Vitamin D3 regulates follicular development and intrafollicular vitamin D biosynthesis and signaling in the primate ovary. Front Physiol. 2018;9:1600. doi:10.3389/fphys.2018.01600.

All Products Cited: AMH ELISA AL-105

 

Younis A, Hawkins KC. Validation of the Access AMH Assay & its Comparison with Labcorp Ultrasensitive Assay. Poster session at American Society for Reproductive Medicine; 2016 Oct 17-21; Salt Lake City, Utah.

All Products Cited: AMH ELISA AL-105

 

Zhou W, Fang F, Zhu W, Chen ZJ, Du Y, Zhang J. Bisphenol A and Ovarian Reserve among Infertile Women with Polycystic Ovarian Syndrome. Int J Environ Res Public Health. 2016 Dec 27;14(1). pii: E18.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Zhu J, Li T, Xing W, Lin H, Ou J. Chronological age vs biological age: a retrospective analysis on age-specific serum anti-Müllerian hormone levels for 3280 females in reproductive center clinic. Gynecol Endocrinol. 2018 Apr 19:1-5.

All Products Cited: AMH ELISA AL-105

 

Ziwei X, Jian H, Xinyu C, Wei Y, Gang L. Clinical value of serum anti-mullerian hormone in diagnosis of polycystic ovarian syndrome (in Chinese). 2015. Retrieved from http://www.j-fzyx.com

All Products Cited: AMH ELISA AL-105

 

BMP-15
BMP-15 ELISA AL-179
Cadenas J, Pors SE, Kumar A, Kalra B, Kristensen SG, Andersen CY, Mamsen LS. Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. Reprod Biol Endocrinol. 2022;20(126):1-10. doi:10.1186/s12958-022-01000-6(917).

All Products Cited: GDF-9 antibodies AB-325-x; BMP-15 antibodies AB-324-x; GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Chowdavarapu K, Patel AS, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Laitinen MP, Hyvonen M, Ritvos O, Kumar A. Development of Novel ELISAs for Human GDF-9 and BMP-15 homodimers and the GDF-9:BMP-15 heterodimer. Poster presented at 99th Endocrine Society Annual Meeting; 2017 April 1-4; Orlando, FL

All Products Cited: BMP-15 ELISA AL-179; GDF-9 ELISA AL-176

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

C-Peptide
C-Peptide of Insulin ELISA AL-151
Campbell PT, Newton CC, Jacobs EJ, McCullough ML, Wang Y, Rees-Punia E, Guinter MA, Murphy N, Koshiol J, Dehal AN, Rohan T, Strickler H, Petrick J, Gunter M, Zhang X, McGlynn KA, Pollak M, Patel AV, Gapstur SM. Prospective associations of hemoglobin A1c and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort. Cancer Res Commun. 2022 Jul;2(7):653-662. doi: 10.1158/2767-9764.crc-22-0082. Epub 2022 Jul 14. PMID: 36712480; PMCID: PMC9881454.

All Products Cited: C-Peptide of Insulin ELISA AL-151

 

Boutari C, Stefanakis K, Simati S, Guatibonza-García V, Valenzuela-Vallejo L, Anastasiou IA, et al. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity. Cardiovasc Diabetol. 2024;23(174):1-15. doi:10.1186/s12933-024-02264-5.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018; C-Peptide of Insulin ELISA AL-151

 

Guercio BJ, Zhang S, Ou FS, et al. . IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074

All Products Cited: IGFBP-3 (Total) ELISA AL-120; C-Peptide of Insulin ELISA AL-151; IGF-I (Total) ELISA AL-121

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-157; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Stevens VL, Carter BD, McCullough ML, Campbell PT, Wang Y. Metabolomic Profiles Associated with BMI, Waist Circumference, and Diabetes and Inflammation Biomarkers in Women. Obesity (Silver Spring). 2020 Jan;28(1):187-196. doi: 10.1002/oby.22670. Epub 2019 Nov 27. PMID: 31777189.

All Products Cited: C-Peptide of Insulin ELISA AL-151

 

Follistatin
Follistatin ELISA AL-117
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

deMartelly VA, Dreixler J, Tung A, Mueller A, Heimberger S, Fazal AA, Naseem H, Lang R, Kruse E, Yamat M, Granger JP, Bakrania BA, Rodriguez-Kovacs J, Rana S, Shahul S. Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia. J Am Heart Assoc. 2021 Feb;10(5):e018526. doi: 10.1161/JAHA.120.018526

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A. Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Naseem H, Dreixler J, Mueller A, Tung A, Dhir R, Chibber R, Fazal A, Granger JP, Bakrania BA, deMartelly V, Rana S, Shahul S. Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 Jun 16;9(12):e015997. doi: 10.1161/JAHA.119.015997. Epub 2020 Jun 4. PMID: 32495688; PMCID: PMC7429043.

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117, Follistatin-Like 3 ELISA AL-152

 

Paajanen J, Ilonen I, Lauri H, Järvinen T, Sutinen E, Ollila H, Rouvinen E, Lemström K, Räsänen J, Ritvos O, Koli K, Myllärniemi M. Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30287-6. doi: 10.1016/j.cllc.2019.10.013. [Epub ahead of print]

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Short-term treatment with high dose liraglutide improves lipid and lipoprotein profle and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind. Peradze et al. Cardiovasc Diabetol (2019) 18:141 https://doi.org/10.1186/s12933-019-0945-7

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Activin B ELISA AL-150; Follistatin ELISA AL-117;
Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS. Follistatins in glucose regulation of healthy and obese subjects. Diabetes Obes Metab. 2019 Mar; 21(3): 683–690

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, Ghaly W, Mantzoros CS. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3890-3899.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-like 3 ELISA AL-152

 

Qi Zou, Gunnar Engström, Jingxue Pan, Jialin Zhang, Esther J. Perisho, Yanzhu Lin, Russell Wiese, Jonathan M. Wilson, Imre Pavo, Rui Gao, Kevin L. Duffin, Yang De Marinis; 741-P: Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes. Diabetes 14 June 2024; 73 (Supplement_1): 741–P. https://doi.org/10.2337/db24-741-P

All Products Cited: Follistatin ELISA AL-117

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Synolaki E, Papadopoulos V, Divolis G, Tsahouridou O, Gavriilidis E, Loli G, Gavriil A, Tsigalou C, Tziolos NR, Sertaridou E, Kalra B, Kumar A, Rafailidis P, Pasternack A, Boumpas DT, Germanidis G, Ritvos O, Metallidis S, Skendros P, Sideras P. The Activin/Follistatin-axis is severely deregulated in COVID-19 and independently associated with in-hospital mortality. J Infect Dis. 2021 Feb 24:jiab108. doi: 10.1093/infdis/jiab108. Epub ahead of print. PMID: 33625513; PMCID: PMC7928794

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) AL-122

 

Follistatin-Like 3
Follistatin-Like 3 ELISA AL-152
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. Circulation. 2023 Jun 13;147(24):1809-1822. doi:10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. PMID: 37096577.

All Products Cited: Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin (Total) ELISA AL-134

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A. Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Naseem H, Dreixler J, Mueller A, Tung A, Dhir R, Chibber R, Fazal A, Granger JP, Bakrania BA, deMartelly V, Rana S, Shahul S. Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 Jun 16;9(12):e015997. doi: 10.1161/JAHA.119.015997. Epub 2020 Jun 4. PMID: 32495688; PMCID: PMC7429043.

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117, Follistatin-Like 3 ELISA AL-152

 

Paajanen J, Ilonen I, Lauri H, Järvinen T, Sutinen E, Ollila H, Rouvinen E, Lemström K, Räsänen J, Ritvos O, Koli K, Myllärniemi M. Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy. Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30287-6. doi: 10.1016/j.cllc.2019.10.013. [Epub ahead of print]

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Short-term treatment with high dose liraglutide improves lipid and lipoprotein profle and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-…. Peradze et al. Cardiovasc Diabetol (2019) 18:141 https://doi.org/10.1186/s12933-019-0945-7

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Activin B ELISA AL-150; Follistatin ELISA AL-117;
Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Chen J, Ghaly W, Vamvini MT, Mantzoros CS. Effects of oral and intravenous lipid administration on hormones affecting energy balance. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Oxyntomodulin ELISA AL-139

 

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS. Follistatins in glucose regulation of healthy and obese subjects. Diabetes Obes Metab. 2019 Mar; 21(3): 683–690

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, Ghaly W, Mantzoros CS. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3890-3899.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-like 3 ELISA AL-152

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function. Metabolism. 2018 May 9. pii: S0026-0495(18)30120-3.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Mantzoros CS. Leptin-dependent and leptin-independent pathways linking energy sufficiency with reproduction. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Roh JD, Castro C, Yu A, Rana S, Shahul S, Gray KJ, Honigberg MC, Ricke-Hoch M, Iwamoto Y, Yeri A, Kitchen R, Guerra JB, Hobson R, Chaudhari V, Chang B, Sarma A, Lerchenmüller C, Al Sayed ZR, Diaz Verdugo C, Xia P, Skarbianskis N, Zeisel A, Bauersachs J, Kirkland JL, Karumanchi SA, Gorcsan J 3rd, Sugahara M, Damp J, Hanley-Yanez K, Ellinor PT, Arany Z, McNamara DM; IPAC Investigators; Hilfiker-Kleiner D, Rosenzweig A. Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human. Sci Transl Med. 2024 Apr 17;16(743):eadi0077. doi: 10.1126/scitranslmed.adi0077. Epub 2024 Apr 17. PMID: 38630848; PMCID: PMC11331492.

All Products Cited: Activin A ELISA AL-110; Follistatin Like-3 ELISA AL-152

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) AL-122

 

Free IGF-I
IGF-I (Free) (Rat/Mouse) ELISA AL-136
Guerra-Cantera S, Frago LM, Jiménez-Hernaiz M, Collado-Pérez R, Canelles S, Ros P, García-Piqueras J, Pérez-Nadador I, Barrios V, Argente J, Chowen JA. The metabolic effects of resumption of a high-fat diet after weight loss are sex dependent in mice. Sci Rep. 2023;13(13227):1-12. doi:10.1038/s41598-023-40514-w.

All Products Cited: IGF-I (Free) (Rat/Mouse) ELISA AL-136

 

IGF-I (Free) ELISA AL-122
Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

IGF-I (Free) ELISA AL-122
Barrios V, Frago LM, Canelles S, Guerra-Cantera S, Arilla-Ferreiro E, Chowen JA, Argente J. Leptin modulates the response of brown adipose tissue to negative energy balance: Implication of the GH/IGF-I axis. Int J Mol Sci. 2021;22(2827):1-16. doi:10.3390/ijms22062827.

All Products Cited: IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Cheng TS, Noor U, Watts E, Pollak M, Wang Y, McKay J, et al. Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition. BMC Cancer. 2024;24(676):1-10. doi:10.1186/s12885-023-11425-w.

All Products Cited: IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Guerra-Cantera S, Frago LM, Collado-Pérez R, Canelles S, Ros P, Freire-Regatillo A, et al. Sex differences in metabolic recuperation after weight loss in high-fat diet-induced obese mice. Front Endocrinol (Lausanne). 2021;12:796661. doi:10.3389/fendo.2021.796661.

All Products Cited: IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Guerra-Cantera S, Frago LM, Jiménez-Hernaiz M, Ros P, Freire-Regatillo A, Barrios V, Argente J, Chowen JA. Impact of long-term HFD intake on the peripheral and central IGF system in male and female mice. Metabolites. 2020;10(462):1-21. doi:10.3390/metabo10110462.

All Products Cited: IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Nimptsch K, Aydin EE, Chavarria RFR, Janke J, Poy MN, Oxvig C, Steinbrecher A, Pischon T. Pregnancy-associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2), but not PAPP-A, are associated with circulating total IGF-1 in a human adult population. Sci Rep. 2024;14:1770. doi:10.1038/s41598-024-52074-8.

All Products Cited: PAPP-A2 ELISA AL-109; IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Pellikaan K, Elizabeth M, Hokken-Koelega ACS, van den Berg SA, de Graaff-Herder L. Reference intervals for bioavailable IGF-I values in Dutch healthy children, adolescents, and young adults. J Endocr Soc. 2023;7(Supplement_1). doi:10.1210/jendso/bvad114.1422.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Shulman DS, Merriam P, Choy E, et al. Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer Med. 2023;12:15207-15216. doi: 10.1002/cam4.6208.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120

 

IGF-I (Free) ELISA AL-122
Uchenunu O, Zhdanov AV, Hutton P, Jovanovic P, Wang Y, Andreev DE, et al. Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells. FEBS Open Bio. 2022;12(959-982). doi:10.1002/2211-5463.13398.

All Products Cited: IGF-I (Free) ELISA AL-122

 

IGF-I (Free) ELISA AL-122
Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

FSH
FSH (Dried Blood Spot) ELISA AL-187
Kumar T, Chauhan R, Kalra B, Patel AS, Chauhan S, Kumar A. Novel comparative analysis of dried blood spot and serum ELISAs for AMH, FSH, and LH in patients seeking IVF treatment. J Endocr Soc. 2019;3(Supplement_1)

All Products Cited: AMH (pico) ELISA AL-124; AMH (DBS) ELISA AL-129; LH (DBS) ELISA AL-190; FSH (DBS) ELISA AL-187

 

Medica ACO, Whitcomb BW, Shliakhsitsava K, Dietz AC, Pinson K, Lam C, Romero SAD, Sluss P, Sammel MD, Su HI. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors. J Clin Endocrinol Metab. 2021 Feb; 106(2): e1002–e1013.
Published online 2020 Nov 3. doi: 10.1210/clinem/dgaa797

All Products Cited: AMH (DBS) ELISA AL-129; FSH (DBS) ELISA AL-187

 

Medica ACO, Whitcomb BW, Shliakhsitsava K, Dietz AC, Pinson K, Lam C, Romero SAD, Sluss P, Sammel MD, Su HI. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors. J Clin Endocrinol Metab. 2021 Feb; 106(2): e1002–e1013.
Published online 2020 Nov 3. doi: 10.1210/clinem/dgaa797

All Products Cited: FSH (DBS) ELISA AL-187; AMH (DBS) ELISA AL-129

 

Medica ACO, Whitcomb BW, Shliakhsitsava K, Dietz AC, Pinson K, Lam C, Romero SAD, Sluss P, Sammel MD, Su HI. Beyond Premature Ovarian Insufficiency: Staging Reproductive Aging in Adolescent and Young Adult Cancer Survivors. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e1002-e1013. doi: 10.1210/clinem/dgaa797. PMID: 33141175; PMCID: PMC7823232

All Products Cited: AMH (DBS) ELISA AL-129; FSH (DBS) ELISA AL-187

 

Riepsamen AH, Donoghoe MW, Baerwald A, Pankhurst MW, Lien S, Chong YH, Robertson DM, Ledger WL, Gilchrist RB. Serum concentrations of GDF9 and BMP15 across the menstrual cycle. J Endocr Soc. 2021;5(Supplement_1). doi:10.1210/jendso/bvab048.

All Products Cited: FSH (DBS) ELISA AL-187

 

FSH ELISA AL-186
Harris BS, Steiner AZ, Jukic AM. Ovarian Reserve Biomarkers and Menstrual Cycle Length in a Prospective Cohort Study. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3748-e3759. doi: 10.1210/clinem/dgab204

All Products Cited: FSH ELISA AL-186; AMH ELISA AL-105; Inhibin B ELISA AL-107

 

GDF-15
GDF-15 (H-Specific) ELISA AL-1018
Boutari C, Stefanakis K, Simati S, Guatibonza-García V, Valenzuela-Vallejo L, Anastasiou IA, et al. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity. Cardiovasc Diabetol. 2024;23(174):1-15. doi:10.1186/s12933-024-02264-5.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018; C-Peptide of Insulin ELISA AL-151

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Fejzo M, Rocha N, Cimino I, Lockhart SM, Petry CJ, Kay RG, Burling K, Barker P, George AL, Yasara N, Premawardhena A, Gong S, Cook E, Rimmington D, Rainbow K, Withers DJ, Cortessis V, Mullin PM, MacGibbon KW, Jin E, Kam A, Campbell A, Polasek O, Tzoneva G, Gribble FM, Yeo GSH, Lam BYH, Saudek V, Hughes IA, Ong KK, Perry JRB, Sutton Cole A, Baumgarten M, Welsh P, Sattar N, Smith GCS, Charnock-Jones DS, Coll AP, Meek CL, Mettananda S, Hayward C, Mancuso N, O’Rahilly S. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06921-9. Epub ahead of print. PMID: 38092039.

All Products Cited: GDF-15 Antibodies; GDF-15 (H-Specific) ELISA AL-1018

 

Kalra B, Parekh H, Patel AS, Mistry S, Hyvonen M, Kumar A. Development of Novel ELISAs for Total GDF-15 and H-Specific GDF-15. Ansh Labs, Webster, TX; University of Cambridge, Cambridge, United Kingdom. Poster presentation at the Association for Diagnostics and Laboratory Medicine; 2024; Chicago, Illinois.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) AL-122

 

Valenzuela-Vallejo L, Chrysafi P, Bello-Ramos J, Bsata S, Mantzoros CS. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism. 2022 Aug;133:155237. doi: 10.1016/j.metabol.2022.155237. Epub 2022 Jun 11. PMID: 35700837.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

GDF-15 (Total) ELISA AL-1014
Boutari C, Stefanakis K, Simati S, Guatibonza-García V, Valenzuela-Vallejo L, Anastasiou IA, et al. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity. Cardiovasc Diabetol. 2024;23(174):1-15. doi:10.1186/s12933-024-02264-5.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018; C-Peptide of Insulin ELISA AL-151

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Kalra B, Parekh H, Patel AS, Mistry S, Hyvonen M, Kumar A. Development of Novel ELISAs for Total GDF-15 and H-Specific GDF-15. Ansh Labs, Webster, TX; University of Cambridge, Cambridge, United Kingdom. Poster presentation at the Association for Diagnostics and Laboratory Medicine; 2024; Chicago, Illinois.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Valenzuela-Vallejo L, Chrysafi P, Bello-Ramos J, Bsata S, Mantzoros CS. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism. 2022 Aug;133:155237. doi: 10.1016/j.metabol.2022.155237. Epub 2022 Jun 11. PMID: 35700837.

All Products Cited: GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

GDF-9
GDF-9 ELISA AL-176
Cadenas J, Pors SE, Kumar A, Kalra B, Kristensen SG, Andersen CY, Mamsen LS. Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. Reprod Biol Endocrinol. 2022;20(126):1-10. doi:10.1186/s12958-022-01000-6(917).

All Products Cited: GDF-9 antibodies AB-325-x; BMP-15 antibodies AB-324-x; GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Chowdavarapu K, Patel AS, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Laitinen MP, Hyvonen M, Ritvos O, Kumar A. Development of Novel ELISAs for Human GDF-9 and BMP-15 homodimers and the GDF-9:BMP-15 heterodimer. Poster presented at 99th Endocrine Society Annual Meeting; 2017 April 1-4; Orlando, FL

All Products Cited: BMP-15 ELISA AL-179; GDF-9 ELISA AL-176

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-176; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kristensen SG. Altered Levels of TGF-Beta Superfamily Growth Factors in Small Antral Follicle Fluids from Polycystic Ovaries. Poster session presented at the International Congress of Endocrinology, 2018 Dec 1-4, Cape Town South Africa.

All Products Cited: GDF-9 ELISA AL-176; AMH ELISA AL-105; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117

 

Ting A, Savjani G, Kalra B, Kumar A, Stouffer R, Zelinski M. Dynamics of Growth and Differentiation Factor-9 and Inhibin B Production in Macaque Developing Follicles During 3-Dimensional Culture. Poster Presentation at ASRM 2017 Oct 28-Nov 1, San Antonio TX.

All Products Cited: GDF-9 ELISA AL-176; Inhibin B ELISA AL-107

 

GDF-9/BMP-15
GDF-9/BMP-15 Complex ELISA AL-181
Cadenas J, Pors SE, Kumar A, Kalra B, Kristensen SG, Andersen CY, Mamsen LS. Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM. Reprod Biol Endocrinol. 2022;20(126):1-10. doi:10.1186/s12958-022-01000-6(917).

All Products Cited: GDF-9 antibodies AB-325-x; BMP-15 antibodies AB-324-x; GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

GIP
GIP (Intact) ELISA AL-1022
Kumar A, Patel AS, Parekh H, Kumar T, Eskandari A, Mistry S, Kalra B. Development of GIP ELISAs: The Next Level of Diabetes Management. Poster presentation at the Association for Diagnostics and Laboratory Medicine; 2024; Chicago, Illinois.

All Products Cited: GIP (Intact) ELISA AL-1022; GIP (Total) ELISA AL-1013

 

GIP
GIP (Total) ELISA AL-1013
Kumar A, Patel AS, Parekh H, Kumar T, Eskandari A, Mistry S, Kalra B. Development of GIP ELISAs: The Next Level of Diabetes Management. Poster presentation at the Association for Diagnostics and Laboratory Medicine; 2024; Chicago, Illinois.

All Products Cited: GIP (Intact) ELISA AL-1022; GIP (Total) ELISA AL-1013

 

Glicentin
Glicentin ELISA AL-185
D’Alessio D, Kumar A, Kalra B, Mistry S, Tong J. Novel ELISA Assays Demonstrate Specificity of Islet and Intestinal Processing of Proglucagon. Volume 4, Issue Supplement_1, April May 2020, SUN-LB124, https://doi.org/10

All Products Cited: GLP-1 ELISA AL-172; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185

 

Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-157; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Yanni AE, Kokkinos A, Binou P, Papaioannou V, Halabalaki M, Konstantopoulos P, Simati S, Karathanos VT. Postprandial glucose and gastrointestinal hormone responses of healthy subjects to wheat biscuits enriched with L-arginine or branched-chain amino acids of plant origin. Nutrients. 2022;14(4381):1-17. doi:10.3390/nu14204381.

All Products Cited: Glicentin ELISA AL-185

 

GLP-1
GLP-1 ELISA AL-172
D’Alessio D, Kumar A, Kalra B, Mistry S, Tong J. Novel ELISA Assays Demonstrate Specificity of Islet and Intestinal Processing of Proglucagon. Volume 4, Issue Supplement_1, April May 2020, SUN-LB124, https://doi.org/10

All Products Cited: GLP-1 ELISA AL-172; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185

 

Gray SM, Hoselton AL, Krishna R, Slentz CA, D’Alessio DA. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2500-2510. doi: 10.1210/clinem/dgac396. PMID: 35775723; PMCID: PMC9387711.

All Products Cited: Glucagon ELISA AL-157; GLP-1 ELISA AL-172

 

Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Kim SH, Abbasi F, Nachmanoff C, Stefanakis K, Kumar A, Kalra B, Savjani G, Mantzoros CS. Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial. Diabetes Obes Metab. 2021 Feb;23(2):489-498. doi: 10.1111/dom.14242

All Products Cited: GLP-1 ELISA AL-172

 

Kumar A, Kalra B, Mistry S, Patel AS, Budhavarapu V, Chatterji T, Savjani G, Krishna R, D’Alessio D. Development of Novel Specific and Sensitive ELISAs for Proglucagon-Derived Peptides. Poster presented at 69th AACC Meeting; 2017 July 30-Aug 3; San Diego, CA

All Products Cited: Glucagon ELISA AL-157; GLP-1 ELISA AL-172; Oxyntomodulin ELISA AL-139

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-157; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

GLP-2
GLP-2 ELISA AL-174
Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-157; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Glucagon
Glucagon ELISA AL-157
D’Alessio D, Kumar A, Kalra B, Mistry S, Tong J. Novel ELISA Assays Demonstrate Specificity of Islet and Intestinal Processing of Proglucagon. Volume 4, Issue Supplement_1, April May 2020, SUN-LB124, https://doi.org/10

All Products Cited: GLP-1 ELISA AL-172; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185

 

Gray SM, Hoselton AL, Krishna R, Slentz CA, D’Alessio DA. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2500-2510. doi: 10.1210/clinem/dgac396. PMID: 35775723; PMCID: PMC9387711.

All Products Cited: Glucagon ELISA AL-157; GLP-1 ELISA AL-172

 

Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Kumar A, Kalra B, Mistry S, Patel AS, Budhavarapu V, Chatterji T, Savjani G, Krishna R, D’Alessio D. Development of Novel Specific and Sensitive ELISAs for Proglucagon-Derived Peptides. Poster presented at 69th AACC Meeting; 2017 July 30-Aug 3; San Diego, CA

All Products Cited: Glucagon ELISA AL-157; GLP-1 ELISA AL-172; Oxyntomodulin ELISA AL-139

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-157; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Upadhyay J, Panagiotou G, Anastasilakis A, Mantzoros C. Oxyntomodulin and Glucagon in Healthy Humans: Anthropometric, Hormonal, and Metabolic Predictors and Response to Glucose Load and Exercise. Abstract – ADA Supported Research, Integrated Physiology / Obesity. Not Dated

All Products Cited: Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Upadhyay J, Perakakis N, Panagiotou G, Anastasilakis AD, Mantzoros CS. Regulation of the proglucagon-derived hormones in healthy and in obese after bariatric surgery. Poster Presentation. Unknown Conference

All Products Cited: Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

IGFBP-2
IGFBP-2 ELISA AL-140
Kazemi M, Jarrett BY, Parry SA, Thalacker-Mercer AE, Hoeger KM, Spandorfer SD, Lujan ME. . Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3400-e3414. doi: 10.1210/clinem/dgaa426

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

IGFBP-3
IGFBP-3 (Intact) ELISA AL-149
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Fujimoto M, Andrew M, Liao L, Zhang D, Yildirim G, Sluss P, Kalra B, Kumar A, Yakar S, Hwa V, Dauber A. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation. Endocrinology. 2019 Jun 1;160(6):1363-1376. doi: 10.1210/en.2018-00755.

All Products Cited: IGF-I (Free) (Rat/Mouse) ELISA; IGF-I (Rat/Mouse) ELISA; IGFBP-3 (Intact) ELISA AL-149

 

Fujimoto M, Khoury JC, Khoury PR, Kalra B, Kumar A, Sluss P, Oxvig C, Hwa V, Dauber A. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. European journal of endocrinology, 182(3), 363–374. https://doi.org/10.1530/EJE-19-0859

All Products Cited: IGF-I (Total) AL-121; IGF-I (Free) AL-122; IGFBP-3 (Total) AL-120; IGFBP-3 (Intact) AL-149; PAPP-A2 AL-109

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGFBP-3 (Total) ELISA AL-120
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Dauber A, Munoz-Calvo MT, Barrios V, Domene HM, Kloverpris S, Serra-Juhe C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GA, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Perez-Jurado LA, Argente J. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016 Mar 31;8(4):363-74.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-5 ELISA AL-127; PAPP-A2 AL-109

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131

 

Fujimoto M, Khoury JC, Khoury PR, Kalra B, Kumar A, Sluss P, Oxvig C, Hwa V, Dauber A. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. European journal of endocrinology, 182(3), 363–374. https://doi.org/10.1530/EJE-19-0859

All Products Cited: IGF-I (Total) AL-121; IGF-I (Free) AL-122; IGFBP-3 (Total) AL-120; IGFBP-3 (Intact) AL-149; PAPP-A2 AL-109

 

Guercio BJ, Zhang S, Ou FS, et al. . IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074

All Products Cited: IGFBP-3 (Total) ELISA AL-120; C-Peptide of Insulin ELISA AL-151; IGF-I (Total) ELISA AL-121

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Shulman DS, Merriam P, Choy E, et al. Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer Med. 2023;12:15207-15216. doi: 10.1002/cam4.6208.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGFBP-4
IGFBP-4 (Intact) ELISA AL-128
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119. doi: 10.1055/a-0794-6163. Epub 2018 Nov 29. PMID: 30497090.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. doi: 10.1158/1535-7163.MCT-14-0880. Epub 2015 Feb 18. PMID: 25695953; PMCID: PMC4394033.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; Rat / Mouse IGF-I ELISA AL-137; PAPP-A Neutralizing Antibodies

 

 

Bøtkjær JA, Pors SE, Petersen TS, Kristensen SG, Jeppesen JV, Oxvig C, Andersen CY. Transcription profile of the insulin-like growth factor signaling pathway during human ovarian follicular development. Assist Reprod Genet
. 2019 May;36(5):889-903. doi: 10.1007/s10815-019-01432-x. Epub 2019 Mar 15.

All Products Cited: IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGFBP-4 (Intact) ELISA AL-128; IGF-II ELISA AL-131

 

Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, Ferrer M, Aranda-Nevado MC, Serra-Gregori J, Núñez J, García C, Bayes-Genis A. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018 Apr 30;17(1):63. doi: 10.1186/s12933-018-0710-3.

All Products Cited: Stanniocalcin 2 ELISA AL-143; PAPP-A (pico) ELISA AL-101; IGFBP-4 (Intact) ELISA AL-128

 

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros C. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019 Nov;100:153959. doi: 10.1016/j.metabol.2019.153959. Epub 2019 Aug 8.

All Products Cited: IGF-II ELISA AL-131; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358. doi: 10.1210/jc.2018-01581. PMID: 30388235.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGFBP-4 (Total) ELISA AL-126
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119. doi: 10.1055/a-0794-6163. Epub 2018 Nov 29. PMID: 30497090.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. doi: 10.1158/1535-7163.MCT-14-0880. Epub 2015 Feb 18. PMID: 25695953; PMCID: PMC4394033.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; Rat / Mouse IGF-I ELISA AL-137

 

Bøtkjær JA, Pors SE, Petersen TS, Kristensen SG, Jeppesen JV, Oxvig C, Andersen CY. Transcription profile of the insulin-like growth factor signaling pathway during human ovarian follicular development. Assist Reprod Genet
. 2019 May;36(5):889-903. doi: 10.1007/s10815-019-01432-x. Epub 2019 Mar 15.

All Products Cited: IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGFBP-4 (Intact) ELISA AL-128; IGF-II ELISA AL-131

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I ELISA (Total) AL-121; IGF-II ELISA AL-131

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Nur SI, Ozturk A, Kavas M, Bulut I, Alparslan S, Aydogan ES, Atinkaya BC, Kolay M, Coskun A. IGFBP-4: A promising biomarker for lung cancer. J Med Biochem. 2021 Jun 5;40(3):237-244. doi: 10.5937/jomb0-25629. PMID: 34177367; PMCID: PMC8199439.

All Products Cited: IGFBP-4 (Total) ELISA AL-126

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358. doi: 10.1210/jc.2018-01581. PMID: 30388235.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Parry S, McCarthy C, Devine A, Leite R. Markers of placental dysfunction and spontaneous preterm birth. Amer Jour Obst Gyne, January 2020, Volume 222, Issue 1, Supplement S1-S760 (SMFM 40th Annual Meeting–The Pregnancy Meeting)

All Products Cited: PAPP-A2 ELISA AL-109; IGFBP-4 (Total) ELISA AL-126

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGFBP-5
IGFBP-5 ELISA AL-127
Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Bøtkjær JA, Pors SE, Petersen TS, Kristensen SG, Jeppesen JV, Oxvig C, Andersen CY. Transcription profile of the insulin-like growth factor signaling pathway during human ovarian follicular development. Assist Reprod Genet
. 2019 May;36(5):889-903. doi: 10.1007/s10815-019-01432-x. Epub 2019 Mar 15.

All Products Cited: IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGFBP-4 (Intact) ELISA AL-128; IGF-II ELISA AL-131

 

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros C. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019 Nov;100:153959. doi: 10.1016/j.metabol.2019.153959. Epub 2019 Aug 8.

All Products Cited: IGF-II ELISA AL-131; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131

 

Heitzeneder S, Shem J, Khan J, Mackall C. Pregnancy Associated Plasma Protein A (PAPP-A) Is A Novel Therapeutic Target In Ewing Sarcoma. Presented at 8th Ovarian Cancer Research; 2016 May 15-17; Niagra Falls, ON, Canada.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGF-I
IGF-I (Free) (Rat/Mouse) ELISA AL-136
Fujimoto M, Andrew M, Liao L, Zhang D, Yildirim G, Sluss P, Kalra B, Kumar A, Yakar S, Hwa V, Dauber A. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation. Endocrinology. 2019 Jun 1;160(6):1363-1376. doi: 10.1210/en.2018-00755.

All Products Cited: IGF-I Free (Rat/Mouse) ELISA AL-136; IGF-I (Total) (Rat/Mouse) ELISA AL-137; IGFBP-3 (Intact) ELISA AL-149

 

Meln I, Wolff G, Gajek T, Koddebusch J, Lerch S, Harbrecht L, Hong W, Bayindir-Buchhalter I, Krunic D, Augustin HG, Vegiopoulos A. Dietary calories and lipids synergistically shape adipose tissue cellularity during postnatal growth. Mol Metab. 2019 Jun;24:139-148. doi: 10.1016/j.molmet.2019.03.012. Epub 2019 Apr 5

All Products Cited: IGF-I Free (Rat/Mouse) ELISA AL-136

 

Sarmento-Cabral A, Del Rio-Moreno M, Vazquez-Borrego MC, Mahmood M, Gutierrez-Casado E, Pelke N, Guzman G, Subbaiah PV, Cordoba-Chacon J, Yakar S, Kineman RD. GH directly inhibits steatosis and liver injury in a sex-dependent and IGF1-independent manner. J Endocrinol. 2021 Jan;248(1):31-44. doi: 10.1530/JOE-20-0326. PMID: 33112796; PMCID: PMC7785648.

All Products Cited: IGF-I Free (Rat/Mouse) ELISA AL-136

 

IGF-I (Total) (Rat/Mouse) ELISA AL-137
Fujimoto M, Andrew M, Liao L, Zhang D, Yildirim G, Sluss P, Kalra B, Kumar A, Yakar S, Hwa V, Dauber A. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation. Endocrinology. 2019 Jun 1;160(6):1363-1376. doi: 10.1210/en.2018-00755.

All Products Cited: IGF-I Free (Rat/Mouse) ELISA AL-136; IGF-I (Total) (Rat/Mouse) ELISA AL-137; IGFBP-3 (Intact) ELISA AL-149

 

IGF-I (Free) ELISA AL-122
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGF-I (Rat/Mouse) ELISA AL-137

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGF-I (Rat/Mouse) ELISA AL-137; PAPP-A Neutralizing Antibodies

 

Cabrera-Salcedo C, Mizuno T, Tyzinski L, Andrew M, Vinks AA, Frystyk J, Wasserman H, Gordon CM, Hwa V, Backeljauw P, Dauber A. Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4568-4577.

All Products Cited: PAPP-A2 ELISA AL-109; IGF-I (Free) ELISA AL-122

 

Damen, L.; Elizabeth, M.S.M.; Donze, S.H.; van den Berg, S.A.A.; de Graaff, L.C.G.; Hokken-Koelega, A.C.S. Free Insulin-like Growth Factor (IGF)-I in Children with PWS. J. Clin. Med. 2022, 11, 1280. https://doi.org/10.3390/jcm11051280

All Products Cited: IGF-I (Free) ELISA AL-122

 

Dauber A, Munoz-Calvo MT, Barrios V, Domene HM, Kloverpris S, Serra-Juhe C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GA, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Perez-Jurado LA, Argente J. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016 Mar 31;8(4):363-74.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-5 ELISA AL-127; PAPP-A2 AL-109

 

Fujimoto M, Khoury JC, Khoury PR, Kalra B, Kumar A, Sluss P, Oxvig C, Hwa V, Dauber A. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. European journal of endocrinology, 182(3), 363–374. https://doi.org/10.1530/EJE-19-0859

All Products Cited: IGF-I (Total) AL-121; IGF-I (Free) AL-122; IGFBP-3 (Total) AL-120; IGFBP-3 (Intact) AL-149; PAPP-A2 AL-109

 

Guerra-Cantera S, Frago LM, Díaz F, Ros P, Jiménez-Hernaiz M, Freire-Regatillo A, Barrios V, Argente J, Chowen JA. Short-Term Diet Induced Changes in the Central and Circulating IGF Systems Are Sex Specific. Front Endocrinol (Lausanne). 2020 Aug 11;11:513. doi: 10.3389/fendo.2020.00513. PMID: 32849298; PMCID: PMC7431666.

All Products Cited: IGF-I (Free) ELISA AL-122

 

Heitzeneder S, Shem J, Khan J, Mackall C. Pregnancy Associated Plasma Protein A (PAPP-A) Is A Novel Therapeutic Target In Ewing Sarcoma. Presented at 8th Ovarian Cancer Research; 2016 May 15-17; Niagra Falls, ON, Canada.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Kumar A, Kalra B, Chowdavarapu K, Shah S, Savjani G, Oxvig C. Development of IGF-1 ELISA Assays to Measure Free and Total Circulating IGF-1. Poster session presented at the 96th Annual Endocrine Society Meeting; 2014 Jun 21-24; Chicago, IL.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

Kumar A, Kalra B, Chowdavarapu K, Shah S, Savjani G, Oxvig C. Development of IGF-1 ELISA Assays to Measure Free and Total Circulating IGF-1. Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Pellikaan K, Elizabeth M, Donze S, van den Berg S, van Doorn J, Peeters RP, Hokken-Koelega A, Graaff L. Normal IGF-bioactivity and low free IGF-I in patients with Prader-Willi syndrome with high total serum IGF-I: immunoreactive IGF-I concentrations poorly reflect IGF bio-activity and bio-availability. Endocrine Abstracts (2019) 63 GP175 | DOI: 10.1530/endoabs.63.GP175

All Products Cited: IGF-I (Free) ELISA AL-122

 

Valenzuela-Vallejo L, Chrysafi P, Agraz M, Connelly M, Papatheodoridis G, Verrastro O, Mingrone G, Mantzoros CS. GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) LEVELS IS ASSOCIATED WITH THE PRESENCE AND SEVERITY OF NAFLD. Nutr Diabetes. 2022 Feb 22;12(1):9. doi: 10.1038/s41387-022-00187-2. PMID: 35194014; PMCID: PMC8863897

All Products Cited: GDF-15 (H-Specific) ELISA AL-1018; Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Free) ELISA AL-122

 

IGF-I (Total) ELISA AL-121
Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A ELISA AL-101

 

Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; Rat / Mouse IGF-I ELISA AL-137; PAPP-A Neutralizing Antibodies

 

Dauber A, Munoz-Calvo MT, Barrios V, Domene HM, Kloverpris S, Serra-Juhe C, Desikan V, Pozo J, Muzumdar R, Martos-Moreno GA, Hawkins F, Jasper HG, Conover CA, Frystyk J, Yakar S, Hwa V, Chowen JA, Oxvig C, Rosenfeld RG, Perez-Jurado LA, Argente J. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016 Mar 31;8(4):363-74.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-5 ELISA AL-127; PAPP-A2 AL-109

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131

 

Fujimoto M, Khoury JC, Khoury PR, Kalra B, Kumar A, Sluss P, Oxvig C, Hwa V, Dauber A. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. European journal of endocrinology, 182(3), 363–374. https://doi.org/10.1530/EJE-19-0859

All Products Cited: IGF-I (Total) AL-121; IGF-I (Free) AL-122; IGFBP-3 (Total) AL-120; IGFBP-3 (Intact) AL-149; PAPP-A2 AL-109

 

Guercio BJ, Zhang S, Ou FS, et al. . IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074

All Products Cited: IGFBP-3 (Total) ELISA AL-120; C-Peptide of Insulin ELISA AL-151; IGF-I (Total) ELISA AL-121

 

Hjortebjerg R, Rasmussen LM, Gude MF, Irmukhamedov A, Riber LP, Frystyk J, De Mey JGR. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients. J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa617. doi: 10.1210/clinem/dgaa617. PMID: 32875328.

All Products Cited: IGF-I (Total) ELISA AL-121, IGFBP-4 (Intact) ELISA AL-126, Stanniocalcin 2 ELISA AL-143; PAPP-A ELISA AL-106

 

Kazemi M, Jarrett BY, Parry SA, Thalacker-Mercer AE, Hoeger KM, Spandorfer SD, Lujan ME. . Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3400-e3414. doi: 10.1210/clinem/dgaa426

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140

 

Kumar A, Kalra B, Chowdavarapu K, Shah S, Savjani G, Oxvig C. Development of IGF-1 ELISA Assays to Measure Free and Total Circulating IGF-1. Poster session presented at the 96th Annual Endocrine Society Meeting; 2014 Jun 21-24; Chicago, IL.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

Kumar A, Kalra B, Chowdavarapu K, Shah S, Savjani G, Oxvig C. Development of IGF-1 ELISA Assays to Measure Free and Total Circulating IGF-1. Presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Panagiotou G, Papakonstantinou E, Vagionas A, Polyzos SA, Mantzoros CS. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study. J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; IGF-I (Total) ELISA AL-121; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Pellikaan K, Elizabeth M, Hokken-Koelega ACS, van den Berg SA, de Graaff-Herder L. Reference intervals for bioavailable IGF-I values in Dutch healthy children, adolescents, and young adults. J Endocr Soc. 2023;7(Supplement_1). doi:10.1210/jendso/bvad114.1422.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Shulman DS, Merriam P, Choy E, et al. Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer Med. 2023;12:15207-15216. doi: 10.1002/cam4.6208.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 (Total) ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

IGF-II
IGF-II ELISA AL-131
Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Bøtkjær JA, Pors SE, Petersen TS, Kristensen SG, Jeppesen JV, Oxvig C, Andersen CY. Transcription profile of the insulin-like growth factor signaling pathway during human ovarian follicular development. Assist Reprod Genet
. 2019 May;36(5):889-903. doi: 10.1007/s10815-019-01432-x. Epub 2019 Mar 15.

All Products Cited: IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGFBP-4 (Intact) ELISA AL-128; IGF-II ELISA AL-131

 

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros C. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019 Nov;100:153959. doi: 10.1016/j.metabol.2019.153959. Epub 2019 Aug 8.

All Products Cited: IGF-II ELISA AL-131; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131

 

Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J. The IGF–PAPP-A–Stanniocalcin axis in serum and ascites associates with prognosis in patients with ovarian cancer. Int J Mol Sci. 2024;25(2014):1-16. doi:10.3390/ijms25042014.

All Products Cited: IGF-II ELISA AL-131; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109; Stanniocalcin 2 ELISA AL-143

 

Hjortebjerg R, Pedersen DA, Mengel-From J, Jørgensen LH, Christensen K, Frystyk J. Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins. Front Endocrinol (Lausanne). 2023;14:1193742. doi:10.3389/fendo.2023.1193742.

All Products Cited: IGF-II ELISA AL-131; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Kazemi M, Jarrett BY, Parry SA, Thalacker-Mercer AE, Hoeger KM, Spandorfer SD, Lujan ME. . Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3400-e3414. doi: 10.1210/clinem/dgaa426

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140

 

Kumar A, Kalra B, Kommareddy V, Chowdavarapu K, Mistry S, Savjani G, Oxvig C. Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-2 ELISA AL-140; IGFBP-3 (Intact) ELISA AL-149; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J.Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During DevelopmentJ Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143

 

Inhibin
Inhibin (Total) ELISA AL-134
Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Erickson JA, Grenache DG. Performance evaluation of a total inhibin ELISA and reference intervals in female and male populations. Poster session presented at American Association of Clinical Chemistry 2017; July 30-Aug 3, San Diego, CA.

All Products Cited: Inhibin (Total) ELISA AL-134

 

Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. Circulation. 2023 Jun 13;147(24):1809-1822. doi:10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. PMID: 37096577.

All Products Cited: Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin (Total) ELISA AL-134

 

Horst B, Pradhan S, Chaudhary R, Listik E, Quintero-Macias L, Choi AS, et al. Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers. Commun Biol. 2022;5(536):1-13. doi:10.1038/s42003-022-03495-6.

All Products Cited: Inhibin (Total) ELISA AL-134

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Lambert-Messerlian G, Steinhoff M, Kumar A, Eklund EE, Moore R. Comparison of Inhibin Alpha Subunit and Antimüllerian Hormone Immunoreactivity in Granulosa Cell and Mucinous Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):71-77.

All Products Cited: Inhibin alpha antibodies; AMH antibodies; Inhibin (Total) ELISA AL-134; AMH ELISA AL-105

 

Priyanka S, Laura J, Ben H, Victoria A, Shrikant P, Prabhjot K, Tapasya S, Nadine H, Balázs G, Eugenia B, Nam L, Karthikeyan M. Inhibin is a novel paracrine factor for tumor angiogenesis and metastasis. Cancer Res. 2018 June 01; 78(11): 2978–2989. doi:10.1158/0008-5472.CAN-17-2316

All Products Cited: Inhibin (Total) ELISA AL-134

 

Inhibin A
Inhibin A (Equine / Canine / Rodent) ELISA AL-161
Ball BA, Davolli GM, Esteller-Vico A, Fleming BO, Wynn MAA, Conley AJ. Inhibin-A and Inhibin-B in stallions: Seasonal changes and changes after down-regulation of the hypothalamic-pituitary-gonadal axis. Theriogenology. 2019 Jan 1;123:108-115. doi: 10.1016/j.theriogenology.2018.09.036. Epub 2018 Sep 27. PMID: 30296651.

All Products Cited: Inhibin A (Equine / Canine / Rodent) ELISA AL-161; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Conley AJ, Scholtz EL, Dujovne G, Cotterman RF, Legacki EL, Uliani RC, Alvarenga MA, Ball BA, Kalra B, Savjani GV, Kumar A. Inhibin-A and inhibin-B in cyclic and pregnant mares, and mares with granulosa-theca cell tumors: Physiological and diagnostic implications. Theriogenology. 2018 Mar 1;108:192-200.

All Products Cited: Inhibin A (Equine / Canine / Rodent) ELISA AL-161; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

Habara O, Logan CY, Kanai-Azuma M, Nusse R, Takase HM. WNT signaling in pre-granulosa cells is required for ovarian folliculogenesis and female fertility. Development. 2021 May 1;148(9):dev198846. doi: 10.1242/dev.198846

All Products Cited: AMH (Rat/Mouse) ELISA AL-113; Inhibin A (Equine / Canine / Rodent) ELISA AL-161

 

Inhibin A
Inhibin A (pico) ELISA AL-184
Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Inhibin A
Inhibin A ELISA AL-123
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Andersen CY. Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle. Mol Hum Reprod (2017) 23 (1): 16-24.

All Products Cited: Inhibin A ELISA AL-123

 

Fought AJ, Kuhn K, Schauer IE, Zhang H, D’Alessandro A. Maternal obesity in early pregnancy is associated with decreased active IGF-I availability and increased leptin concentrations. J Endocr Soc. 2019;3(Supplement_1). doi:10.1210/js.2019-SAT-LB045.

All Products Cited: PAPP-A2 ELISA AL-109; Inhibin A ELISA AL-123

 

García-Guerra A, Canavessi AMO, Monteiro PLJ Jr, Mezera MA, Sartori R, Kirkpatrick BW, Wiltbank MC. Trio, a novel bovine high fecundity allele: III. Acquisition of dominance and ovulatory capacity at a smaller follicle size. Biol Reprod. 2018 Mar 1;98(3):350-365. doi: 10.1093/biolre/iox157. PMID: 29425314.

All Products Cited: Inhibin A ELISA AL-123

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A. Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Keikkala E, Forstén J, Ritvos O, Stenman UH, Kajantie E, Hämäläinen E, Räikkönen K, Villa PM, Laivuori H. Serum Inhibin-A and PAPP-A2 in the prediction of re-eclampsia during the first and second trimesters in high-risk women. Pregnancy Hypertens: . 2021 Aug;25:116-122.doi: 10.1016/j.preghy.2021.05.024. Epub 2021 Jun 2.

All Products Cited: Inhibin A ELISA AL-123; PAPP-A2 ELISA AL-109; PAPP-A ELISA AL-106

 

Kim A, Ebbert K, Cordeiro MH, Romero M, Zhu J, Serna VA, Whelan KA, Woodruff TK, Kurita T. Cell Autonomous Phosphoinositide 3-Kinase Activation in Oocytes Disrupts Normal Ovarian Function Through Promoting Survival and Overgrowth of Ovarian Follicles. Endocrinology. 2015 Apr; 156(4): 1464–1476.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Kim SY, Ebbert K, Cordeiro MH, Romero MM, Whelan KA, Suarez AA, Woodruff TK, Kurita T. Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors. Cancer Res. 2016 Jul 1;76(13):3851-61

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Lahlou N, Santullli P, Guibourdenche J, Beldjord C, Kottler, M, Chapron C, Gompel A. Unexpected Inhibin B, Insulin-like Peptide 3, and Testosterone Production By Mother Ovaries in a Pregnancy with Sustained High Hcg Levels. a Clue to Hyperreactio Luteinalis?. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123

 

Lambert-Messerlian GM, Eklund EE, Neveux LM, Palomaki GE. Measuring maternal serum screening markers for Down’s syndrome in plasma collected for cell-free DNA testing. J Med Screen. 2017 Sep;24(3):113-119.

All Products Cited: PAPP-A ELISA AL-106; Inhibin A ELISA AL-123

 

Lawrenz B, Depret Bixio L, Coughlan C, Andersen CY, Melado L, Kalra B, Savjani G, Fatemi HM, Kumar A. Inhibin A—A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI. Front Endocrinol (Lausanne). 2020 May 15;11:307. doi: 10.3389/fendo.2020.00307. PMID: 32499758; PMCID: PMC7243678.

All Products Cited: Inhibin A ELISA AL-123

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Inhibin A
Inhibin A ELISA AL-123
Liv C Poulsen, Agnieszka K Warzecha, Nathalie S Bülow, Leif Bungum, Nicholas S Macklon, Claus Yding Andersen, Sven O Skouby, Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol, Human Reproduction, Volume 37, Issue 7, July 2022, Pages 1557–1571, https://doi.org/10.1093/humrep/deac119

All Products Cited: Inhibin B ELISA AL-107; Inhibin A ELISA AL-123

 

Neuman RI, Alblas van der Meer MM, Nieboer D, Saleh L, Verdonk K, Kalra B, Kumar A, Alpadi K, van den Meiracker AH, Visser W, Danser AHJ. PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia. J Am Heart Assoc. 2020 Oct 20;9(19):e018219. doi: 10.1161/JAHA.120.018219. Epub 2020 Sep 29. PMID: 32990126; PMCID: PMC7792419

All Products Cited: Inhibin A ELISA AL-123; PAPP-A2 ELISA AL-109

 

Neuman RI, Alblas van der Meer MM, Nieboer D, Saleh L, Verdonk K, Kalra B, Kumar A, Alpadi K, van den Meiracker AH, Visser W, Danser AHJ. PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia. J Am Heart Assoc. 2020 Oct 20;9(19):e018219. doi: 10.1161/JAHA.120.018219. Epub 2020 Sep 29. PMID: 32990126.

All Products Cited: PAPP-A2 ELISA AL-109; Inhibin A ELISA AL-123

 

Pranpanus S, Kor-Anantakul O, Suntharasaj T, Suwanrath C, Hanprasertpong T, Pruksanusak N, Petpichetchian C, Suksai M, Chainarong N, Sawaddisan R. . Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country. PLoS One. 2021 May 13;16(5):e0251381. doi: 10.1371/journal.pone.0251381

All Products Cited: Inhibin A ELISA AL-123

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Wongkrajang P, Jittikoon J, Sangroongruangsri S, Talungchit P, Ruangvutilert P, Panchalee T, et al. Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand. PLoS ONE. 2023;18(4). doi:10.1371/journal.pone.0284829.

All Products Cited: Inhibin A ELISA AL-123

 

Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, McKinnon KE, Dokic D, Rashedi AS, Haisenleder DJ, Malpani SS, Arnold-Murray CA, Chen K, Jiang M, Bai L, Nguyen CT, Zhang J, Laronda MM, Hope TJ, Maniar KP, Pavone ME, Avram MJ, Sefton EC, Getsios S, Burdette JE, Kim JJ, Borenstein JT, Woodruff TK. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat Commun. 2017 Mar 28;8:14584.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Ye J, Chen QJ, He W, Zhang J, Ye HJ, Fu YL, Lyu QF, Kuang YP. Impact of progesterone on inhibins during controlled ovarian stimulation. Reprod Dev Med 2017;1:69-76.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Yu SY, Luan Y, Tang S, Abazarikia A, Dong R, Caffrey TC, Hollingsworth MA, Oupicky D, Kim SY. Uncovering tumor-promoting roles of Activin A in pancreatic ductal adenocarcinoma. Adv Sci (Weinh). 2023;10(2207010):1-13. doi:10.1002/advs.202207010.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123

 

Inhibin B
Inhibin B (Equine / Canine / Rodent) ELISA AL-163
Ball BA, Davolli GM, Esteller-Vico A, Fleming BO, Wynn MAA, Conley AJ. Inhibin-A and Inhibin-B in stallions: Seasonal changes and changes after down-regulation of the hypothalamic-pituitary-gonadal axis. Theriogenology. 2019 Jan 1;123:108-115. doi: 10.1016/j.theriogenology.2018.09.036. Epub 2018 Sep 27. PMID: 30296651.

All Products Cited: Inhibin A (Equine / Canine / Rodent) ELISA AL-161; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Conley AJ, Scholtz EL, Dujovne G, Cotterman RF, Legacki EL, Uliani RC, Alvarenga MA, Ball BA, Kalra B, Savjani GV, Kumar A. Inhibin-A and inhibin-B in cyclic and pregnant mares, and mares with granulosa-theca cell tumors: Physiological and diagnostic implications. Theriogenology. 2018 Mar 1;108:192-200.

All Products Cited: Inhibin A (Equine / Canine / Rodent) ELISA AL-161; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Hallberg I, Olsson H, Lau A, Wallander S, Snell A, Bergman D, Ström Holst B. Endocrine and dog factors associated with semen quality. Sci Rep. 2024;14(718):1-11. doi:10.1038/s41598-024-51242-0.

All Products Cited: Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Johnson AK, Hollinshead FK, Berger T, Cotterman RF, Caruso CJ, Conley AJ. Anti-Müllerian hormone and inhibin-B concentrations vary cyclically in nonovulating queens within reference ranges established for determining gonadal status in cats. J Am Vet Med Assoc. 2023 Aug 22;261(12):1796-1803. doi: 10.2460/javma.23.06.0320. PMID: 37607677.

All Products Cited: AMH (Canine/Feline) ELISA AL-116; Inhibin B (Equine / Canine / Rodent) ELISA AL-163

 

Inhibin B
Inhibin B (Ultra-Sensitive) ELISA AL-195
Barbotin AL, Kumar A, Kalra B, Savjani G, Mitchell V, Pigny P. SAT-043 Utility of Ultrasensitive Inhibin B Measurement for the Management of Men with Non-Obstructive Azoospermia. Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020, SAT-043, https://doi.org/10.1210/jendso/bvaa046.659

All Products Cited: Inhibin B Ultra Sensitive ELISA AL-195

 

Barbotin AL, Kumar A, Kalra B, Savjani G, Mitchell V, Pigny P. Utility of ultrasensitive inhibin B measurement for the management of men with non-obstructive azoospermia. J Endocr Soc. 2020;4(Supplement_1). doi:10.1210/jendso/bvaa046.

All Products Cited: Inhibin B (Ultra-Sensitive) ELISA AL-195

 

Danis RB, Sriprasert I, Ho J, Kumar A, McGinnis L, Stanczyk F. Bioavailable Inhibin B (Inh B)may be a better marker of oocyte yield than currently used markers of ovarian reserve. Fertility and Sterility Volume 114, Issue 3, Supplement, E453, September 01, 2020 DOI: https://doi.org/10.1016/j.fertnstert.2020.08.1308

All Products Cited: Inhibin B (Ultra-Sensitive) ELISA AL-195

 

Luu TH, Kuhn K, Bradford AP, Johnson R, Carlson N, Kumar TR, Polotsky AJ. Obese women exhibit reduced inhibin B and estradiol secretion following pulsatile intravenous FSH administration. J Endocr Soc. 2021;5(Supplement_1). doi:10.1210/jendso/bvab048.

All Products Cited: Inhibin B (Ultra-Sensitive) ELISA AL-195

 

Inhibin B
Inhibin B CLIA AL-207
Attaelmannan M, Pandian R, Thomassian K, Khachatryan S, Kumar A. Development and Validation of an Improved Chemiluminescent Assay for Inhibin B. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: Inhibin B CLIA AL-207

 

Inhibin B
Inhibin B ELISA AL-107
Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 29:155397. doi: 10.1016/j.metabol.2022.155397. Epub ahead of print. PMID: 36587801.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Anastasilakis AD, Polyzos SA, Rodopaios NE, Makras P, Kumar A, Kalra B, Mantzoros CS. Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study. Metabolism. 2022 Dec 30;141:155397. doi: 10.1016/j.metabol.2022.155397.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA Al-153; Follistatin ELISA AL-117; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123; Follistatin-Like 3 ELISA AL-152

 

Calvert ME, Kalra B, Patel A, Kumar A, Shaw ND. Serum and urine profiles of TGF-β superfamily members in reproductive aged women. Clin Chim Acta. 2022 Jan 1;524:96-100. doi: 10.1016/j.cca.2021.12.002. Epub 2021 Dec 5. PMID: 34875272; PMCID: PMC8740174.

All Products Cited: Inhibin A (pico) ELISA AL-184; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; AMH (PCOCheck) ELISA AL-196; Activin A ELISA AL-110; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; GDF-9/BMP-15 Complex ELISA AL-181; GDF-15 (Total) ELISA AL-1014; GDF-15 (H-Specific) ELISA AL-1018

 

Chaudhary S, Walia R, Bhansali A, Dayal D, Sachdeva N, Singh T, Bhadada SK. . FSH-stimulated Inhibin B (FSH-iB): A Novel Marker for the Accurate Prediction of Pubertal Outcome in Delayed Puberty. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3495-e3505. doi: 10.1210/clinem/dgab357

All Products Cited: Inhibin B ELISA AL-107

 

Chinya A, Ratan SK, Aggarwal SK, Garg A, Mishra TK. Association of Levels of Serum Inhibin B and Follicle-stimulating Hormone with Testicular Vascularity, Volume, and Echotexture in Children with Undescended Testes. J Indian Assoc Pediatr Surg. 2017 Jan-Mar;22(1):3-8. doi: 10.4103/0971-9261.194609. PMID: 28082768; PMCID: PMC5217136

All Products Cited: Inhibin B ELISA AL-107

 

Corvest V, Lemaire P, Brailly-Tabard S, Brauner R. Puberty and Inhibin B in 35 Adolescents With Pituitary Stalk Interruption Syndrome. Front Pediatr. 2020 Jun 11;8:304. doi: 10.3389/fped.2020.00304. eCollection 2020

All Products Cited: Inhibin B ELISA AL-107

 

Danis RB, Sriprasert I, Ho JR, M LK, Kumar A, Stanczyk FZ. Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation. F&S Reports, Available online 31 March 2021. https://doi.org/10.1016/j.xfre.2021.03.005

All Products Cited: Inhibin B ELISA AL-107

 

Du YY, Guo N, Wang YX, Hua X, Deng TR, Teng XM, Yao YC, Li YF. Urinary phthalate metabolites in relation to serum anti-Müllerian hormone and inhibin B levels among women from a fertility center: a retrospective analysis. Du et al. Reproductive Health (2018) 15:33 https://doi.org/10.1186/s12978-018-0469-8

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Duijkers IJM, Klipping C, Jost M, Bastidas A, Foidart JMF. The effect of estetrol/drospirenone on ovarian function is similar to a well-established combined oral contraceptive: results from a phase 2 study. J Endocr Soc. 2021;5(Supplement_1). doi:10.1210/jendso/bvab048.

All Products Cited: Inhibin B ELISA AL-107

 

Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM, Burnett-Bowie SA, Darakananda K, Donahoe PK, Harlow SD, Prizand SH, Joffe H, Kumar A, Martin DE, McConnell D, Merrilat S, Morrison A, Pastore LM, Randolph JF, Greendale GA, Santoro N. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women’s Health Across the Nation. The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 4, April 2020, Pages e1862–e1871, https://doi.org/10.1210/clinem/dgz283

All Products Cited: AMH (MenoCheck) (pico) ELISA AL-124; Inhibin B ELISA AL-107

 

Guaragna-Filho G, Calixto AR, Astur ABLV, Paula GB, Oliveira LC, Morcillo AM, Gonçalves EM, Mello MP, Maciel-Guerra AT, Guerra-Junior G. Leydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion: a case-control study. Sao Paulo Med J. 2022;140(2):163-170. doi:10.1590/1516-3180.2021.0042.R1.08062021.

All Products Cited: Inhibin B ELISA AL-107

 

Guaragna-Filho G, Calixto AR, De Paula GB, De Oliveira LC, Morcillo AM, De Mello MP, Maciel-Guerra AT, Guerra-Junior G. Comparison between two inhibin B ELISA assays in 46,XY testicular disorders of sex development (DSD) with normal testosterone secretion. J Pediatr Endocrinol Metab. 2018 Jan 26;31(2):191-194. doi: 10.1515/jpem-2017-0351. PMID: 29306929.

All Products Cited: Inhibin B ELISA AL-107

 

Harris BS, Steiner AZ, Jukic AM. Ovarian Reserve Biomarkers and Menstrual Cycle Length in a Prospective Cohort Study. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3748-e3759. doi: 10.1210/clinem/dgab204

All Products Cited: FSH ELISA AL-186; AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Istanbullu S, Lahlou N, Chevenne D, Léger J, Carel J, Martinerie L. Constitutional delay of puberty or hypogonadotropic hypogonadism: Diagnostic value of inhibin B and AMH measurements. Abstract presented at 55th European Society for Paediactric Endocrinology; 2016; Sep 10-12; Paris, France.

All Products Cited: Inhibin B ELISA AL-107

 

J Cadenas, L C Poulsen, D Nikiforov, M L Grøndahl, A Kumar, K Bahnu, A L M Englund, J Malm, G Marko-Varga, I Pla, A Sanchez, S E Pors, C Yding Andersen, Regulation of human oocyte maturation in vivo during the final maturation of follicles, Human Reproduction, Volume 38, Issue 4, April 2023, Pages 686–700, https://doi.org/10.1093/humrep/dead024

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Activin A ELISA AL-110; GDF-9 ELISA AL-176; GDF-9/BMP-15 Complex ELISA AL-181; BMP-15 ELISA AL-179

 

Jain M, Kalsi AK, Srivastava A, Gupta YK, Halder A. High Serum Estradiol and Heavy Metals Responsible for Human Spermiation Defect-A Pilot Study. J Clin Diagn Res. 2016 Dec;10(12):RC09-RC13.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Kalra B, Patel A, Kommareddy V, Ganapathy K, Mistry S, Budhavarapu V, Savjani G, Pasternack A, Ritvos O, Hyvonen M, Kumar A. Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3. Poster presented at 98th Annual Endocrine Society Meeting; 2016 Apr 1-3; Boston, MA.

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Activin B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152

 

Kano M, Hsu JY, Saatcioglu HD, Nagykery N, Zhang L, Morris Sabatini ME, Donahoe PK, Pépin D. Neoadjuvant Treatment With Mullerian Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield. J Endocr Soc. 2019 Jul 22;3(11):2123-2134. doi: 10.1210/js.2019-00190. eCollection 2019 Nov 1

All Products Cited: Inhibin B ELISA AL-107

 

Kim A, Ebbert K, Cordeiro MH, Romero M, Zhu J, Serna VA, Whelan KA, Woodruff TK, Kurita T. Cell Autonomous Phosphoinositide 3-Kinase Activation in Oocytes Disrupts Normal Ovarian Function Through Promoting Survival and Overgrowth of Ovarian Follicles. Endocrinology. 2015 Apr; 156(4): 1464–1476.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Kim SY, Ebbert K, Cordeiro MH, Romero MM, Whelan KA, Suarez AA, Woodruff TK, Kurita T. Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors. Cancer Res. 2016 Jul 1;76(13):3851-61

All Products Cited: Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Kristensen SG, Kumar A, Kalra B, Pors SE, Bøtkjær JA, Mamsen LS, Colmorn LB, Fedder J, Ernst E, Owens LA, Hardy K, Franks S, Andersen CY. Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6371-6384. doi: 10.1210/jc.2019-01094. PMID: 31287539.

All Products Cited: GDF-9 ELISA AL-179; AMH (pico) ELISA AL-124; Inhibin-A ELISA AL-123; Inhibin-B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin-A ELISA AL-110; Activin-B ELISA AL-150; Activin AB ELISA AL-153; Follistatin ELISA AL-117; FTSL-3 ELISA AL-152

 

Kristensen SG, Kumar A, Mamsen LS, Kalra B, Pors SE, Bøtkjær JA, Macklon KT, Fedder J, Ernst E, Hardy K, Franks S, Andersen CY. Intrafollicular concentrations of the oocyte-secreted factors GDF9 and BMP15 vary inversely in polycystic ovaries. J Clin Endocrinol Metab. 2022 May 2:dgac272. doi: 10.1210/clinem/dgac272. Epub ahead of print. PMID: 35511085.

All Products Cited: GDF-9 ELISA AL-176; BMP-15 ELISA AL-179; GDF-9/BMP-15 Complex ELISA AL-181; AMH ELISA AL-105; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; Inhibin (Total) ELISA AL-134; Activin B ELISA AL-110; Activin AB ELISA AL-153; Follistatin ELISA AL-117

 

Kumar A, Kalra B, Patel A, Shah S. Development of a Sensitive Inhibin B ELISA Optimized to Eliminate False Positive Results. Poster session presented at: American Association for Clinical Chemistry; 2013; Jul 30-Aug 1; Houston, TX.

All Products Cited: Inhibin B ELISA AL-107

 

Lahlou N, Santullli P, Guibourdenche J, Beldjord C, Kottler, M, Chapron C, Gompel A. Unexpected Inhibin B, Insulin-like Peptide 3, and Testosterone Production by Mother Ovaries in a Pregnancy with Sustained High hCG Levels. A Clue to Hyperreactio Luteinalis? . Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107; Inhibin A ELISA AL-123

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Liu DM, Torchen LC, Sung Y, Paparodis R, Legro RS, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Human Reproduction, Vol.29, No.12 pp. 2764–2772, 2014 Oct 21.

All Products Cited: Inhibin B ELISA AL-107

 

Liv C Poulsen, Agnieszka K Warzecha, Nathalie S Bülow, Leif Bungum, Nicholas S Macklon, Claus Yding Andersen, Sven O Skouby, Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol, Human Reproduction, Volume 37, Issue 7, July 2022, Pages 1557–1571, https://doi.org/10.1093/humrep/deac119

All Products Cited: Inhibin B ELISA AL-107; Inhibin A ELISA AL-123

 

Mamsen LS, Charkiewicz K, Anderson RA, Telfer EE, McLaughlin M, Kelsey TW, Kristensen SG, Gook DA, Ernst E, Andersen CY. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019 Jun;111(6):1217-1225.e3. doi: 10.1016/j.fertnstert.2019.02.003. Epub 2019 Mar 25. PMID: 30922638.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Manente L, Pecoraro S, Picillo E, Gargiulo U, Gargiulo P, De Luca A, Politano L. Molecular evidence of apoptotic pathway activation in semen samples with high DNA fragmentation. In Vivo. 2015 Mar-Apr;29(2):289-94.

All Products Cited: Inhibin B ELISA AL-107

 

Mons J, Mahé-Poiron D, Mansuy JM, Lheureux H, Nigon D, Moinard N, et al. Effects of acute dengue infection on sperm and virus clearance in body fluids of men. Emerg Infect Dis. 2022;28(6):1146-1153. doi:10.3201/eid2806.212317.

All Products Cited: Inhibin B ELISA AL-107

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Chrysafi P, Anastasilakis AD, Mantzoros CS. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function. Metabolism. 2018 May 9. pii: S0026-0495(18)30120-3.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Perakakis N, Upadhyay J, Ghaly W, Chen J, Mantzoros CS. Leptin-dependent and leptin-independent pathways linking energy sufficiency with reproduction. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Qiaofei H, Liming H, Mingyue N, Qin W, Ying F, Yinmei D, Yanhong Z, Shuyu W, Chenghong Y, Xiaokui Y. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women. Hu et al. Journal of Ovarian Research (2017) 10:32 DOI 10.1186/s13048-017-0326-3

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Sharma SK, Jain S, Bahl P, Potturi P, Rathi M, Naidu S, Sachdeva N, Dhir V, Jain S. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study. Sharma et al. Arthritis Research & Therapy (2020) 22:189 https://doi.org/10.1186/s13075-020-02292-y

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017 Oct 10;318(14):1367-1376. doi: 10.1001/jama.2017.14588.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Tencer J, Lemaire P, Brailly-Tabard S, Brauner R. Serum inhibin B concentration as a predictor of age at first menstruation in girls with idiopathic central precocious puberty. PLoS One. 2018 Dec 14;13(12):e0205810. doi: 10.1371/journal.pone.0205810. eCollection 2018.

All Products Cited: Inhibin B ELISA AL-107

 

Ting A, Savjani G, Kalra B, Kumar A, Stouffer R, Zelinski M. Dynamics of Growth and Differentiation Factor-9 and Inhibin B Production in Macaque Developing Follicles During 3-Dimensional Culture. Poster Presentation at ASRM 2017 Oct 28-Nov 1, San Antonio TX.

All Products Cited: GDF-9 ELISA AL-176; Inhibin B ELISA AL-107

 

Torchen L, Kumar A, Kalra B, Savjani G, Sisk R, Legro R, Dunaif A. Brothers and Fathers of Women with PCOS Have Altered Testicular Function. Poster session presented at: Endocrine Society’s 96th Annual Meeting; 2014; June 21-24; Chicago, IL.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Torchen LC, Kumar A, Kalra B, Savjani G, Sisk R, Legro RS, Dunaif A. Increased antim€ullerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil Steril. 2016 Jul;106(1):50-55.

All Products Cited: Inhibin B ELISA AL-107; AMH ELISA AL-105

 

Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat Commun. 2017;8(14584):1-14. doi:10.1038/ncomms14584(904).

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Xiao S, Coppeta JR, Rogers HB, Isenberg BC, Zhu J, Olalekan SA, McKinnon KE, Dokic D, Rashedi AS, Haisenleder DJ, Malpani SS, Arnold-Murray CA, Chen K, Jiang M, Bai L, Nguyen CT, Zhang J, Laronda MM, Hope TJ, Maniar KP, Pavone ME, Avram MJ, Sefton EC, Getsios S, Burdette JE, Kim JJ, Borenstein JT, Woodruff TK. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat Commun. 2017 Mar 28;8:14584.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Xingming Z, Qian Y. Relationship between inhibin B and different clinical phenotypes of polycystic ovary syndrome. Chinese Journal of Practical Gynecology and Obstetrics. 2017 eleven pages 1183-1188.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

Ye J, Chen QJ, He W, Zhang J, Ye HJ, Fu YL, Lyu QF, Kuang YP. Impact of progesterone on inhibins during controlled ovarian stimulation. Reprod Dev Med 2017;1:69-76.

All Products Cited: Inhibin A ELISA AL-123; Inhibin B ELISA AL-107

 

Zhou W, Fang F, Zhu W, Chen ZJ, Du Y, Zhang J. Bisphenol A and Ovarian Reserve among Infertile Women with Polycystic Ovarian Syndrome. Int J Environ Res Public Health. 2016 Dec 27;14(1). pii: E18.

All Products Cited: AMH ELISA AL-105; Inhibin B ELISA AL-107

 

LH
LH (Dried Blood Spot) ELISA AL-190
Din HN, Singh-Carlson S, Corliss HL, Hartman SJ, Strong D, Madanat H, Su HI. Perceived and Objective Fertility Risk Among Female Survivors of Adolescent and Young Adult Cancer. JAMA Netw Open. 2023 Oct 2;6(10):e2337245. doi: 10.1001/jamanetworkopen.2023.37245. PMID: 37819662; PMCID: PMC10568355.

All Products Cited: AMH (DBS) ELISA AL-129; LH (DBS) ELISA AL-190

 

Kumar T, Chauhan R, Kalra B, Patel AS, Chauhan S, Kumar A. Novel comparative analysis of dried blood spot and serum ELISAs for AMH, FSH, and LH in patients seeking IVF treatment. J Endocr Soc. 2019;3(Supplement_1)

All Products Cited: AMH (pico) ELISA AL-124; AMH (DBS) ELISA AL-129; LH (DBS) ELISA AL-190; FSH (DBS) ELISA AL-187

Kumar T, Chauhan R, Kalra B, Patel AS, Chauhan S, Kumar A. Novel comparative analysis of dried blood spot and serum ELISAs for AMH, FSH, and LH in patients seeking IVF treatment. J Endocr Soc. 2019;3(Supplement_1)

All Products Cited: AMH (pico) ELISA AL-124; AMH (DBS) ELISA AL-129;LH (DBS) ELISA AL-190; FSH (DBS) ELISA AL-187

 

MBP
MBP CLIA AL-208
Lu J, Grenache D. Performance Evaluation of the AnshLite Myelin Basic Protein Chemiluminescent Immunoassay using Cerebrospinal Fluid. Poster session presented at American Association for Clinical Chemistry; 2014 Jul 27-31; Chicago, IL.

All Products Cited: MBP CLIA AL-208

 

MBP ELISA AL-108
de Almeida SM, Rotta I, Ribeiro CE, Oliveira MF, Chaillon A, de Pereira AP, Cunha AP, Zonta M, Bents JF, Raboni SM, Smith D, Letendre S, Ellis RJ. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization- case study. J Neurovirol. 2017 Jun;23(3):460-473. doi: 10.1007/s13365-017-0518-z

All Products Cited: MBP ELISA AL-108

 

MPGF
MPGF ELISA AL-175

Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-127; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-127; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Oxyntomodulin
Oxyntomodulin ELISA AL-139
D’Alessio D, Kumar A, Kalra B, Mistry S, Tong J. Novel ELISA Assays Demonstrate Specificity of Islet and Intestinal Processing of Proglucagon. Volume 4, Issue Supplement_1, April May 2020, SUN-LB124, https://doi.org/10

All Products Cited: GLP-1 ELISA AL-172; Glucagon ELISA AL-157; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185

 

Fothergill LJ, Ringuet MT, Sioras E, Hunne B, Fazio Coles TE, Martins PR, Furness JB. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat. Cell Tissue Res. 2019 Feb;375(2):359-369. doi: 10.1007/s00441-018-2921-z. Epub 2018 Sep 27. PMID: 30259122.

All Products Cited: Oxyntomodulin ELISA AL-139

 

Fothergill LJ, Ringuet MT, Sioras E, Hunne B, Fazio Coles TE, Martins PR, Furness JB. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat. Cell Tissue Res. 2019 Feb;375(2):359-369.

All Products Cited: Oxyntomodulin ELISA AL-139

 

Jiang H, Pang S, Zhang Y, Yu T, Liu M, Deng H, et al. A phase 1b randomized controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes. Nat Commun. 2022;13(3613):1-13. doi:10.1038/s41467-022-31328-x(905).

All Products Cited: Oxyntomodulin ELISA AL-139

 

Kim S, Abbasi F, Nachmanoff C, Kumar A, Kalra B, Savjani G, Mantzoros C. Effect of Liraglutide Treatment on Proglucagon-Derived Peptides. JESOCI, Volume 4, Abstract Supplement, 2020

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-127; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; MPGF ELISA AL-175

 

Kumar A, Kalra B, Mistry S, Patel AS, Budhavarapu V, Chatterji T, Savjani G, Krishna R, D’Alessio D. Development of Novel Specific and Sensitive ELISAs for Proglucagon-Derived Peptides. Poster presented at 69th AACC Meeting; 2017 July 30-Aug 3; San Diego, CA

All Products Cited: Glucagon ELISA AL-157; GLP-1 ELISA AL-172; Oxyntomodulin ELISA AL-139

 

Legro R, Dodson W, Estes S, Kunselman A, Coutifaris C, Dokras A. Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome. Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON-233, https://doi.org/10.1210/js.2019-MON-233

All Products Cited: Activin A ELISA AL-110; Follistatin ELISA AL-117; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Perakakis N, Chen J, Ghaly W, Vamvini MT, Mantzoros CS. Effects of oral and intravenous lipid administration on hormones affecting energy balance. Poster session presented at the Obesity Week Meeting; 2017 Oct 29-Nov 2; Washington DC.

All Products Cited: Activin A ELISA AL-110; Activin B ELISA AL-150; Follistatin-Like 3 ELISA AL-152; Oxyntomodulin ELISA AL-139

 

Perakakis N, Farr OM, Mantzoros CS. Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward- and attention-related brain centres in response to visual food cues in adults with obesity: A cross-sectional functional MRI study. Diabetes Obes Metab. 2021 May;23(5):1202-1207. doi: 10.1111/dom.14315. Epub 2021 Jan 22. PMID: 33417264.

All Products Cited: Oxyntomodulin ELISA AL-139

 

Perakakis N, Kalra B, Angelidi AM, Kumar A, Gavrieli A, MYannakoulia M, Mantzoros CS. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial. Metabolism, Volume 129, 2022, 155157, ISSN 0026-0495, https://doi.org/10.1016/j.metabol.2022.155157.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Oxyntomodulin ELISA AL-139; Glicentin ELISA AL-185; Glucagon ELISA AL-127; MPGF ELISA AL-175; C-Peptide of Insulin ELISA AL-151

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Richard Legro, William Dodson, Stephanie Estes, Allen Kunselman, Christos Coutifaris, Anuja Dokras, MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, MON–233, https://doi.org/10.1210/js.2019-

All Products Cited: Follistatin ELISA AL-117; Activin A ELISA AL-110; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; IGF-I (Total) ELISA AL-121; IGFBP-2 ELISA AL-140; Oxyntomodulin ELISA AL-139

 

Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab. 2021 Jan 1;106(1):108-119. doi: 10.1210/clinem/dgaa682. PMID: 32968804; PMCID: PMC7765645

All Products Cited: Activin A ELISA AL-110; Activin AB ELISA AL-153; Inhibin A ELISA AL-123; Inhibin B ELISA AL-107; AMH ELISA AL-105, IGF-I (Total) ELISA AL-121, IGFBP-2 ELISA AL-140; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Follistatin ELISA AL-117; Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139

 

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Klapa MI, Candela M, Rampelli S, Lehoux S, Lázaro I, Sala-Vila A, Brigidi P, Cummings RD, Mantzoros CS. Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross-over, randomized, double-blind, controlled inpatient physiology study. Diabetes Obes Metab. 2019 Sep;21(9):2086-2095. doi: 10.1111/dom.13773. Epub 2019 Jul 2. PMID: 31087608; PMCID: PMC6684390.

All Products Cited: Oxyntomodulin ELISA AL-139

 

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS. Lorcasse1rin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six-month, randomized, placebo-controlled, double-blind clinical trial. Diabetes Obes Metab. 2019 Jun;21(6):1487-1492. doi: 10.1111/dom.13655. Epub 2019 Mar 18. PMID: 30724455; PMCID: PMC6504613.

All Products Cited: Oxyntomodulin ELISA AL-139

 

Upadhyay J, Panagiotou G, Anastasilakis A, Mantzoros C. Oxyntomodulin and Glucagon in Healthy Humans: Anthropometric, Hormonal, and Metabolic Predictors and Response to Glucose Load and Exercise. Abstract – ADA Supported Research, Integrated Physiology / Obesity. Not Dated

All Products Cited: Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

Upadhyay J, Perakakis N, Panagiotou G, Anastasilakis AD, Mantzoros CS. Regulation of the proglucagon-derived hormones in healthy and in obese after bariatric surgery. Poster Presentation. Unknown Conference

All Products Cited: Oxyntomodulin ELISA AL-139; Glucagon ELISA AL-157

 

PAPP-A
PAPP-A (pico) CLIA AL-201
Kalra B, Kumar A, Tran A, Oxvig C, Shah S. Development of a fully characterized picoPAPP-A chemiluminescence assay for male and female serum evaluation. Poster session presented at American Association for Clinical Chemistry; 2012 Jul 16-19; Los Angeles, CA.

All Products Cited: PAPP-A (pico) CLIA AL-201

 

PAPP-A (pico) ELISA AL-101
Al-Khafaji H, Noer PR, Alkharobi H, Alhodhodi A, Meade J, El-Gendy R, Oxvig C, Beattie J. A characteristic signature of insulin-like growth factor (IGF) axis expression during osteogenic differentiation of human dental pulp cells (hDPCs): Potential co-ordinated regulation of IGF action. Growth Horm IGF Res. 2018 Oct-Dec;42-43:14-21. doi: 10.1016/j.ghir.2018.07.003. Epub 2018 Jul 26. PMID: 30071469; PMCID: PMC6259625.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Anastasilakis AD, Koulaxis D, Upadhyay J, Pagkalidou E, Kefala N, Perakakis N, Polyzos SA, Economou F, Mantzoros CS. Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls. Horm Metab Res. 2019 Feb;51(2):112-119.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; PAPP-A (pico) ELISA AL-101

 

Becker M, Haluska P, Bale L, Oxvig C, Conover C. A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts. Mol Cancer Ther. 2015 Apr;14(4):973-81. Epub 2015 Feb 18.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; Rat / Mouse IGF-I ELISA AL-137; PAPP-A Neutralizing Antibodies

 

Boldt H, Bale L, Resch Z, Exvig C, Overgaard M, Conover C. Effects of Mutated Pregnancy-Associated Plasma Protein-A on Atherosclerotic Lesion Development in Mice. Endocrinology. 2013 January; 154(1):246-252.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Botkjaer JA, Borgbo T, Kloverpris S, Noer PR, Oxvig C, Andersen CY. Effect of pregnancy-associated plasma protein-A (PAPP-A) single-nucleotide polymorphisms on the level and activity of PAPP-A and the hormone profile in fluid from normal human small antral follicles. Fertil Steril. 2016 Dec;106(7):1778-1786.e8.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Bøtkjær JA, Jeppesen JV, Wissing ML, Kløverpris S, Oxvig C, Mason JI, Borgbo T, Andersen CY. Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels. Fertil Steril. 2015 Nov;104(5):1294-301.e1. doi: 10.1016/j.fertnstert.2015.07.1152. Epub 2015 Aug 18. PMID: 26297643.

All Products Cited: PAPP-A (pico) ELISA AL-101; AMH Antibodies

 

Botkjær JA, Noer PR, Oxvig C, Yding Andersen C. A common variant of the pregnancy-associated plasma protein-A (PAPPA) gene encodes a protein with reduced proteolytic activity towards IGF-binding proteins. Sci Rep . 2019 Sep 13;9(1):13231. doi: 10.1038/s41598-019-49626-8.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Brohus M, Gorbunova V, Faulkes C, Overgaard MT, Conover CA. The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat. PLOS ONE. 2015 December 22.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, Ferrer M, Aranda-Nevado MC, Serra-Gregori J, Núñez J, García C, Bayes-Genis A. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018 Apr 30;17(1):63. doi: 10.1186/s12933-018-0710-3.

All Products Cited: Stanniocalcin 2 ELISA AL-143; PAPP-A (pico) ELISA AL-101; IGFBP-4 (Intact) ELISA AL-128

 

Davidge-Pitts C, Escande CJ, Conover CA. Preferential expression of PAPPA in human preadipocytes from omental fat. Journal of Endocrinology (2014) 222, 87–97.

All Products Cited: PAPP-A (pico) ELISA AL-101

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros C. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019 Nov;100:153959. doi: 10.1016/j.metabol.2019.153959. Epub 2019 Aug 8.

All Products Cited: IGF-II ELISA AL-131; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109

 

Hada M, Oh H, Pfeiffer RM, Falk RT, Fan S, Mullooly M, Pollak M, Geller B, Vacek PM, Weaver D, Shepherd J, Wang J, Fan B, Mahmoudzadeh AP, Malkov S, Herschorn S, Brinton LA, Sherman ME, Gierach GL. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy. Breast Cancer Res. 2019 Jul 23;21(1):81. doi: 10.1186/s13058-019-1162-8. PMID: 31337427; PMCID: PMC6651938.

All Products Cited: PAPP-A mAb; PAPP-A (pico) ELISA AL-101

 

Heitzeneder S, Shem J, Khan J, Mackall C. Pregnancy Associated Plasma Protein A (PAPP-A) Is A Novel Therapeutic Target In Ewing Sarcoma. Presented at 8th Ovarian Cancer Research; 2016 May 15-17; Niagra Falls, ON, Canada.

All Products Cited: PAPP-A (pico) ELISA AL-101; IGF-I (Free) ELISA AL-122; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128

 

Hjortebjerg R, Espelund U, Rasmussen TR, Folkersen B, Steiniche T, Georgsen JB, Oxvig C, Frystyk J. Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer. Front Endocrinol (Lausanne). 2020 Sep 2;11:614. doi: 10.3389/fendo.2020.00614. PMCID: PMC7492290.

All Products Cited: PAPP-A (pico) ELISA AL-101; PAPP-A2 AL-109

 

Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J. The IGF–PAPP-A–Stanniocalcin axis in serum and ascites associates with prognosis in patients with ovarian cancer. Int J Mol Sci. 2024;25(2014):1-16. doi:10.3390/ijms25042014.

All Products Cited: IGF-II ELISA AL-131; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109; Stanniocalcin 2 ELISA AL-143

 

Jepsen MR, Kloverpris S, Mikkelsen JH, Pedersen JH, Fuchtbauer EM, Lisbeth S, Laursen LS, Oxvig C. Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis. J. Biol. Chem. 2015 290: 3430

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Kashyap S, Hein KZ, Chini CC, Lika J, Warner GM, Bale LK, Torres VE, Harris PC, Oxvig C, Conover CA, Chini EN. Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. JCI Insight. 2020 Feb 27;5(4):e135700. doi: 10.1172/jci.insight.135700. PMID: 31990681; PMCID: PMC7101148.

All Products Cited: PAPP-A Antibodies; PAPP-A (pico) ELISA AL-101

 

Marouli E, Graff M, Medina-Gomez C, et al. Rare and low-frequency coding variants alter human adult height. Nature. 2017 Feb 9;542(7640):186-190. doi: 10.1038/nature21039

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Mikkelsen JH1, Resch ZT, Kalra B, Savjani G, Kumar A, Conover CA, Oxvig C. Indirect targeting of IGF receptor signaling in vivo by substrate-selective inhibition of PAPP-A proteolytic activity. Oncotarget. 2014 Jan ; 5(4):1014-25.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Polyzos SA, Perakakis N, Boutari C, Kountouras J, Ghaly W, Anastasilakis AD, Karagiannis A, Mantzoros CS. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e390–400. doi: 10.1210/clinem/dgz172. PMID: 31690932; PMCID: PMC7112980.

All Products Cited: GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; MPGF ELISA AL-175; Oxyntomodulin ELISA AL-139; Follistatin-Like 3 ELISA AL-152; Activin B ELISA AL-150; IGF-I (Total) ELISA AL-121; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; PAPP-A (pico) ELISA AL-101

 

Thomsen J, Hjortebjerg R, Espelund U, Ørtoft G, Vestergaard P, Magnusson NE, Conover CA, Tramm T, Hager H, Høgdall C, Høgdall E, Oxvig C, Frystyk J. PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma. Oncotarget. 2015 Oct 13;6(31):32266-78.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

Torres D, Hou X, Bale L, Heinzen EP, Maurer MJ, Zanfagnin V, Oberg AL, Conover C, Weroha SJ. . Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A. PLoS One. 2019 Nov 21;14(11):e0224564. doi: 10.1371/journal.pone.0224564

All Products Cited: PAPP-A (pico) ELISA AL-101; PAPP-A Antibodies

 

Zhong Q, Chu H, Wang G, Zhang C, Li R, Guo F, et al. Structural insights into the covalent regulation of PAPP-A activity by proMBP and STC2. Cell Discov. 2022;8(137):1-17. doi:10.1038/s41421-022-00502-2.

All Products Cited: PAPP-A (pico) ELISA AL-101

 

PAPP-A CLIA AL-206
Kumar A, Kalra B, Patel A, Oxvig C. Development of a well characterized Total PAPP-A chemiluminescent assay for maternal serum evaluation. Poster session presented at the 94th Annual Endocrine Society Meeting; 2012 Jun 23-26; Houston, TX.

All Products Cited: PAPP-A CLIA AL-206

 

PAPP-A ELISA AL-106
Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Buhimschi IA, Zhao G, El Helou Y, Frye LJ, Winikoff B, Raymond EG. . Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational Age. J Appl Lab Med. 2021 Jul 30;jfab057. doi: 10.1093/jalm/jfab057

All Products Cited: PAPP-A ELISA AL-106

 

Donegan D, Bale LK, Conover CA. PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy. J Endocrinol. 2016 Oct;231(1):71-80. doi: 10.1530/JOE-16-0205. Epub 2016 Aug 12. PMID: 27519211.

All Products Cited: PAPP-A ELISA AL-106; IGFBP-3 (Total) ELISA AL-120; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; IGF-I (Total) ELISA AL-121; IGF-II ELISA AL-131

 

Espelund U, Renehan AG, Cold S, Oxvig C, Lancashire L, Su Z, Flyvbjerg A, Frystyk J. Prognostic relevance and performance characteristics of serum IGFBP-2 and PAPP-A in women with breast cancer: a long-term Danish cohort study. Cancer Med. 2018;7(6):2391-2404. doi:10.1002/cam4.1504.

All Products Cited: PAPP-A ELISA AL-106

 

Espelund US, Bjerre M, Hjortebjerg R, Rasmussen TR, Lundby A, Hoeflich A, Folkersen BH, Oxvig C, Frystyk J. Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3526-3534.

All Products Cited: PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Frye LJ, Buhimschi IA, Raymond EG, Zhao G, Winikoff B. PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use population. Biomark Med. 2023;17(2):73-85. doi:10.2217/bmm-2022-0653.

All Products Cited: PAPP-A ELISA AL-106

 

Gude MF, Hjortebjerg R, Oxvig C, Thyø AA, Magnusson NE, Bjerre M, Pedersen SB, Frystyk J. PAPP-A, IGFBP-4 and IGF-II are secreted by human adipose tissue cultures in a depot-specific manner. Eur J Endocrinol. 2016 Dec;175(6):509-519. doi: 10.1530/EJE-16-0569. Epub 2016 Sep 1. PMID: 27585595.

All Products Cited: PAPP-A ELISA AL-106

 

Hjortebjerg R, Pedersen DA, Mengel-From J, Jørgensen LH, Christensen K, Frystyk J. Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins. Front Endocrinol (Lausanne). 2023;14:1193742. doi:10.3389/fendo.2023.1193742.

All Products Cited: IGF-II ELISA AL-131; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Hjortebjerg R, Rasmussen LM, Gude MF, Irmukhamedov A, Riber LP, Frystyk J, De Mey JGR. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients. J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa617. doi: 10.1210/clinem/dgaa617. PMID: 32875328.

All Products Cited: IGF-I (Total) ELISA AL-121, IGFBP-4 (Intact) ELISA AL-126, Stanniocalcin 2 ELISA AL-143; PAPP-A ELISA AL-106

 

Hjortebjerg R, Thomsen KL, Agnholt J, Frystyk J. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. BMC Gastroenterol. 2019 Jun 3;19(1):83. doi: 10.1186/s12876-019-1000-6. PMID: 31159802; PMCID: PMC6547608.

All Products Cited: PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Keikkala E, Forstén J, Ritvos O, Stenman UH, Kajantie E, Hämäläinen E, Räikkönen K, Villa PM, Laivuori H. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women. Pregnancy Hypertens: . 2021 Aug;25:116-122.doi: 10.1016/j.preghy.2021.05.024. Epub 2021 Jun 2.

All Products Cited: Inhibin A ELISA AL-123; PAPP-A2 ELISA AL-109; PAPP-A ELISA AL-106

 

Lambert-Messerlian GM, Eklund EE, Neveux LM, Palomaki GE. Measuring maternal serum screening markers for Down’s syndrome in plasma collected for cell-free DNA testing. J Med Screen. 2017 Sep;24(3):113-119.

All Products Cited: PAPP-A ELISA AL-106; Inhibin A ELISA AL-123

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Salameh M, Lee J, Palomaki G, Eklund E, Curran P, Suarez JAR, Lambert-Messerlian G, Bourjeily G. . Snoring and markers of fetal and placental wellbeing. Clin Chim Acta. 2018 Oct;485:139-143. doi: 10.1016/j.cca.2018.06.039

All Products Cited: PAPP-A ELISA AL-106

 

PAPP-A2
PAPP-A2 CLIA AL-209
Kalra B, Kumar A, Tran A, Oxvig C. Development of a well characterized PAPP-A2 chemiluminescence assay to measure PAPP-A2 in maternal biological fluids. Poster session presented at American Association for Clinical Chemistry; 2012 Jul 16-19; Los Angeles, CA.

All Products Cited: PAPP-A2 CLIA AL-209

 

PAPP-A2 ELISA AL-109
Babiker A, Al Noaim K, Al Swaid A, et al. Short stature with low insulin-like growth factor 1 availability due to pregnancy-associated plasma protein A2 deficiency in a Saudi family. Clin Genet. 2021;100(5):601-606. doi: 10.1111/cge.14030.

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Intact) ELISA AL-128; IGFBP-4 (Total) ELISA AL-126; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Cabrera-Salcedo C, Mizuno T, Tyzinski L, Andrew M, Vinks AA, Frystyk J, Wasserman H, Gordon CM, Hwa V, Backeljauw P, Dauber A. Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4568-4577.

All Products Cited: PAPP-A2 ELISA AL-109; IGF-I (Free) ELISA AL-122

 

Dauber A, et al. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol Med. 2016 Mar 31;8(4):363-74.

All Products Cited: PAPP-A2 ELISA AL-109

 

Dereke J, Nilsson C, Strevens H, Landin-Olsson M, Hillman M. Pregnancy-associated plasma protein-A2 levels are increased in early-pregnancy gestational diabetes: a novel biomarker for early risk estimation. Diabet Med. 2020 Jan;37(1):131-137. doi: 10.1111/dme.14088. Epub 2019 Aug 14.

All Products Cited: PAPP-A2 ELISA AL-109

 

DiPrisco B, Kumar A, Kalra B, Savjani GV, Michael Z, Farr O, Papathanasiou AE, Christou H, Mantzoros C. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019 Nov;100:153959. doi: 10.1016/j.metabol.2019.153959. Epub 2019 Aug 8.

All Products Cited: IGF-II ELISA AL-131; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109

 

Espelund US, Bjerre M, Hjortebjerg R, Rasmussen TR, Lundby A, Hoeflich A, Folkersen BH, Oxvig C, Frystyk J. Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3526-3534.

All Products Cited: PAPP-A ELISA AL-106; PAPP-A2 ELISA AL-109

 

Fought AJ, Kuhn K, Schauer IE, Zhang H, D’Alessandro A. Maternal obesity in early pregnancy is associated with decreased active IGF-I availability and increased leptin concentrations. J Endocr Soc. 2019;3(Supplement_1). doi:10.1210/js.2019-SAT-LB045.

All Products Cited: PAPP-A2 ELISA AL-109; Inhibin A ELISA AL-123

 

Frystyk J, Teran E, Gude MF, Bjerre M, Hjortebjerg R. Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology. Growth Horm IGF Res. 2020 Aug-Oct;53-54:101330. doi: 10.1016/j.ghir.2020.101330. Epub 2020 Jul 4. PMID: 32693362.

All Products Cited: Stanniocalcin 2 ELISA AL-143; PAPP-A2 ELISA AL-109

 

Fujimoto M, Khoury JC, Khoury PR, Kalra B, Kumar A, Sluss P, Oxvig C, Hwa V, Dauber A. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. European journal of endocrinology, 182(3), 363–374. https://doi.org/10.1530/EJE-19-0859

All Products Cited: IGF-I (Total) AL-121; IGF-I (Free) AL-122; IGFBP-3 (Total) AL-120; IGFBP-3 (Intact) AL-149; PAPP-A2 AL-109

 

Hansen YB, Myrhøj V, Jørgensen FS, Oxvig C, Sørensen S. First trimester PAPP-A2, PAPP-A and hCGβ in small-for-gestational-age pregnancies. Clin Chem Lab Med. 2016 Jan;54(1):117-23. doi: 10.1515/cclm-2015-0230. PMID: 26544105.

All Products Cited: PAPP-A2 ELISA AL-109

 

Hjortebjerg R, Espelund U, Rasmussen TR, Folkersen B, Steiniche T, Georgsen JB, Oxvig C, Frystyk J. Pregnancy-Associated Plasma Protein-A2 Is Associated With Mortality in Patients With Lung Cancer. Front Endocrinol (Lausanne). 2020 Sep 2;11:614. doi: 10.3389/fendo.2020.00614. PMCID: PMC7492290.

All Products Cited: PAPP-A (pico) ELISA AL-101; PAPP-A2 AL-109

 

Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J. The IGF–PAPP-A–Stanniocalcin axis in serum and ascites associates with prognosis in patients with ovarian cancer. Int J Mol Sci. 2024;25(2014):1-16. doi:10.3390/ijms25042014.

All Products Cited: IGF-II ELISA AL-131; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109; Stanniocalcin 2 ELISA AL-143

 

Kalra B, Kumar A, Tran A, Oxvig C, Shah S. Development of a well characterized PAPP-A2 ELISA to measure PAPP-A2 in maternal biological fluids. Poster session presented at the 94th Annual Endocrine Society Meeting; 2012 Jun 23-26; Houston, TX.

All Products Cited: PAPP-A2 ELISA AL-109

 

Keikkala E, Forstén J, Ritvos O, Stenman UH, Kajantie E, Hämäläinen E, Räikkönen K, Villa PM, Laivuori H. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women. Pregnancy Hypertens: . 2021 Aug;25:116-122.doi: 10.1016/j.preghy.2021.05.024. Epub 2021 Jun 2.

All Products Cited: Inhibin A ELISA AL-123; PAPP-A2 ELISA AL-109; PAPP-A ELISA AL-106

 

Kloverpris S, Gaidamauskas E, Rasmussen LCV, Overgaard MT, Kronborg C, Knudsen UB, Christiansen M, Kumar A, Oxvig C. A robust immunoassay for pregnancy-associated plasma protein-A2 based on analysis of circulating antigen: Establishment of normal ranges in pregnancy. Mol. Hum. Reprod. first published online June 25, 2013.

All Products Cited: PAPP-A2 ELISA AL-109

 

Kumar A, Kalra B, Patel AS, Kommareddy V, Savjani G, Nagalla S. Novel Biochemical Markers Help Aid in Stratifying Patients at Risk of Preeclampsia and Adverse Events. Poster presented at AACC Meeting; 2018 July 30-Aug 2; Chicago, IL

All Products Cited: Glycosylated Fibronectin ELISA AL-160; PAPP-A2 ELISA AL-109

 

Munnangi S, Gross S, Madankumar R, Salcedo G, Reznik S. Pregnancy associated plasma protein-A2: A novel biomarker for down syndrome. Placenta. 35 (2014): 900-906.

All Products Cited: PAPP-A2 ELISA AL-109

 

Neuman RI, Alblas van der Meer MM, Nieboer D, Saleh L, Verdonk K, Kalra B, Kumar A, Alpadi K, van den Meiracker AH, Visser W, Danser AHJ. PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia. J Am Heart Assoc. 2020 Oct 20;9(19):e018219. doi: 10.1161/JAHA.120.018219. Epub 2020 Sep 29. PMID: 32990126.

All Products Cited: Inhibin A ELISA AL-123; PAPP-A2 ELISA AL-109

 

Neuman RI, Alblas van der Meer MM, Nieboer D, Saleh L, Verdonk K, Kalra B, Kumar A, Alpadi K, van den Meiracker AH, Visser W, Danser AHJ. PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia. J Am Heart Assoc. 2020 Oct 20;9(19):e018219. doi: 10.1161/JAHA.120.018219. Epub 2020 Sep 29. PMID: 32990126.

All Products Cited: PAPP-A2 ELISA AL-109; Inhibin A ELISA AL-123

 

Nimptsch K, Aydin EE, Chavarria RFR, Janke J, Poy MN, Oxvig C, Steinbrecher A, Pischon T. Pregnancy-associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2), but not PAPP-A, are associated with circulating total IGF-1 in a human adult population. Sci Rep. 2024;14:1770. doi:10.1038/s41598-024-52074-8.

All Products Cited: PAPP-A2 ELISA AL-109; IGF-I (Free) ELISA AL-122

 

Parry S, McCarthy C, Devine A, Leite R. Markers of placental dysfunction and spontaneous preterm birth. Amer Jour Obst Gyne, January 2020, Volume 222, Issue 1, Supplement S1-S760 (SMFM 40th Annual Meeting–The Pregnancy Meeting)

All Products Cited: PAPP-A2 ELISA AL-109; IGFBP-4 (Total) ELISA AL-128

 

Steinbrecher A, Janke J, Poy MN, Oxvig C, Pischon T. Pregnancy-Associated Plasma Protein-A2 and Anthropometry, Lifestyle, and Biochemical Factors in a Human Adult Population. Sci Rep. 2017 Sep 5;7(1):10455.

All Products Cited: PAPP-A2 ELISA AL-109

 

Wang J, Hu H, Liu X, Zhao S, Zheng Y, Jia Z, Chen L, Zhang C, Xie X, Zhong J, Dong Y, Liu J, Lu Y, Zhao Z, Zhai Y, Zhao J, Cao Z. Predictive values of various serum biomarkers in women with suspected preeclampsia: A prospective study. J Clin Lab Anal. 2021 May;35(5):e23740. doi: 10.1002/jcla.23740. Epub 2021 Feb 22

All Products Cited: PAPP-A2 ELISA AL-109; Glycosylated Fibronectin ELISA AL-160

 

Proglucagon
Proglucagon ELISA AL-1019
Stefanakis K, Kokkinos A, Argyrakopoulou G, et al. Circulating levels of proglucagon derived peptides are differentially regulated by the glucagon like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study. Diabetes Obes Metab. 023;25(9):2561‐2574. doi:10.1111/dom.15141

All Products Cited: C-Peptide of Insulin ELISA AL-151; Glicentin ELISA AL-185; GLP-1 ELISA AL-172; GLP-2 ELISA AL-174; Glucagon ELISA AL-157; Proglucagon ELISA AL-1019; MPGF ELISA AL-175; Oxyntomodulin AL-139

 

Stanniocalcin 2
Stanniocalcin 2 ELISA AL-143
Cediel G, Rueda F, Oxvig C, Oliveras T, Labata C, de Diego O, Ferrer M, Aranda-Nevado MC, Serra-Gregori J, Núñez J, García C, Bayes-Genis A. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction. Cardiovasc Diabetol. 2018 Apr 30;17(1):63. doi: 10.1186/s12933-018-0710-3.

All Products Cited: Stanniocalcin 2 ELISA AL-143; PAPP-A (pico) ELISA AL-101; IGFBP-4 (Intact) ELISA AL-128

 

Frystyk J, Teran E, Gude MF, Bjerre M, Hjortebjerg R. Pregnancy-associated plasma proteins and Stanniocalcin-2 – Novel players controlling IGF-I physiology. Growth Horm IGF Res. 2020 Aug-Oct;53-54:101330. doi: 10.1016/j.ghir.2020.101330. Epub 2020 Jul 4. PMID: 32693362.

All Products Cited: Stanniocalcin 2 ELISA AL-143; PAPP-A2 ELISA AL-109

 

Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J. The IGF–PAPP-A–Stanniocalcin axis in serum and ascites associates with prognosis in patients with ovarian cancer. Int J Mol Sci. 2024;25(2014):1-16. doi:10.3390/ijms25042014.

All Products Cited: IGF-II ELISA AL-131; PAPP-A (pico) ELISA AL-101; PAPP-A2 ELISA AL-109; Stanniocalcin 2 ELISA AL-143

 

Hjortebjerg R, Pedersen DA, Mengel-From J, Jørgensen LH, Christensen K, Frystyk J. Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins. Front Endocrinol (Lausanne). 2023;14:1193742. doi:10.3389/fendo.2023.1193742.

All Products Cited: IGF-II ELISA AL-131; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Hjortebjerg R, Rasmussen LM, Gude MF, Irmukhamedov A, Riber LP, Frystyk J, De Mey JGR. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients. J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa617. doi: 10.1210/clinem/dgaa617. PMID: 32875328.

All Products Cited: IGF-I (Total) ELISA AL-121, IGFBP-4 (Intact) ELISA AL-126, Stanniocalcin 2 ELISA AL-143; PAPP-A ELISA AL-106

 

Hjortebjerg R, Thomsen KL, Agnholt J, Frystyk J. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. BMC Gastroenterol. 2019 Jun 3;19(1):83. doi: 10.1186/s12876-019-1000-6. PMID: 31159802; PMCID: PMC6547608.

All Products Cited: PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Martín-Rivada Á, Guerra Cantera S, Campillo-Calatayud A, Andrés-Esteban EM, Sánchez Holgado M, Martos-Moreno GÁ, Pozo J, Güemes M, Soriano-Guillén L, Pellicer A, Oxvig C, Frystyk J, Chowen JA, Barrios V, Argente J. Pappalysins and Stanniocalcin and Their Relationship With the Peripheral IGF Axis in Newborns and During Development. J Clin Endocrinol Metab. 2022 Sep 28;107(10):2912-2924. doi: 10.1210/clinem/dgac453. PMID: 35902207.

All Products Cited: IGF-I (Free) ELISA AL-122; IGF-I ELISA AL-120; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; PAPP-A ELISA AL-106; Stanniocalcin 2 ELISA AL-143

 

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. PMID: 33493282.

All Products Cited: Follistatin ELISA AL-117; Follistatin-Like 3 ELISA AL-152; Activin A ELISA AL-110; Activin B ELISA AL-150; Stanniocalcin 2 ELISA AL-143; IGF-I (Free) ELISA AL-122

 

Rodríguez-Lorenzo S, Francisco DMF, Vos R, van het Hof B, Rijnsburger M, Schroten H, et al. Altered secretory and neuroprotective function of the choroid plexus in progressive multiple sclerosis. Acta Neuropathol Commun. 2020;8(35):1-13. doi:10.1186/s40478-020-00903-y.

All Products Cited: Stanniocalcin2 ELISA AL-143

 

Vicente Barrios, Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Sandra Canelles, Francisca Moreno-Macián, Carmen De Mingo-Alemany, Maurizio Delvecchio, Roberta Pajno, Danilo Fintini, Julie A Chowen, Jesús Argente, Increased IGFBP Proteolysis, IGF-I Bioavailability, and Pappalysin Levels in Children With Prader-Willi Syndrome, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024, Pages e1776–e1786, https://doi.org/10.1210/clinem/dgad754

All Products Cited: IGF-I (Total) ELISA AL-121; IGF-I (Free) ELISA AL-122; IGF-II ELISA AL-131; IGFBP-3 (Total) ELISA AL-120; IGFBP-3 (Intact) ELISA AL-149; IGFBP-4 (Total) ELISA AL-126; IGFBP-4 (Intact) ELISA AL-128; IGFBP-5 ELISA AL-127; Stanniocalcin 2 ELISA AL-143